Pneumovax VAERS
[back] VAERS  [back] Pneumovax

PNEUMO, 23-VALENT (PNEUMOVAX)
Learn about PNEUMO, 23-VALENT (PNEUMOVAX) serious adverse events reported to Food and Drug Administration (FDA).
Total reports: 2651
Reported hospitalizations: 1294      Reported deaths: 40

 

http://patientville.com/vaccine/pneumo31_side_effects.htm

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. On 12-29-05 patient stated that he was unable to move his left arm. On Friday, a nurse at the senior center looked at his arm and said that it was warm to touch and reddened from his shoulder to his elbow..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pt developed 2-3 blister reaction within 24 hr. pain swelling. Pt was seen rx with Prednisone, Claritin. Pt was seen again drained the tense blister clear serous fluid drained..Patient was receiving Aspirin Oral 81mg (1 tablet qd), Glucophage 500mg (1 tab po bid), Keflex 500mg (1 tab po tid), Lipitor 20mg (1 QD), Prednisone 10mg (40 MG PO ONCE DAILY X 5 DAYS), Vicodin 5-500mg (1 tablet po q 6 hours-prn pain), Zoloft 50mg (1 tab po qd).Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 09. Client had pain in arm in the evening after shot given. Took 2 Tylenols before going to bed. Awoke to fine arm reddened, warm and a little sore.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 19. Information has been received from a office manager in a physicians office concerning an adult male with asthma who on Dec 19 2005 was vaccinated intramuscularly in the left arm with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). Concomitant therapy included unspecified inhalers for the treatment of asthma. On Dec 21 2005, the patient presented to the physicians office with left arm tenderness to touch, slight swelling, and a rash that encircled the arm like a bracelet. It was.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a 92 year old female who in approximately 1978 (at age 65) was vaccinated with Pneumococcal 23v polysaccharide vaccine (pneumococcal 23v polysaccharide vaccine was approved Jul 07 1983). On Dec 20 2005, the patient contracted pneumonia and was hospitalized. Chest x ray and unspecified labs indicated that streptococcal pneumoniae may be involved. The patients pneumonia was reported as not recovered. Pneumonia was considered to be immediately life thre.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. Subsequently. the patient recovered from injection site tenderness, injection site redness and fluid collection which progressed down arm. Injection site tenderness, injection site redness and fluid collection which.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. Subsequently, the patient recovered from injection site tenderness, injection site redness and also fluid collection which progressed down arm. Injection site tenderness, injection site redness and also fluid collect.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. Subsequently, the patient recovered from injection site tenderness, injection site redness and fluid collection which progressed down arm. Injection site tenderness, injection site redness and fluid collection which prog.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. The patient received antibiotic treatment. Subsequently, the patient recovered from injection site tenderness, injection site redness and fluid collection which progressed down arm. Injection site tenderness, injecti.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an office nurse concerning a patient who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently the patient experienced injection site tenderness, injection site redness and also fluid collection which progressed down arm. The patient received antibiotic treatment. Subsequently, the patient recovered from injection site tenderness, injection site redness and fluid collection which progressed down arm. Injection site tenderness, injecti.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 09. Case received form another manufacturer on Dec 22 2005 under the reference number WAES0511USA01987. It was initially reported by a health care professional that a 66 year old female patient received a dose of Fluzone no preservative 2005-2006, lot number U1825EA, intra muscularly in the left deltoid and a dose of Pneumovax 23, lot number 651318/1006P, intra muscularly in the right deltoid. The next day, the patient developed a fever of 102 degrees F. In addition, she had redness, swelling, pain and warmth o.Patient was receiving Crestor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Initial report received on Dec 22 2005 from another manufacturer, report WAES0511USA03324. A 62 year old female patient with a history of hypertension was vaccinated in the left deltoid with her first dose of Fluzone no preservative 2005-2006, lot number U1825EA and in the right deltoid with a 0.5 ml first dose of another manufacturers Pneumovax 23 vaccine, lot number 650082/0691P on Nov 10 2005. On Nov 12 2005 at 8:30 the patient was seen by a physician and presented with redness and swelling at the inject.Paient has the following illness history - The patient has a pre existing condition of hypertension..Patient was receiving Lipitor, Plavix..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 21. Patient received Fluzone and Pneumovax in left deltoid at 11:00am on 10/21/05. Later that evening her left arm became very painful, red and swollen. She sent to the ER that evening and then x2 on 10/22/05 with continued pain.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 27 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Right upper arm erythema and induration with extension to the axilla, associated with axillary adenopathy. Fevers and chills noted at onset of symptoms. PCP prescribed Keflex.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 04. Left arm is very swollen and red. Pt c/o 7/10 left arm pain. C/o limited ROM of left arm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 29. Hives and itching symptoms. Seen by doctor and given Zyrtec..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pt states 2 days after vaccine administered had redness, swelling, itching, cellulitis in area Pneumococcal vaccine administered..Paient had Well Adult.Paient has the following illness history - Sulfa.Patient was receiving Hyzarr 50/12.5mg Crestor 10mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 06. Information has been received from a registered nurse concerning a female patient who on 06-Oct-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot # 650087/0815P). On 07-Oct-2005 the patient experienced injection site reaction with an extremely high fever (103 F), soreness/body aches, nausea and vomiting. The patient was treated with cephalexin. Subsequently, the patient recovered from the injection site reaction, fever, soreness/body aches, nausea and vomiting on an unspecified date. The.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 19. Information has been received from an office manager concerning a 29 year old female with a drug allergy to acetaminophen (+) oxycodone hydrochloride (TYLOX) and asthma who on 19-Dec-2005 was vaccinated intramuscularly in the left arm with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot #650329/0747P). Concomitant therapy included fluticasone propionate (FLOVENT). On 21-Dec-2005 the patient presented to the office with left arm swelling from the shoulder to the bend of her elbow, hive type bum.Patient was receiving Flovent.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WY, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. 4 inch band around arm approximately 2 inches below injection site, red hot, swollen. Neck swollen under chin area, tender to touch, no fever. During time for reporting in office, arm decreased in color and temperature. Patient states she received a pneumonia shot in 1994..Paient has the following illness history - Anemia, Spinal cord tumor, many severe allergies, TMJ, Chronic Fatigue Syndrome, Carpal Tunnel Syndrome, Migraines, Endometriosis..Patient was receiving Ritalin, Allegra, Vanconase, Benadryl, Nexium. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Within about 4-24 hours the patient noted her arm becoming red, painful and swollen down to her finger tips. She had difficulty getting dressed due to the pain and edema today..Paient has the following illness history - Patient denied. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 11. Patient received pneumonia vaccine 10/11/05 on 10/12/05 area (L deltoid) was painful and red. Patient noted "streaks"; reported to Health Department. I referred him to his physician. Upon follow-up with patient, I found his physician had him take "allergy medicine" and redness and pain subsided.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 19. 12-21-05 erythemia at injection site and pain on axilla-clarinex 5mg x 7day on Amoxicillin for dental infection..Paient had Dental infection. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Redness and swelling at injection site. Swelling extended to the elbow from the shoulder.Paient had Diabetes.Paient has the following illness history - Kearne-Sayre Syndrome; Diabetes; Elevated Cholesterol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. A slight red area appeared on 12/29/05 on upper L arm. Area is 2.5 x3. Not warm to the touch but is tender. Patient having no problems with movement in the extremity. Dad of patient not sure if she is receiving Tylenol or Benadryl. Advised to use Tylenol for the soreness and warm compresses.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 56 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Patient developed redness and swelling at injection site into armpit/lymph nodes and up shoulder lasting for 2 days. No fever developed. Area felt hot to touch..Paient has the following illness history - Allergy-nuts.Patient was receiving Bromide 1cc SC right arm given since day received IV Glutathione 7cc and 10cc phospholipid choline IV. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 15. Within 24 hours of injection patient reported increased swelling, increased pain left arm and redness to entire body. No itching, no difficulty breathing. On return to clinic pain and swelling had improved, no redness seen to body. Very slight swelling of injection arm - well below injection site with slight warmth - no redness to site. Within 2 days no symptoms..Paient had NO.Paient has the following illness history - Allergy to IVP dye.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning a female who was vaccinated IM in the deltoid with a standard 0.5 nl dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R or 650083/0746P). Subsequently the patient developed arm swelling and pain. The pain in her arm caused the patient to fall and break her hip. Unspecified medical attention was sought the patients outcome was unknown. There was no product quality complaint involved. Upon internal review, the patient's hip fracture was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. After 24 hrs-next day: 1)L arm slight swollen and red at the site; 2)Arm moved only with difficulty and pain; 3)Lymph glands in axilla swollen and painful; 4)pain across back and down L breast when movement of arms..Paient has the following illness history - Metamucil, Penicillin, Phenobarbital.Patient was receiving Vitamins, Quinine Sulfate, Estrogen patch. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 27. Information has been received from a health professional concerning an 83 year old female with hypertension, high cholesterol and a shellfish allergy who on Dec 27 2005 was vaccinated IM in the left arm with a second 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Concomitant therapy included lisinopril (Zestril), warfarin sodium (Coumadin), potassium chloride (K Dur), furosemide (Lasix Furosemide), metoprolol succinate (Toprol XL Tablets), atorvastatin calcium (Lipitor), sertrali.Paient has the following illness history - Hypertension, Cholesterol high, shellfish allergy..Patient was receiving Xanax;Lipitor;Nexium;Lasix (Furosemide);Imdur;Zestril;Toprol XL Tablets; K-DUR;Zoloft;Coumadin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 09. Vaccine given SQ left lateral inferior arm, 10cmx 7 cm redness, induration 4x4cm. Tx to include Benadryl , warm pack and f/u 1-12-06 in clinic for re-eval..Paient has the following illness history - Advil-rash.Patient was receiving Aricept, Celebrex, Oxybutynin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NJ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 14. Information has been received from a nurse concerning a 57 year old white female (previously reported as 72 year old female) with asthma and no history of adverse drug reactions or allergies. On Dec 14 2005, the patient was vaccinated intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Concomitant therapy included levothyroxine (Levoxyl), pirbuterol acetate (Maxair), fluticasone propionate + salmeterol xinafoate (Advair) and bupropion HCL (Wellbutrin). On Dec 15.Paient has the following illness history - Asthma.Patient was receiving Wellbutrin, Advair, Levoxyl, Maxair.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 03. L arm and erythema distal to and at site of injection with warmth or tender to touch. Patient states that 2 o'clock after injection L arm began to be sore and red and progressed through the day and night. Patient given Allegra 60mg, Medrol Dose Pack-offered pain med-pt declined pain medicine.Paient has the following illness history - NFDA, Hyperlipidemia, Prostate CA-stable.Patient was receiving Lipitor 40mg 1/2 qid.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 09. Numbness and weakness in legs progressed to arms, face about 1 week before presenting to physician 12/27/05. Tx: IVIG. Diagnosed GBS..Paient has the following illness history - Asthma; GERD; S/P knee replacement.Patient was receiving ASA; Nexium; Pulmicort; Singulair; Milk thistle. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Fluzone vaccine administered by accident. Patient had local reaction at age 19. She has never had the flu vaccine since. Patient reacted with redness and itchiness..Paient had Arthritis flare.Paient has the following illness history - NIDDM, HTN, GERD, CVA, Asthma, Allergies, Diverticulosis, Gastric bypass.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 20. Patient received pneumococcal vaccine, lot# 0877R, right deltoid in clinic 12/20/05. Called office 12/22/05 to report right deltoid pain, itching, redness, swelling at injection site, et syncope on 12/20/05. Advised to go to ER. 12/23/05 notified patient at ER with fever 103, severe body myalgias, HA, suspects meningitis. Work up for meningitis was negative. WBC 20,000. Patient was discharged 12/27/05..Paient has the following illness history - No known allergies. Congenital Heart Disease - ASD..Patient was receiving Elidel PRN, Klonopin 0.5 mg PRN anxiety, Lexapro 20 mg daily..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 39 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 20. Patient received Pneumococcal Pneumovax vaccine IM right deltoid lot #0605R. Called 12/22/05 to report right arm swelling, heat, itching, underarm pain. Advised patient to take allegra and ibuprofen. 12/23/05 called patient. Patient doing better, pain gone, swelling improved..Paient has the following illness history - No known allergies. Congenital Heart Disease.S/P coarctation repair..Patient was receiving Paxil 20 mg PO Daily, Albuterol inhalation daily, Allegra D PO Daily PRN, Xanax PRN, Tenormin 25 mg PO BID. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 28. Patient went to ER with local reaction to left arm from pneumovax 23 lot #0740R. Swelling, pain at site..Paient has the following illness history - CAD, HTN, hyperlipidemia..Patient was receiving diprolene 0.05mg, lisinopril 20 mg, lisinopril/HTCZ 20/25, allergra 180 mg daily, toprol XL 125 mg daily, zocor 20 mg qhs, colace 100 mg bid, ASA 325 mg daily..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 15. Patient Recieved Pneumovax for pneumonia vaccine and was a little nervous because of her severe allergy to different types of nuts. 5 - 10 minutes after her vaccination she felt fine. About 20 - 25 minutes later, the patient felt a bit warm and felt like she was itching all over. She described it as wearing wool. She was a little red and felt like she had a couple of red marks on her. She otherwise felt fine. She was administerd 50 mg of oral Benadryl and rested in a chair for 30- 40 minutes. The patient fe.Paient has the following illness history - nut, erythromycin, penicillin, sulfa allergy. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 12. PT REPORTED RASH FROM SHOULDER TO ELBOW, SLIGHTLY ITCHY, TX'D WITH BENADRYL 25MG, RASH GONE IN 4 DAYS..Paient has the following illness history - HTN, GERD, SEASONAL ALLERGIES, MILD OA.Patient was receiving HCTZ, METOPROLOL, NEXIUM, RANITADINE, ALLEGRA, CALCIUM, FOLIC ACID, GLUCOSAMINE, FLAXSEED. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 22. Vaccine administered in left deltoid 11am 12/22/05. Patient states arm swelled, red, painful to touch by 8pm on 12/22/05. Reported to Dr. on 12/23/05. States arm is improving and will use Benadryl for reaction.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WV, USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 09. Swollen, red, hot L arm.Paient has the following illness history - armpit/hot-rash. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 29. This patient who was hospitalized for endometrial cancer was administered a pneumococcal vaccine on 08/29/2005. On 08/30/2005 she noticed increased pain and swelling at the pneumococcal injection site. The inflamed area around the injection site was 2 inches. The affected area was warm to the touch and was treated with ice packs. The patient was prescribed Benadryl orally 25-50 mg as needed..Paient had endometrial cancer.Patient was receiving dalteparin, lorazepam, oxycodone, Coumadin, Colace. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 21. Information has been received from a physician concerning an 83 year old female patient with an iodine allergy who in 21-Dec-2005 was vaccinated in the left deltoid with a dose of pneumococcal 23v polysaccharide vaccine. At the time of vaccination the patient had "PMR", low back pain, atrial arrhythmias, and hypertension. On the same day, 21-Dec-2005, following vaccination, the patient experienced a systemic reaction "following revaccination" and became completely white and stiffened up. Unspecified medical.Paient has the following illness history - Iodine Allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a Registered Nurse concerning a 74 year old male consultant with an allergy to penicillin who on 26-Oct-2005 at 11:00 a.m. was vaccinated IM in left deltoid with his first dose of pneumococcal 23v polysaccharide vaccine (lot #651539/6607R). The patient was ill with chronic sinusitis at the time of vaccination. There was no concomitant medication. On the same day, the patient's left arm became sore. On 27-Oct-2005 the patient felt fatigued and developed redness over left ar.Paient has the following illness history - Penicillin Allergy;Chronic Sinusitis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 22. On 12/23 patient developed fever up to 104 at home. Presents to hosp ER and noted document that left arm demonstrates an area of erythema about the size of a silver dollar, tender to touch and indurated. Fever continued per patients about 12 days. Admitted on 12/31 for evaluation meningitis..Paient has the following illness history - Hx of Pneumonia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 15. Night of vaccine arm was very painful; shoulder and upper arm next morning noticed very swollen and warm. No intervention done lasted about 3-4 days.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 13. R deltoid. Circular red raised, warm, tender to touch, 3x4 circular area..Paient has the following illness history - Yellow dye MSO4-tye#3. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 06. Within 1/2 hour arm became painful and swollen at site. The swelling continued and spread from shoulder to elbow over the next 24-48 hours. Patient contacted an on-call physician and was prescribed Omnicef with 3 doses. About 18 hours the swelling almost totally resolved still had muscle tenderness. No fever..Paient had URI.Paient has the following illness history - No allergies or birth defects. Anorexia nervosa.Patient was receiving Celexa 40mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Patient presents 1/11/06 with L arm swollen, red, hard, warm in large area distal to vaccination sites. No streaking, margins of induration uneven. Denies itching, reports fever. Prescribed Keflex, Motrin and Benadryl..Paient had Abdomen tenderness.Paient has the following illness history - Adult onset diabetes mellitus, Osteoarthritis.Patient was receiving Prilosec, Naprosyn, Tylenol #3, Glipizide.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 14. L deltoid to elbow red, warm and tender to touch.Paient has the following illness history - PCN, erythromycin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 31. Inflamed, hot, hard, fever 101, achiness and neck stiff..Paient has the following illness history - Asthma Gout.Patient was receiving Inderal LA;Allopurinol;Albuterol Inhaler;Flonase;Claritin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 12. Patient received a pneumonia polysaccharide vaccine on 01/12/2006 at 2:30pm. Patient reports that left arm became sore and could not use arm about 3 hours after receiving vaccine. Patient also reports pain in left shoulder and elbows and weakness in knees. Patient also reported having a fever that night with nausea and reporting having flatulence. Patient evaluation on 01/13/2006. Temperature of 99.2 degrees. No swelling in left arm, but tenderness noted in the left bicep and tricep. Patient reports.Paient has the following illness history - Hypertension, Heart Disease.Patient was receiving Vitron, Niacin, Lopressor, Hydrochlorothiazide, Calcium, Aspirin, Potassium, Multivitamin, Ibuprofen.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 22. Chills and sore arm, not sure how long lasted, but did resolve..Paient had No.Paient has the following illness history - Hypertension, Hyperlipidemia, Arthritis, Claudication..Patient was receiving ASA, Celebrex, Plavix, Zocor, HCTZ, Terazasin, Toprol, Zetia, MVI. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 09. Information has been received from a registered nurse concerning a 46 year old female who on 09-Jan-2006 was vaccinated intramuscularly in the right arm with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). Later that same day on 09-Jan-2006, the patient developed redness, pain, swelling, and hardness to her right arm. On 10-Jan-2006, the patient contracted the office to report the symptoms and that she could not lift her right arm. The physician started the patient on therapy wi.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a physician concerning an approximately 80 year old female with type II diabetes mellitus and asthma who on approximately 11/07/2005 was vaccinated SQ with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot # 649914/0578P). Concomitant therapy included an unspecified oral therapy. the physician reported that the patient had been previously vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (date unknown). Subsequently the patient developed redness.Paient has the following illness history - Type II diabetes mellitus;Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a physician concerning a 45 year old female with type II diabetes mellitus who on approximately 11/07/2005 was vaccinated SQ with a dose of Pneumococcal 23v polysaccharide vaccine (lot #649914/0578P) and a dose of influenza virus vaccine (unspecified) into the opposite arm (unspecified). Concomitant therapy included an unspecified oral therapy. Subsequently the patient developed redness, pain and swelling to the arm that was used for the Pneumococcal 23v polysaccharide vac.Paient has the following illness history - Type II Diabetes Mellitus.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Swollen from shoulder to elbow- red and warm to touch. Encourage to apply cold compress and follow up with PMD.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Profound myalgia upper extremities. Myositis. Several days after injection reaction at 6 wks post..Paient has the following illness history - CAD;Hyperlipidemia;Tremors.Patient was receiving Inderal 120mg la and qd;Trental 400mg tid. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Pt come to VNA office 1/12 or 1/13 and said he still had soreness in right arm from pneumonia shot. He had been to see his doctor. His DR told him to get an x-ray first. Rx was dated 11/22/05. He still had not done so..Patient was taken to emergency room. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. On 1/10/06 pt received influenza and pneumococcal vaccine in the left deltoid area. Pt returned on 1/13/06 reporting increased swelling and redness in this area. DR. assessed pt placed on Augmentin 875 mg bid x8 days..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 16. Left arm 16 x 20 cm induration with edge of erythema central pallor, warmth administered 9:30 swelling by 5 pm follow day current description. Right arm 4 x 4.5 cm total erythema, swelling, warmth at sit of Menactra 24 hours later..Paient has the following illness history - Asthma;Allergy to ibuprofen, aspirin;Suspected allergy to shellfish..Patient was receiving Singular 5mg qns;Advair 100/20 one BID; Zyrtec D one BID. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Nurse gave Pneumovax vaccine that had expired on June 2005 to this patient. In talking to the mother on 11/17/05 she reported that child had a red swollen L arm on 11/8/05. Patient had fever(did not take). Mom took child to Dr. who gave oral Benadryl and Tylenol. Arm remained red and swollen on 11/9/05. Child okay within two days and Benadryl and Tylenol. MD to check with another MD about whether to repeat in light of local reaction and child condition. (Sickle cell disease).Paient has the following illness history - Sickle Cell Disease.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DE, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Patient called to report that he had swelling of his upper arm - the same arm the pneumonia shot was given. Swelling subsided by PM 10/28. No redness.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 82 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 09. PATIENT DEVELOPED A RED, SWOLLEN, ITCHY UPPER ARM AT THE ADMINISTRATION SITE WITHIN 12 HOURS OF ADMINISTRATION. PATIENT TREATED WITH STAT ORAL DIPHENYDRAMINE PRESCRIBED BY PHYSICIAN. ALSO PRESCRIBED FOR THE ADVERSE REACTION WAS ATARAX 25MG PO Q 6 HRS PRN X 3 DAYS..Paient had 1/5/06 RESIDENT WAS PRESCRIBED LEVAQUIN 500MG X 10 DAYS AS WELL AS MUCO-FEN DM FOR UPPER RESPIRATORY SYMPTOMS..Paient has the following illness history - ALLERGIC TO PENICILLIN CONGESTIVE HEART FAILURE HYPERTENSION ATRIAL FIBRILLATION GERD.Patient was receiving MUCOFEN-DM, LEVAQUIN, HEPARIN SUB-Q (D/C'D ON 1/6/06) NITROGLYCERIN OINTMENT, CARAFATE, DIGOXIN, COLACE, ASPIRIN, COUMADIN, LASIX, PPD (TUBERSOL) WAS ADMINISTERED UPON ADMISSION TO THE NURSING FACILITY 1/3/06.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 91 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 12. PATIENT DEVELOPED WARM, SWOLLEN, TENDER, REDDENED AREA AT INJECTION SITE..Paient has the following illness history - ALLERGY TO PENICILLINS, SULFA, BACTRIM, PROCARDIA, ISOSORBIDE. CONGESTIVE HEART FAILURE, HYPERTHYROIDISM, HYPERTENSION, CORONARY ARTERY DISEASE.Patient was receiving PPD (TUBERSOL/APLISOL) DONE UPON ADMISSION TO FACILITY AT 1/10/06. AMBIEN 5MG PRN INSOMNIA, PLAVIX, ASPIRIN, ZOCOR, ALTACE, KLOR-CON, PROTONIX, TOPROL XL, LASIX, PRN ZOFRAN. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 03. Pt developed erythema, induration at site of immunization. She presented to the ER as erythema spread down her arm and up shoulder. High fever. Admitted to hospital. Seen by infections disease specialist who felt reaction was cellulitis in hospital x5 days on IV a lot..Paient had Pneumonia.Paient has the following illness history - Patient with Multiple Sclerosis on REBIF.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 36 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 02. Contracted cellulitis within hours of receiving flu shot. Extremely sick almost hospitalized. I was on antibiotics for 14 days..Paient has the following illness history - Penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. 24 hrs status post injection, pt has erythema, edema and pain at site. Pt also with fever of 101 &102, no CP, no SOB..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. I receved flu and pneumococcal vaccine on 11-08-05 were I work at 1:15 pm. The flu shot went in my right arm and pneumococcal in the left arm. I felt some stinging after the pneunococcal shot was given in the left arm but didn't make anything of the situation. By 5:00 PM I went to the office and told the first aid person to look at my left arm because it felt like it was on fire and I couldn't raise my arm. She took one look at it and called the head person of first aid on my shift and decided to take me.Paient had Site reaction and blood poisoning..Paient has the following illness history - Multiple Sclerosis, under active thyroid..Patient was receiving Avonex for treatment M.S., paxil 20mg, clonazepam 1mg levothyroxine 137mg.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 21. On 1/20/06 patient telephoned to Department of Health. Pt. states aprox. 5 days post vaccination(10/21/05) had rash on back, arm leg and feet, which later blistered. Pt. was evaluated by pvt. MD. Pt. states doctor informed her that rash was due to "the flu and/or pneumonia shot". Doctor is on vacation until 1/31/06 and is not available for confirmation. Pt. also states that has blisters on feet and has home health nurses to come weekly to do foot and dressing care. Pt. states had received flu shot before.Paient has the following illness history - HTN.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. PATIENT DEVELOPED CELLULITIS AT THE SITE REQUIRING ANTIBIOTICS APPROXIMATELY TWO DAYS AFTER INJECTION..Paient had HEP C. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, child 10 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 07. Flu and Pneumovax given on Dec 7 2005. Since vaccine running increased fever, malaise, myalgias. And testing CRP, bloodwork etc negative, fever on and off about 6 weeks. Had redness, swelling, tenderness to R arm site 2 days after inject given. Still running on and off fever, malaise, myalgias..Paient had Sinus infection.Paient has the following illness history - Diabetic. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, child 4 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 24. Came into office 1-25-06 complaining of leg pain. Examined by Dr; found to have severe quadricep muscle spasm, fever and swelling to the site of vaccine..Paient had runny nose/cough/congestion (cold).Patient was receiving On Nasonex at time of vaccine. Gave Tylenol and Motrin for pain after vaccine..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Pt received Pneumovax while at her reg office visit pt called back 01/12/2006 to report increased redness, warmth, edema left arm and painful symptoms resolving now after cold packs and Benadryl PRN.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Pt c/o 12-24 hours after receiving Pneumovax. Pt c/o swelling, redness, warmth from deltoid to elbow. Aches also, resolved 72 hours after shots..Paient has the following illness history - Allergic Sulfa, Naprosyn.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 13. Tongue swelled that evening, he was treated in ER with Cortisone and Benadryl and problem resolved by the next day..Paient has the following illness history - Diabetes, Hypercholesterolemia, Hypertension, allergic rhinitis..Patient was receiving Lisinopril, Metformin, Lipitor, ASP..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, child 00.5 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 05. 14 hours after immunizations were administered, developed a low grade fever. Two hours later, she began seizing. She had 3 seizures in 20 minutes. Was taken to the ER, had a temp of 101.4, was given Motrin, seizures seemed to stop, was discharged with "fever related tremors." Later that day, she had 2 more seizures, went back to ER, was admitted after having 3-5 more seizures. Episodes continued for 9 days, approx 5 minutes to 4 hours apart, lasting anywhere from 10-15 seconds to 3 minutes. Testing included.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 12. Allergic dermatitis, erythematous maculopapular rash on post and trunk, extremity..Paient has the following illness history - Ibuprofen, Iodine.Patient was receiving HCTZ. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 03. Pain, weakness and decreased range of motion of L arm since 11/3/05 when Pneumovax injection was given in L arm (deltoid). Affects entire arm from L shoulder to forearm (on of sensation. Seen in clinic 1/3/05 and 1/19/05 with same symptoms.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Swelling, rash, pain, erythema at injection site, extends to shoulder and down L arm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 26. L arm swelling at site of Td. Induration and tender erythema, 7x12 cm, chills, c/w cellulitis..Paient had No.Paient has the following illness history - Egg, erythromycin allergies..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 33 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 25. Information has been received from a physician concerning a "normally very healthy" 33 year old white female non-smoker with a history of acute otitis media, caesarean section requiring hospitalization, and an allergy to clarithromycin (Biaxin) who on 25-Nov-2005 at 09:30 am was vaccinated in the right deltoid with an eighth dose of pneumococcal 23v polysaccharide vaccine (lot #A651319/1007P). Illness at the time of vaccination included bilateral maxillary sinusitis. The patient was hospitalized for celluli.Paient had Maxillary Sinusitis;Upper Respiratory Tract Infection.Patient was receiving Augmentin, Nubain, Phenergan, Zithromax, Levaquin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 20. Information has been received from a pharmacist concerning a 35 year old female with congenital heart disease who on 12/20/2005 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot # 651859/0877R), right deltoid intramuscularly. On 12/23/2005 the patient experienced redness, pain, itching, swelling at the injection site. She then developed syncope. She went to the ER. She was admitted to the hospital for high fever (103F), headache and severe myalgia. She was tested for a multiple of t.Paient has the following illness history - Heart disease congenital..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from LA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Information has been received from a health professional concerning a 55 year old female with penicillin allergy and unspecified allergies who on 10-Jan-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (lot #651330/1048P), intramuscularly. Concomitant therapy included allergy shots and cholesterol medicine. On 10-Jan-2006 the patient's arm had a red swollen (size of an orange) reaction with a dark center in it. The area was located around the injection site. Also, the pati.Paient has the following illness history - Penicillin allergy, Hypersensitivity.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a physician concerning an approximately 60 year old female with type II diabetes mellitus who on approximately 11/07/2005 was vaccinated SQ with a dose of Pneumococcal 23v polysaccharide vaccine (lot #649914/0578P) and a dose of influenza virus vaccine (unspecified) into the opposite arm (unspecified). Concomitant therapy included an unspecified oral therapy. Subsequently the patient developed redness, pain and swelling to the arm that was used for the Pneumococcal 23v pol.Paient has the following illness history - Type II diabetes mellitus..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 11. Information has been received from a pharmacist concerning an 81 year old female inpatient, with drug hypersensitivity to aspirin and meperidine hydrochloride, and allergy to penicillin, and a history of dyspnea and hypertension as an emergency, who on 1/11/2006 was vaccinated with a second dose of Pneumococcal 23v polysaccharide vaccine. The patient was an inpatient at the hospital at the time of vaccination. It was reported that the patient had been vaccinated two weeks earlier with a dose of Pneumococca. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 14. Fever 103, sore arm, hives/welts down both arms..Patient was receiving Nasonex, Poly Vi Flor. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Cellulitis-like warm erythematous skin 1x9 cm in length below injection site..Patient was receiving Capoten, Hydrochlorothiazide Mantox cream, Lovastatin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 21 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Large painful local reaction with > 10 cm swollen, erythematous, indurated area with fever 102 degrees F..Paient has the following illness history - Asthma.Patient was receiving Yasmin. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 25 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 27. Reaction to Pneumococcal Vaccine: Redness, Heat, Pain & Swelling at injection site along with Headache, chills, slight fever. Patient seen in office, verbalized instructions to use Motrin, cold packs, Benadryl, and to watch for increased symptoms. Will follow up with patient tomorrow.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 84 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 29. On Mon 01/3/06 10:00 found injection site red ring and pale flesh colored center..Paient had Unstable angina, Afib, UTI resolved..Paient has the following illness history - Sulfa, Amoxil. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Fever, chills, temp, headache, dry cough, anorexia, weight loss..Paient had Viral upper respiratory.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 18. Left thigh red, swollen and hard.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 01. Injection site red, tender, swollen arthralgia left arm. F/U visit 01/11/2006 pt C/O tenderness, slight redness..Paient had Follow up visit.Paient has the following illness history - DM II, Depression, Obesity.Patient was receiving Prozac, Amitriptyline, Xanax, Glucotrol XL. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a physician concerning a 71 year old female with hypertension 7/28/1999, hyperlipidaemia06/26/2001 and pneumoconiosis 1989 who on 1/7/2005 at approximately 11:00am, was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included benidipine hydrochloride (Coniel), pravastatin NA (mevalotin), vitamin E nicotinate (juvela N) and Clotiazepam (Rize). 11/7/2005, in the evening, the patient developed injection site swelling, warmth and redness.Paient has the following illness history - Hypertension, Hyperlipidemia, Pneumoconiosis..Patient was receiving Coniel;Rize 5mg;Mevalotin;Juvela N 200mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a physician concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient developed an injection site reaction and extreme swelling. The patient's outcome was unknown. Follow up information has been received from a physician and from medical records concerning a 53 year old white female smoker (1/2) pack a day) with hypothyroidism, hyperlipidemia, hypertension, and on therapy for menopause, and a history of kidney.Paient has the following illness history - Kidney stone, colonoscopy, tubal ligation, nausea, ovary removal, hypothyroidism, menopause, hyperlipidemia, smoker, hypertension..Patient was receiving Activella;Vytorin;Levothroid;Diovan. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). It was reported in a published article, title as stated above and presented at the 2005 annual meeting of the American college of allergy, asthma and immunology, Nov 3-9 2005 concerning a 23 year old female with chronic mucocutaneous candidiasis who began to suffer from persistent thrush, failure to thrive, recurrent otitis media (staph aureus) and pneumonia (staph aureus and pseudomonas aeruginosa) since 6 weeks of age, who was vaccinated with Pneumococcal 23v polysaccharide vaccine (manufacturer unknown),.Paient has the following illness history - Failure to thrive, Pneumonia, Transplant, Serositis, candidiasis, Otitis media chronic, chronic mucocutaneous candidiasis..Patient was taken to emergency room. Patient died.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 09. Information has been received from a nurse practitioner concerning a 49 year old female with a history of hypertension, polycythaemia Vera and allergies to soy products who on 12/09/2005 at approximately 2:00 pm was vaccinated with a first dose of Pneumococcal 23v polysaccharide vaccine 0.5ml (lot 650453/079P), in the right deltoid. Concomitant therapy that day included a dose of hepatitis A virus vaccine (unspecified) (+) hepatitis B virus vaccine (unspecified) (lot AHABB28AB), in the left deltoid. Concomi.Paient has the following illness history - Polycythemia vera;Hypersensitivity;Hypertension.Patient was receiving Atacand, Toprol XL tablets.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 01. R arm pain and swelling post flu and pnemovax injections warm to touch. Sx noted after 24 hrs of injections- local reaction..Paient had non.Paient has the following illness history - Depression, acne, allergy to septra, allergy to lexapro..Patient was receiving tetracycline 250mg caps bid for acne, temazepam 15mg caps 1 cap q hs,prn, tretinoin 0.05% cr for acne, avelox 400 mg tab 1 tab qd, minocycline 50 mg caps 1 cap qd for acne. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 03. Pain at injection site that spread to shoulder joint, under arm and down toward elbow, around to back, and up toward neck. Difficulty sleeping. Soreness was severe upon movement of arm in the night (worse between 1:30a.m. and 1:00p.m.). General feeling of sickness and fatigue for approximately 30 hours after vaccination. Arm itching and sore to the touch and difficulty raising it 39 hours after vaccination. Received first Pneumovax in 2000..Paient has the following illness history - Diabetes type 1. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 01. Streaks on R arm one day post vaccine. General lethargy and seen by Dr. on 2/2/06 at 7pm. Received hydrocortisone shot and Augmentin.Paient had cold.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 03. Initial report received on 1/30/2006 from the patients parent. A 38 year old female patient with a history of pericarditis and insulin dependent diabetes had received an administration (route not reported) of Fluzone SV 2005-2006 USP lot number not reported, in the left arm, and an administration route not reported, of another manufacturers Pneumovax 23 vaccine, lot number not reported in the left arm on 11/03/2005. that same day the patient developed chest and shoulder pain. the patient was uncomfortable f.Paient has the following illness history - Per the reporter, the patient had no illnesses at the time of the vaccination. The patient had a history of pericarditis and insulin dependent diabetes. She was taking Cozaar, Levoxyl and Lantus at the time of the vaccination..Patient was receiving Cozaar;Levoxyl;Lantus.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 03. Left upper arm inferiously with 11.0 X 9.0 C erythema with mild increased warmth, only slight induration at superior aspect..Paient had swollen ankle.Patient was receiving MVI, HCTZ 25 mg qd, Atenolol 100 mg qd, prednisone 5 mg, cozaar 100 mg qd, actonel 25 mg wkly, asda 81 mg qd, omega 3 & 6 qd, pravachol 40mg qd, k-dur 10 meq qd. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Information has been received from a registered pharmacist concerning a 51 year old male with history of psychiatric issues, history of seizures "that occurred a long time ago" who "one week ago" was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml), intramuscularly. Subsequently, the patient experienced seizures. The patient was treated with levetiracetam (KEPRA), and "is much better now." The reporter considered seizures to be other important medical event (OMIC). Additional infor.Paient has the following illness history - Convulsion;Psychiatric disorder NOS.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a published literature article concerning a 7/12 year old male who was vaccinated with Pneumococcal 23v polysaccharide vaccine and varicella virus vaccine live (date unknown). On an unspecified date, the patient developed neutropenia, x linked agammaglobulinemia, streptococcus pneumonia (serotype 18F) meningitis, pneumonia, varicella titer was negative and he did not developed antibody responses to diphtheria, tetanus and pneumococcal antigens. At the time of this report,. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 07. Patient had pneumonia shot 2/7/06 - Right arm is red, swollen and firm from shoulder to elbow. Also area is itching. No pain, patient started feeling itchiness in right upper arm last evening. Zyrtec 10mg to take one daily for 7 days given 2/8/06. B/P 108/64-60-20-98.Paient has the following illness history - Diabetes;HTN;Anxiety;Depression;Hypercholesterolemia.Patient was receiving ASA;Atenolol;Fluoxetine;Fosamax;HCTL; Ibuprofen;Lantus;Lisinopril;Nasacort;Zoloft.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 87 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Redness, warm, tenderness at injection site. Patient also complained of feeling "woozy" next day. Pt. given Zyrtec. Redness decreased and better within 2 days after injection..Paient had fatigue.Paient has the following illness history - hypertension, hyperlipidemia, aortic stenosis.Patient was receiving Fosrnopril, furosemide. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 06. Pt reported soreness night of vaccine, next morning came into clinic, arm red, warm, tender approximately 5x6 area. Pt will take Benadryl..Patient was receiving Lipitor, Premarin, Omeprazole. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 11. Cellulitis around injection site.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 25 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 06. Initial report received on 09/Jan/2006 from a health care provider. A 25 year old male patient had received and administration (route not reported) of Menactra, lot number U1877AA, in the left deltoids; a subcutaneous injection of YF-VAX, lot number UE664AB, in the right arm; an administration (route not reported) of another manufacturer's Pneumococcal vaccine, lot number 1047P, in the left deltoid and an administration (route not reported) of another manufacturer's Hepatitis B vaccine, lot number 0031P, in.Paient has the following illness history - The patient had no illness or pre-existing medical conditions at the time of this report..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 25 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Information has been received from a nurse practitioner concerning a 25 year old female inpatient with obesity, other unspecified conditions, latex allergy, morphine allergy, and multiple other medication allergies, who on 12/28/2005 was vaccinated subcutaneously in the left arm with a dose of Pneumococcal 23v polysaccharide vaccine (lot unknown) and influenza virus vaccine (unspecified), prior to discharge from the hospital. Patient was in the hospital for an unspecified reason. Nurse reported that the pat.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The day after vaccination, the patient experienced seizure-like symptoms. Subsequently, the patient also experienced soreness. Unspecified medical attention was sought. At the time of this report. the patient's outcome was unknown. No product quality complaint was involved. Upon internal review, seizure-like symptoms were considered to be an other important me.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ME, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 06. Reddened area app 3" around injection site. Started with shoulder pain in evening worsening during night. No better no worse this am..Paient has the following illness history - Hyperlipidemia, Toe injure, Right knee replacement.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 08. Pt c/o having fever, chills and not feeling well. Pt has red edema on right arm deltoid area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 08. One day post vaccination patient complained of increasing mild redness and soreness. Whole arm started to swell by the time the patient returned home from our office on the day of immunization. Patient went to emergency room; Benadryl recommended..Paient has the following illness history - Hyperlipidemia, depression.Patient was receiving Lexapro 20 mg.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 21 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 01. The patient developed a painful, swollen, mildly red area on her left posterior upper arm. The patient also experienced an increased heart rate (up to 150 bpm), fevers (up to 40.8 C), and increased white blood cell count (up to 26,000). She was started on naproxen 250mg by mouth three times daily..Paient had Pneumonia.Paient has the following illness history - Acute disseminated encephalomyelitis..Patient was receiving APAP, azithromycin, ceftriaxone, famotidine, ferrous sulfate, heparin sodium, albuterol nebulizer. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 09. Pt. c/o low grade fever and injection site was red, swollen, and painful to touch for 4 days after injection..Paient had Elevated blood sugar, newly diagnosed diabetic.Patient was receiving Not on any other meds.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 09. 4:30 went out to dinner drank 4 beers, ate a few french fries and bites of burger then said he wasn't feeling well. 5:30 pm that day nauseated and pale, dicphoratic, stumbling. 1am 2/10/06 till in the middle of the night, disoriented fell and broke rib, nausea, vomiting. Went to ER. These events reported by daughter..Patient was receiving Lipitor, Hydrochlorothiazide, Atenolol, ASA 81mg.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 10. Patient died in her sleep the night after receiving the vaccine..Paient has the following illness history - NKDA or birth defects. Diabetes, HTN, hyperlipidemia, obesity hypothyroidism, GERD, cataracts.Patient was receiving metformin, avandia, lipitor, hctz, cozaar, synthroid, omeprazole, asa. Patient died on -0/00/2006.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 08. Discomfort L arm 2-10-06; Induration and erythema; tenderness; temp 100. Treatment-Medrol Dose pack and Keflex 500 mg 3 times a day for 7days. 2-13-06 (Patient reports resolving). Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, child 9 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 14. 4.5 cm x 6cm on R upper arm pain rated at 7-8 on 1-10 scale. Applied warm compress for about 15min..Paient had Asthma.Patient was receiving Albutero Sulfate 0.083%, Brompheniramine DM/pseudopine, ibuprofen (60mg/5ml) inhaler-Albuterol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a physician concerning a 60 year old male, with unknown pertinent medical history and unknown drug reactions, allergies, who in 10/25/2006 or Nov 2005, was vaccinated route unknown with a dose of Pneumococcal 23v polysaccharide vaccine (lot unknown). In January 2006, the patient experienced Streptococcus Pneuomiae and was hospitalized for 0-3 days. It was reported that the patient was treated with antibiotics while in the hospital. The patients present status was reported.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 11. L upper arm with redness, edema, warm to touch "sore". No shortness of breath..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 18. Patient administered Pneumococcal vaccine in upper right arm. Area of warmth and redness observed..Paient had Bronchitis.Paient has the following illness history - Community -acquired pneumonia, Thrombocytopenia.Patient was receiving Tylenol, Tessalon, Lovenox, guaifenisin la, Moxifloxacin, potassium chloride. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 14. Left upper extremity swelling and pruritus. Chills 1st night after injection 2-14-06. Treatment-warm compress. Increase Left upper extremity- followup with physician. 2/20/06 -"much better swelling down"..Paient had Rash, itchy legs and arms-Maxide reaction.Paient has the following illness history - Maxide; History-hypertension.Patient was receiving Lopressor, cardizimer, Aspirin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AK, USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Soreness at site of pneumonia vaccine 1st night, some itching noted-redness and swelling noted from shoulder to elbow. Lasted 2 weeks. 1st called 11/4/05-noted some improvement after five days 11/4/05. Follow up 12/1/05.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 06. Pneumococcal vaccine given in deltoid IM. Next day arm swollen, hot, red from shoulder to elbow. Pain with movement..Paient has the following illness history - Thrombocytopenia (ITP)l. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AK, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 03. States arm hurt - stinging at site within 3 hours of vaccinations. Continued to worsen in pain, noticed pinkish color at site. Progressively got worse over next 5 days at which time client went to local ER - given pill to swallow and script for Benadryl. Called us on 12/1 and interviewed on 12/2. Arm improved as of today..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Arm swelling, red, warm, painful when touched.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 31. Approx. 4 hours after inj pt called c/o red, warm, 'tight' left deltoid (inj site). Encourage antihistamine and icing area. RC in 4 hours found pts arm red, warm and indurated with diff raising arm due to "tightness @ arm" otherwise felt fine..Paient has the following illness history - Sulfa-Hypersensitivity pneumonitis;2 hours Bird fancious disease..Patient was receiving Fosamax. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 23. Patient given Pneumococcal vaccine, Developed fever, malaise, headache, pain and induration at inj site. Increased WBCs noted. Admitted, treated and released. No sequelae noted.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial report received from another manufacturer, report number WAES0511USA03790, on 2/15/2006. Information was received from a health care professional concerning a 63 year old male patient, with a history of asbestosis, who received an intramuscular, left arm injection of Fluzone SV 2005-2006, lot number 01854AA (not a valid manufacturer lot number), and an intramuscular, first dose, right deltoid injection of Pneumovax 23, lot number 649693/0456P, on 10/26/2005. Three hours post vaccination, the patient.Patient was receiving Lipitor, Celexa, Lisinopril, Hydrochlorothiazide, Vitamins.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 24. Patient given Pneumococcal vaccine developed fever, malaise, pain and swelling at inj site. Treated and resolved with no lasting effect.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 17. Inflammation, severe pain, and redness started in PM on 2/17/06. By the evening of 2/18/06, patient reports severe pain, inability to move right arm, increasing redness of arm passing down past elbow with streaking. Went to ER at this point where she was given Keflex, Percocet and Benadryl. To return to primary MD on 2/21/06..Paient has the following illness history - Thyroid cancer 4/12/05.Patient was receiving Botox-1/28/06, Jasmine, Levoxyl.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 24 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 16. Pt presents to ER with fever of 103.1n nausea, vomiting, headache, overall body pain. All occurring within 12 hours of getting Pneumovax vaccine. Area of injection 8x7 cm area of erythema, warmth and induration in his left deltoid region. Margins of erythema are sharp. Some axillary tenderness without definite adenopathy. Pt also has had intermittent shaking, chills and weakness.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Severe pain at injection site. Right arm - arm was incapacitated. Pt stated he got weak and fainted. ER ov - Oxycodone, Percocet;IV..Paient has the following illness history - Asthma;Rhinitis.Patient was receiving Advair;Rhinocort;Advil;Singular;Proventil.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 02. Left deltoid, red itchy, warm to touch and swollen. Distance line of where redness and edema stop. Used ice to site. Also stated had nausea/aching that lasted approx 12 hours..Paient has the following illness history - History of pneumonia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Fever-headache localized swelling and redness at injection site..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 11. Patient had right shoulder swelling and pain increasing in severity with onset 1.5hrs post pneumoccoal vaccine. Swelling in upper deltoid and hand and fingers, Ecchymosis at inferior border of deltoid muscle. Fluid collection. MRI did reveal rotator cuff tear was present..Paient has the following illness history - Diabetes Mellitus, Status post- pancreas and kidney transplant, recurrent UTI's, osteomyletis, pathology foot fracture.Patient was receiving Fosamax, Lamisil, Pepcid, Sandiamune, Prednisone, Lash, Imuran, Toprol XL, Ferrous Sulfa, orthro tricycline. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2002, 24. Localized reaction to Pneumovax placed 1/24/06. Pt seen 1/27/06. Erythema upper L arm. No weeping, tenderness. Swelling. Rx'd Medrol dosepack Benadryl. 1 week followup..Paient has the following illness history - Celebrex, Hypertension.Patient was receiving Cozaar, Hydrochloride, Aspirin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 13. Tetanus site: induration, color, erythema immediately surrounding injection site 5cm height by 7cm width; Pneumovax site: no reaction at injection site but pt had 2 areas of color and erythema on lower portion of arm-see diagram on back. No lymphadenopathy noted. Low grade fever 100..Patient was receiving Synthroid, triamterene/hydrocholorothiazide, Fosamax, Vagifem. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 25. Day after vaccine in left arm, large red long streaks appeared not at injection site but around arm running toward under arm. Also next 3 days sneezing all day and nose ran clear water all day also arm was sore and painful. Under arm tissue still sensitive, tender..Paient has the following illness history - Heart disease, GERD. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 20. Day after receiving injection developed swelling, pain and redness of upper arm (circumferentially) with chills, no fever documented. Seen in ER 2 days after receiving injection given morphine, Ancel IV and Rx'd po cephalexin..Patient was receiving Fosamax 70 mg one/wk;Levoxyl 50 mcg daily.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 16. Myalgia and fatigue for 4 days after vaccine.Paient has the following illness history - Diabetes Mellitus;Congestive Heart Failure;Sulfa Allergy.Patient was receiving Spironolactone 25mg;Metoprolol 50mg; Vytorin;Temazepam 30mg;Vicodin ES; Bumetanide 1mg;Glipizide ER 5mg; Klor-Con 10mg;Fluconazole 150mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WV, USA. Female patient, child 10.3 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 01. Mom states developed fever evening 2-1-06 and not wanting to apply weight to legs this afternoon 2-2-05. Tylenol/Motrin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 27. Upper left arm cellulitis with erythematous area about 20cm x 15cm, increased temp at site with palpation. Pneumovax administered on 1/27/2006. Pt started pegasys and ribavirin treatment same day for hepatitis C virus Pegasys injection site was right below abdomen..Paient has the following illness history - Hepatitis, asthma, HTN, GERD..Patient was receiving Motrin, Celexa, Singulair, Prilosec, Atrovent, Allegra, Ambien, Advair, Ribavirin, Pegasys, MVI. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. 5 days post vaccine developed very sore reddened upper arm continuing on across her chest. Dx lymphangitis mild cellulitis..Paient has the following illness history - PCN;Demerol;Mobic.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 55 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial report received from another manufacturer, report number WAES0511USA03757, on 15/Feb/2006. A 55 year old female patient, with a history of chronic bronchitis and high cholesterol, received on intramuscular, left arm injection of Fluzone SV 2005-2006, manufacturer lot number U1854AA; and an intramuscular, right deltoid second dose injection of Pneumovax 23, manufacturer, lot number 649693/0456P; on 26/Oct/2005. The patient reportedly received influenza vaccinations yearly. There was no illness at the.Patient was receiving Lipitor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KY, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 13. Received vaccine at 11:15, by 6 pm arm red, hot swollen from shoulder down to elbow..Paient has the following illness history - hydrocodone. Patient recovered.

.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KY, USA. Female patient, 41 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Not able to lift arm, large rough knot at shot site, red solid ring that grew daily.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 17. 02/18/2006 - to ER for redness, swelling, right deltoid - warm to touch, developed 6 hours after pneumovax injection. Treated with Ancef IV, then Keflex for 3 days..Paient had Pre-op physical.Paient has the following illness history - ASA, Bactrim, Floxin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 06. Red arm, swollen, itchy for 1 1/2 hrs then went away.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 21. Patient complains of soreness of left arm. Arm is warm to touch. VHC notified at 10:30. VHC provider evaluated patient and gave instructions: Alternate warm-cold compress for 48 hrs. Take Motrin for pain..Paient has the following illness history - Diabetes.Patient was receiving BP medicine. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Developed severe nausea, vomiting and muscle aches 3-4 days after vaccine. ~1 week after developed severe dizziness, inability to focus, memory loss. Over the next months symptoms have improved slowly. Still complained of severe weakness and fatigue. Can only work 4 hrs day then has to rest..Paient had COPD, bronchitis, Ethohism. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 12. Patient was given Pneumococcal vaccine- developed reaction, swelling at site, pain and induration. (Patient had been admitted to hospital on 2/11/06 for colic, abdominal pain, syncope and collapse, vertigo..Patient was receiving 2/11/06-2/14/2006: Aztreonam; IV hepatin, Lansuprazole, meclizine, morphine sulfate, naprosen, sodium chloride, vancomycin IV. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 01. Localized reaction, redness, burning, itching & edema..Paient has the following illness history - Penicillin, morphine, asortic acid. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 24. Left arm -local swelling 2cm x 2.5 cm area of induration.Paient had J Diabetes Mellitus.Paient has the following illness history - J Diabetes Mellitus. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Swelling and pain onset a few hours after the vaccine was administered on 2/22/06. 2/23/06 significant edema down to elbow. Looks like cellulitis. Started Keflex-well F/U..Paient has the following illness history - NKDA.Patient was receiving Naproxen, Thyroid Armour. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 09. Injection given 02/09/2006 in left arm outer aspect. 02/10/2006 patient developed weakness, shivering and eventually inability to walk. Patient has cerebral palsy. Had right hemisphrectomy 03/21/2001. Mom refused pneumoccal vaccine in the past. History of status epilepticus. Had fever to 101, treated with Motrin. Recovered 02/11/2006..Paient has the following illness history - Cerebral Palsy. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 22. Local reaction, redness, swelling, pain..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AR, USA. Female patient, 17 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 27. Extremely swollen left arm from elbow to shoulder. Swelling into left scapula and left side of neck. Entire upper arm painful & Red. Unable to move arm up or away from body or straighten at elbow. Feeling faint when standing and Nausea from pain. Saw primary physician 2-28-2006; prescribed Medrol Dose Pack. Elbow still swollen on 3-3-06..Paient had Spondoloarthropy.Paient has the following illness history - Allergic -Penicillin, melons, grass, weeds, trees, mold, cats, horses, shrimp, cucumbers, carrotts, peaches, nectarines..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 20. Information has been received from a registered nurse concerning a 68 year old male with asthma and a Naproxen allergy who on 1/20/2006 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). there was no concomitant medication. On 1/21/2006 within 24 hours, the patient experienced swelling, redness and pain in the site and went down the patients arm to the wrist. Unspecified medical attention was sought. It was noted that the patient was unable to work for 3 days,.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 84 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 23. Initial report received from another company (reference number QAES0511USA00613) on 2/28/2006. This information was reported to the other company by a pharmacist. An 84 year old female patient with no reported medical history, had received an intramuscular injection of Fluzone SV 2005-2006 USP, lot number U1806AA, in the right deltoid and an intra muscular injection of Pneumovax 23, lot number 650453/0791P, in the left deltoid on 10/23/2005. The patients daughter called the pharmacist to report that on 10/2. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. On 10/18 her arm was painful, red and swollen. She also had fever, body aches throughout 10/18, 10/19, 10/20 & 10/21. She was also nauseous. When she presented to me on 10/21 her arm was red and splotchy. I referred immediately to MD and called MD and he prescribed Keflex. She also went to MD that night and he confirmed Cellulitis and said Keflex ok..Paient has the following illness history - Allergy - Fluoroquinolones.Patient was receiving Betimol;Premarin; Chlordiazepoxide/amitriptyline.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 25 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 27. L arm at injection site tender eve of injection and progressively became worse. On 3/1/06, an area of induration, redness and warmth at site measured 3" circ with axillary lymph node involvement and much pain. Was sent to MD and was dx with cellulitis. Tx - 500mg keflex q12h for 12 days and off work for 2 days using ice packs to area prn. On 3/3/06, redness has abated as well as induration and most of the pain, but a residual lump is felt. On 3/6/06, the arm is fine - no additional complications..Patient was receiving birth conrol pills.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 02. Local reaction (3 patients in 1 month with local reaction).. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. Vaccine: Pneumovax, given intramuscularly in right deltoid, on 02/28/2006 at 14:40. Patient reports feeling bad starting 16:00-17:00, by 20:00 fever 101.7 degrees, chills, achy all over, then injection site very sore. Next day arm red, swollen, warm..Paient has the following illness history - Hepatitis C, COPD, Obesity, Penicillin and Lidocaine allergy.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 03. Approximately 9 hours after receiving vaccine, patient complained of pain in left shoulder. A large, red, hard raised bump was noted..Paient had Admitted for pneumonia 2 days prior.Patient was receiving Ceftriaxone, carvedilol, Sinemet, azithromycin, escitalopram, fluticasone nasal spray, furosemide, guaifenesin, levothyroxine, losartan, pantoprazole, risperidone, tamsulosin, warfarin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 39 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 18. Fever 101-102, myalgias, swelling, redness moderate 8 cm diameter both deltoid for 5 days following immunization..Paient has the following illness history - History Non Hodgkins Lymphoma s/p bone marrow transplant.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 06. Local reaction to pneumovax given on 03/06/2006..Patient was receiving Vicodin, Erythromycin, Gantanol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 19. Sore arm since vaccine was administered. Woke up on 3/2/06 with pain in the shoulder and arm muscle. In arm vaccinated with the pneumococcal vaccine.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, child 5 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 25. Given pneumovax, had redness and swelling.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. 1 days after injection, redness, cellulitis around the injection..Paient has the following illness history - Discharge summary states scleroderma, hypertension, gi bleed, allergy. msv.Patient was receiving Levaquin;Estrace;Zestril. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from UT, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 01. Local reaction to pneumovax. Erythema/induration of skin left deltoid region, moving down to just above elbow. Started 6 hours after injection. Prescribed medrol pack, keflex, and lortab..Paient had N/A.Patient was receiving Synthroid, maxide. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 01. Severe pain, swelling, redness - same evening. Went to ER - given pain meds and antibiotic..Paient has the following illness history - coronary artery disease, hypertension, diabetes mellitus type II.Patient was receiving ASA, Toprol, Lipitor, Avandia.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning an elderly male who was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot #651320/1008P). Concomitant therapy included an unspecified thyroid medication and naproxen. Subsequently the patient developed cellulitis, burning and redness at the injection site. The patient sought medical attention and was treated with cephalexin (KEFLEX). Subsequently, the patient recovered. the reporting pharmacist considered cellulitis, burni.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Common variable immunodeficiency presenting as lymphonodular hyperplasia pernicious anemia and breast cancer. Journal of Allergy and Clinical Immunology 2006:S110-S110. Information has been received from a published literature abstract concerning a 56 year old female with a history of treated right breast cancer 7 years prior, now in remission, presented with weight loss, anorexia, and loose stools. She was previously well, without fevers. She was a nonsmoker, had no history of recurrent infections and had.Paient has the following illness history - Breast cancer, non smoker..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NH, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. Pt reports redness, swelling, pain at site. Also reports nausea and vomiting since she received medication (vaccine). Pt has been using Tylenol for pain..Patient was receiving Lisinopril, Pravastatin, Lantus Insulin, Zetia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 43 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. Pt developed soreness of arm. Pneumovax given in (extending from shoulder to elbow and toward breast). She also had multiple red swollen nodules. No fever..Paient has the following illness history - Cutaneous lupus/allergies: ASA/TCN/Keflex/PCN/Sulfa/Cipro. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. VACCINE ADMINISTERED 10/31/2005. PT RETURNED TO CLINIC 11/1/2005 COMPLAINING OF REDNESS AND SWELLING IN ARM WHERE VACCINE WAS ADMINISTERED. SOLUMEDROL 125 MG GIVEN IM. ON 11/8/2005 PT RETURNED TO CLINIC FOR FOLLOW-UP AT WHICH TIME SHE FELT BETTER. PT STATED FEELING "CREEPY, CRAWLY" HAD DIMINISHED. PT WAS TAKING BENADRYL AND AYRTEC AT THAT TIME, BUT HAD STOPPED TAKING PREDNISONE DUE TO HYPERACTIVITY..Paient had NO.Paient has the following illness history - ALLERGIES TO PENICILLIN, SULFA, CEPHALEXIN, ASPIRIN, CODEINE, TYLENOL, ZOCOR, TRICOR, POSSIBLE PREDNISONE ALLERGY.Patient was receiving CAPTOPRIL 25MG BID, BENADRYL, SOLUMEDROL, ZYRTEC, PRILOSEC 20MG PRN. Patient died on -0/00/2006.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 11. Patient admitted 2/6-2/13 for coronary bypass surgery. On 2/10 patient received pneumovax vaccine. On 2/11 the patient developed fevers of unknown origin. Fevers treaded downward and patient discharged 2/13. Patient re-hospitalzied 2/15 for fevers of unknown origin up to 102. Infectious disease consult obtained and it was felt that most probable cause of fevers was pneumovax - no other suspected source. All cultures negative. Fever resolved and patient discharge home on 2/17/06..Paient had Recovering from CABG on 2/6/06.Paient has the following illness history - Hypertension, hyperlipidemia, borderline diabetes, SP CABG (CAD), Smoker. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 22 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 13. Rx axillary lymph node swelling and rt arm discomfort. Cellulitis requiring hospitalization and IV-ABX sent home with picc line and IV-ABX developed clots hospitalized again. Dc'd with PO ABX and Coumadin. DVT's L arm.Paient has the following illness history - Rheumatoid Arthritis, Autism.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Hypergammaglobulinemia IgG-2 Subclass Deficiency and Recurrent Infections in Adults. Journal of Allergy Clinical Immunology 2006. Information has been reported in a published abstract article, title as stated above, concerning four patients in a study (three female, one male (WAES#0603USA00735) between the ages of 51-71 years who were vaccinated with pneumococcal 23v polysaccharide vaccine. All four patients had abnormal responses to pneumococcal 23v polysaccharide vaccine; one failed to respond to pneumoco.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. Information has been received from a physician concerning a 67 year old male with osteoarthritis, rheumatoid arthritis, hypertension and hyperlipidemia and no known drug reactions/allergies, who on 28-Feb-2006 was vaccinated intramuscularly in the right deltoid with a 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (Lot #651320/1008P). Concomitant therapy included amlodipine besylate (+) benazepril hydrochloride (LOTREL), atorvastatin calcium (LIPITOR), aspirin, psyllium husk (METAMUCIL), cod liver.Paient has the following illness history - Osteoarthritis, rheumatoid arthritis, hypertension; hyperlipidaemia.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Hypergammaglobulinemia IgG-2 Subclass Deficiency and Recurrent Infections in Adults. Journal of Allergy Clinical Immunology 2006.Information has been reported in a published abstract, title as stated above concerning four patients in a study (three female (WAES#0602USA05966), one male) between the ages of 51-71 years who were vaccinated with pneumococcal 23v polysaccharide vaccine. All four patients had abnormal responses to pneumococcal 23v polysaccharide vaccine vaccine; one failed to respond to pneumococ.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 27. Tachycardia, weakness, Pain in arm vaccine administered radiating into head and neck, nausea..Paient had Noe.Paient has the following illness history - Darvon, migraine headaches, osteopenia, supravenous tachycardia.Patient was receiving Toprol, Mialcalcin, Tylenol #3. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 07. 7cm x 8cm red, warm area at injection site..Paient had Upper respiratory infection..Patient was receiving Levoxyl, Wellbutrin, Claritin, Nasonex..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, child 5 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 17. Lt arm redness/warmth/swelling form deltoid to elbow, with elbow effusion. Was admitted and treated for cellulitis..Paient had Sickle Cell Disease - not sick.Paient has the following illness history - Sickle cell disease.Patient was receiving Amoxicillin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Received injection 3-8-06 called 3/10/06 with c/o redness, warmth at site..Patient was receiving Cholesld Chlor-Trimeton MV1. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 04. WITHIN 2 HOURS OF PNEUMONIA VACCINATION PATIENTS ARM BECAME PAINFUL. IT CONTINUED TO WORSEN BECOMING MORE PAINFUL AND SWOLLEN. PT RETURNED TO CLINIC FOR SYMPTOMS 3 DAYS POST INJECTION. PREDNISONE 40 MG DAILY FOR 2 DAYS GIVEN. IBUPROFEN 200 MG 2 PILLS FOUR TIMES DAILY FOR 2 DAYS. PT SEEN AGAIN 6 DAYS POST INJECTION AND STATED HIS ARM WAS "FEELING FINE"..Paient has the following illness history - HTN, HLP, CARDIOMYOPATHY, COPD, PCN ALLERGY, SULFA ALLERGY.Patient was receiving LIPITOR 5MG, LISINOPRIL 10MG, SPIRONOLACTONE 25MG, ASPIRIN 325MG, COREG6.25MG BID, COMBIVENT INHALER 2 PUFFS QID. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 27. A 72 year old female patient received a pneumococcal vaccine on her left deltoid on 09/27/05. She came to the hospital on 09/28/05 and presented with a red, tender, and swollen left upper extremity. She was admitted to the hospital and she received IV Ancef and oral Augmentin for treatment of suspected cellulitis or an allergic reaction from the vaccine.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 13 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 16. PAIN IN RIGHT ARM UNABLE TO MOVE WIITHOUT PAIN. LOSS OF APPETITE, NAUSEA, ELEVATED TEMPERATURE..Paient had MINOR FLU LIKE SYMPTOMS RUNNY NOSE. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 31. Developed malaise and fever of 101.2 approx 20 hours after vaccination. Entire upper surface of left arm swollen, blotchy red, and sore. Gradual improvement over the next three days. Missed 2 days work. Took ibuprofen, aspirin..Paient has the following illness history - Sulfa allergy Penicillin allergy Allergic rhinitis Depression.Patient was receiving Feverfew herb Paxil. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 15. Fever 103; painfull swelling at the injection site..Paient had Breast Ca Asthma Hypertension.Paient has the following illness history - NKDA.Patient was receiving Prilosec 20mg QD Zoloft 100 mg QD Lisinopril 10mg QD Advair 100/50 mcg Calcium + Vit D Multivitamin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2005, 08. Patient received booster for pneumovax from the pcp office on 11/17/2005 and then was admitted to the hospital for surgery, and as part of their protocol, got pneumovax again. He was discharged post op and returned the next day with fever 103 and painful swollen arm at site of injection extending from deltoid all the way to the forearm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 23. 2/24/06 Sudden onset chills and fever 5 pm. 2/25/06 Generalized weakness, inability to walk 2 am. Hospital admission T=38.3, mild tenderness, no inflammation at injection site of pneumovax. 2/27/06 Erythematous rash left upper arm extending from below injection site to the elbow..Paient has the following illness history - No allergies, ASCVD, CA prostate;Aortic Aneurysm, Pacemaker insertion 02/14/06..Patient was receiving Lipitor, Coreg, Mavik, Ditropan, Zetia, Doxasorin, Spironolactone, aspirin, multiple vitamin.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a 50 year old female nurse, with asthma and penicillin allergy and a history of splenectomy, who on 2/6/06 was vaccinated in her left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650453/0791P). On 2/6/06, within 1 minute of receiving the vaccination in her left arm she began to experience an adverse reaction. She reported that her throat started to close, and she developed a cough. She stated her "chest closed up" and she had a pain in her left shoulde.Paient has the following illness history - Splenectomy; Asthma; Penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 13. Pt was given influenza vaccine and pneumococcal vaccine 3/13/2006 prior to discharge from hospital. He came to the ED 3/15/06 @ 5:39 with a swollen face he was given Benadryl and Prednisone..Paient had Asthma, recovering pneumonia, bronchitis, hypertension.Paient has the following illness history - Information received from ER summary states cerebral palsy as Health HX. msv.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 28. Beginning 3/1/06 swelling and redness of L arm at location of pneumococcal polysach vaccine. Fever and headache started 3/1/06. Fever cont'd thru 3/4. Headache persist, L arm pain persists as of 3/8/06..Paient has the following illness history - HTN.Patient was receiving KCL;Estratest HS;ACIP;Maxite;CA;Metamucil.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 17. SHOT GIVEN ON FRIDAY 8:30 AM 3/17/06. PAIN IN ARM AT SHOT LOCATION STARTED IN THE AFTERNOON AND THE PAIN SPREAD THROUGH MY MUSCLES. MY SKIN WAS SO SENSITIVE I COULD NOT BE TOUCHED AND ALL MY MUSCLES ACHED. AT FIRST THE SHOT AREA WAS NOT RED BUT LATER BECAME INFLAMED AND SPRED OVER MY ARM. I COULD NOT GET OUT OF BED AND EVERY MOVMENT HURT. NO APPETITE. ON SATURDAY I WAS CHILLED & ON SUNDAY I WAS HOT. MONDAY, I AM UP AND ABLE TO FUNCTION BUT MY ARM IS STILL INFLAMED AND SORE. I DIDN'T THINK TO TAKE A TEMPE. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DC, USA. Female patient, 33 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 15. Sore arm around injection site shortly after shot. Soreness continued but diminished through 3/22/2006. Limited movement of arm from 3/16/2006 to 3/20/2006. Redness of the bicep area. 103 degree fever 3/17 - 3/19/2006, 101 degree 3/19 - 3/20/2006..Paient has the following illness history - HIV+.Patient was receiving Wellbutrin XL, Cymbalta, Seroquel. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 43 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 20. Arm swollen at injection site X 4 days. Resolved without medical treatment..Paient has the following illness history - Allergies - PCN HIV, morbid obesity.Patient was receiving Xaletra, combavir, tenodovir. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 33 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 15. Injection site irritated day following injection. On exam (3/17/06). Erythema from elbow to mid-bicep. Treated with cephalexin 500 mg qid 7-10d..Paient has the following illness history - Asymptomatic HIV. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 05. See attached page.Paient has the following illness history - Penicillin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 06. Initial and follow up information has been received from a registered nurse, via a company representative (initial information), concerning a 69 year old male patient, with no known medical allergies, who on 10/06/2005 was vaccinated intramuscularly with a dose of Pneumococcal 23v polysaccharide vaccine (lot 649989/0579P)> it was reported that at the time of vaccination, the patient had acute bronchitis. It was previously reported that on 10/06/2005 the patient developed severe inflammation at his injection.Paient has the following illness history - Bronchitis acute.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Injection given right deltoid. Pt tolerated procedure well. Pt came back to clinic the next day, Oct 19, 2005 with reaction to site where pneumovax given. She had a swollen indurated area on her deltoid which measured 4 x 6.5cm. Mildly tender to palpitation mildly erythematous. Advised to not have further pneumonia vaccines. Benadryl oral and hydrocortisone cream to area, as well as ice..Paient has the following illness history - Hypertension, reflux (GERD), chronic lichen sclerosis of vulva, Post menopausal, Hiatal hernia, Gastritis, osteopenia..Patient was receiving Omeprazole, Norvasc, Calcium with vit D, Fosamax, baby aspirin, Estrace cream.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 93 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 15. Family reported temp 101, lethargy, agitation for 2-3 days, starting 2-3 days after immunization. Was seen in office 11/21/2005 - afebrile; family reported "downhill" from there, no cause of fever/infection identified; continued WBC decreased..Paient had Lymphoma, HTN.Patient was receiving Avalide 150/12.5 1 po qd; Allopurinol 300 mg 1 po qd. Patient died on -1/00/2005.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 03. Information has been received from a medical assistant concerning a 45 year old female with migraines (approximately 18-Mar-2005), multiple sclerosis relapse with optic neuritis and dizziness (approximately September 2005), burning with injections of interferon beta-la (REBIF) therapy, pneumonia (December 2005) and a history of pneumonia (2000) who on 03-Jan-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #651319/1007P). Concomitant suspect therapy included interferon beta-la.Paient had Migraine; Multiple sclerosis relapse; Pneumonia; Injection site irritation.Paient has the following illness history - Pneumonia.Patient was receiving Relpax; Rebif; Levaquin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 22. Cellulitis like reaction, left deltoid area with lymphangitis streaks. Treated with augmention BID X 1 week..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 21. Cellulitis of R upper extremity..Paient had URI.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 81 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 14. Pt c/o severe right arm (deltoid) pain at 6AM (3/15/06. At 1PM right deltoid was noted to be red, warm and swollen, temp 102.4F. Pt did not eat lunch and c/o nausea. He was given Tylenol for pain and temp. At 2:40PM noted to be wheezing. O2 Sat 96-97%. Right arm red,induration 12cm x 27.5cm. He was given Prednisone 40 mg/day x 5 days. Claritin 10mg qid, Zantac 150mg bid..Paient has the following illness history - Penicillin allergy; Alzheimer's, dementia, HTN, depression, anemia, allergic rhinitis..Patient was receiving Lasix, KC1, Celexa, Aricept, Docusate, Flomax, Nasalide, Claritin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 23. 1st 24 hrs painful injection site (fever, chills, shaking); onset of fever, lasted 4 days (b/w 100 degrees and 102.8; increased arm soreness, swollen injection site 3" diameter, Fiery band developed inj site 3/4 the way around arm above elbow, still and painful, cleared in 2 wks..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 16. Pneumovax injection yesterday 30 min after receiving started itching. C/O soreness and warmth. No change since onset. Tx with cool compresses, triamcinolone cream 0.1% tid and Zyrtec 10 mg q day. Initially area red, warm L deltoid 5 1/2" x 6 1/2" not subsided by 3-20-06..Paient has the following illness history - Increase lipids;HTN;Osteopenia;Carotid Stenosis.Patient was receiving Zocor;ASA;Norvasc;Zetia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 09. Pt reported that at pneumococcal site she had pain, swelling, heat, redness which extended down to wrist. Contact ER - nurse advise to take Tylenol. She went to Dr on her traveling. On Monday at 6 pm given 10 days of cephalexin 500 mg to take qid. Direct back or used at 08:30 that decreased swelling. No redness, states she can now bend her elbow and it seem to be getting better. Client asked to call back when she returns from her visit out of town and give additional information of when symptoms subsided c. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 26. L deltoid - pneumococcal vaccine, experienced severe pain scale 1-10 #10. Spoke to Dr 9/27/05. Dr thought it could be reaction from flu shot. There after she reported she were paralyzed from neck to toes could not move. Experienced difficulty breathing, symptoms. Subsided on the third day at 08:30 am..Paient had Cerebral Palsy/Heart Condition. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 04. 10/5/05 In arm right deltoid pneumoccal vaccine site, soreness, warm. Swelling, aching /// /// /// swelling down arm to armpit. Says she took ibuprofen /// also took benadryl last night. Edema progressed /// 4 fingers above her elbow in her right arm /// /// //// //// .. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 03. Pt's daughter reported that on 10/3/05 her mom received pneumococcal vac. around 12:00 noon. R deltoid. Tuesday noted swelling, redness around upper arm, warm to touch mild itching. Swelling extended to above her elbow.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 23. Information has been received from a pharmacist concerning an over 65 year old patient who on approximately 23-Mar-2006 was vaccinated with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. On 23-Mar-2006 "almost instantly" the patient experienced a seizure. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Upon internal review, seizure was considered to be other important medical event (OMIC). Addition.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 21. Swelling, - cellulitis at site with edema, erythema and violaceous hive, positive warm to palpation. Pt placed on Augmentin ES..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AL, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 21. cellulitis at site with edema, erythema and violaccous hue which resolved in 7 days.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 14. Patient cannot move arm around especially in the morning. This started right after reaction on the injection site. Patient uses left arm where he got the pneumovax, to play golf. It has affected his golfing..Paient had pain, redness, site of injection..Paient has the following illness history - N/A. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 81 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 01. 24 hrs after getting flu/pneumo shot. Chest had cough and cold s/s, paralysis of left side, loss of balance and stiff neck lasting 1 1/2 wks. Prostate and windy probs..Paient had Prostate, urinary retention.Paient has the following illness history - Neck injury in 1942..Patient was receiving BP meds.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 29. Local reaction, left deltoid surrounding area, red, warm, tender, swollen to touch. Cold compress applied. Given appt to see MD for further eval..Paient has the following illness history - Diabetes, Hypertension. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 27. Urticaria at injection site - Pruritus of conjunctiva. Gave 25mg of Benadryl intramuscularly and Benadryl cream..Paient had Hypertension.Paient has the following illness history - Allergies to penicillin and potassium.Patient was receiving Nexium, Doxaosin, Lopid, Norvasc, ASA, Toprol XL. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 28. Red warm rash upper arm medial to vaccination site. size about 7cm x 10cm..Paient had no.Paient has the following illness history - amoxicillin.Patient was receiving Zovirax, altace, hydrochlorthiazide, levothyroxine, asa, lipitor, ambien, nasonex, glucosamine sulfate. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NV, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 27. Pt given the vaccine on 3-37-06. Within 24 hrs, pt had compliants of swelling in her rt arm with redness below the injection site, numbness of her left face, tingling and numbness in her arms, headache, nausea and temperature of 101-102 degrees. Temperature on 3-30-06 was 101.3 with a red cellulitis type patch right below the injection site of the rt arm..Paient had possible ear infection.Paient has the following illness history - allergies to Percocet.Patient was receiving Was given Amoxil, but only took one pill.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ME, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 31. Patient complained of pain in left upper arm. Left arm elbow to shoulder reddened, with slight swelling, warm to touch..Paient had Hypertension, GERD.Paient has the following illness history - Hypertension, GERD. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 22. (OMIC) Patient received Pneumovax at routine physical on 3/22/2006 about 11:30am. Complained of burning during injection. That afternoon worsening pain, redness and swelling. Seen in our walk in clinic that evening with 5+cm swollen, red, tender, indurated right deltoid. Treated with 80mg IM depo Medrol. Had swallowing difficulty 20-30 min after taking Cipro 3/23/2006. Went to ER treated for anaphylaxis with EPI, IV Benadryl, Solumedrol and Pepcid. Discharged on a Prednisone taper. Seen at 5:00 pm 3/24/06 a.Paient has the following illness history - Allergic codeine, nonsmoker, HTN, GERD, asthma, allergy, depression, osteoporosis, s/p breast cancer, hyperlipidemia..Patient was receiving Norvasc, Lipitor, Zyrtec, Advair, Seroquel, Prevacid, Lotensin HCT. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, child 00.4 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 09. Persistent fever and irritability for 48 hrs after vaccines.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 24. Serum sickness, arthralgia/fever.Paient has the following illness history - CAD, HTN, DM, Allergy Atacand, Lipitor..Patient was receiving Norvasc, Zoloft, ASA. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Moderate upper arm swelling, redness, and pain, nausea, myalgias..Paient has the following illness history - Allergies: codeine, mycin, Talwin, Demerol, Claritin D, Vioxx, Peanuts, Mold, dust, trees, all narcotics except Darvocet, Flexeril..Patient was receiving Zyrtec, Celebrex, Nasonex, Estadise, Nexum, Skelaxin, Tramadol, Acular, Albuterol, Azmacort, Elidel cream, Multi Vit, Fiberon, calcium, Ferrous sulfate, Sudafed.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 18 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 13. Extreme pain by late afternoon - could not sleep because of pain- took Tylenol. Saw doctor on 12/15/2005, was given anti-inflammatory medicine- doctor stated immunization possibly given too high and in joint - arm fine as of today..Paient had NO.Paient has the following illness history - NO.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Right upper arm swelling, pain warmth. Rx: cool compresses/ibuprofen..Paient has the following illness history - Codeine/2 pack/urticaria allergies. On teraydine for acute.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 24. No reaction to medication. Possible injection to wrong site. Subacromial space. Causing lt shoulder and neck pain, moderate pain..Paient has the following illness history - DM II, HTN, Hyperlipidemia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 02. Upon admission, patient reported erythema and warm to touch at the pneumococcal vaccine injection site. She received the vaccine as an outpatient.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 04. Left upper arm is red, and hot to touch with a welt at the injection site, temperature has been between 100 and 100.6 (oral). Client is taking Tylenol for fever and discomfort, cool compress to injection site.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 1996, 01. Information has been received from a male consumer regarding a case in litigation who in 11/1996, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included a dos of influenza virus vaccine (unspecified). Within 24 hours, the patient was in the ER with saucer size blotches on his torso, thighs, arms, and sides. Prednisone was prescribed (in descending amounts) along with clobetasol propionate (Temovate) and was ineffective. Two months later, it erupted again with the.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 29. 8-10cm erythema, swollen area. Prescribed steroids and Augmentin..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 20. Rapid onset in 12 hrs of left arm swelling/redness. MRI confirmed cellulitis, superficial fascitis. 4/21/06 Discharge Summary of 16 pages reviewed. Final diagnosis confirmed cellulitis. He appeared slightly confused at times, but seemed alert and appropriate when questioned. He described the pain as 10/10..Paient has the following illness history - S/P Splenectomy, Migraine HT;s, Seasonal allergies. 4/22/06 Per review of d/c summary, pt was told in the past that he had borderline diabetes..Patient was receiving Nortriptyline, Zomig, Lipitor, ibuprofen, Claritin and Depakote.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 15. Pneumococcal 23 given SQ to patient, returned next day with swollen painful arm. Admitted 3/17 - 3/19 for cellulitis at injection site..Patient was receiving Singulair, Zyrtec, Concerta, Ditropan.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 04. Cellulitis at injection site in left deltoid 4" x 4" red swollen area..Paient had Annual Physical.Paient has the following illness history - Hypertension, Increased cholesterol, GERD.Patient was receiving Premarin, Zocor, Baby ASA, Prilosec, Hyzaar, Advair Discus.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 25 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 21. On 3/22/06, day after injection, pt reported left upper arm swollen, red, and painful. Seen by Dr on 3/23 had low grade fever, instructed to take Benadryl, Motrin and call if S/SX worsen. 3/24 pt advised to go to ER for evaluation. Hospital reports induration increased, pt left arm mobility impaired due to pain. Admitted placed on Vnosyn, not effective, changed to Vancomycin..Paient has the following illness history - Chronic Neutropenia, Glycogen storage disease, Crohn's disease..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient, 75 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 04. Extreme tenderness at injection site beginning about 8-10 hours following administration into left deltoid 1 1/2 - 2" area of pale erythema at site.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Redness, swelling below injection site with fever..Paient has the following illness history - PCN, Darvocet, Sulfa, ASA, HTN, Gout, CAD, osteoporosis.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Erythema To RT Deltoid post Pneumovax very itchy spreading. Malaise no fever. Placed on Keflex and Benadryl.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 22 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 11. Edema, pain, induration - improving. Treated with Indocin, Benadryl, APAP, Cold packs..Paient had ETOH detoxification/ in withdrawal.Paient has the following illness history - GERD, Asthma, Hepatitis C. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 29. On 03/29/06, patient presented to the immunization clinic in the am for Tdap and pneumococcal as per ordered by Her Dr. On 3/30/2006 pt had appt with her doctor for other reasons. Pt was sent to immunization appt to all out VAERS form. Per pt. Doctor prescription. PCN and was told to apply ice to shot site to decrease swelling. Per pt about 6:00pm she c/o stiffness and soreness (scale of 1-10 per pt pain rates 7) where pneumococcal was given. SQ site was warm to the touch and measured 64 x 69cm, no other co. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 13. Extreme pain in arm of injection site, 5 hours later pain caused nausea and dizziness. Next day, heavy nasal and sinus congestion. On the third, I reported to the local walk-in clinic because it was a Sat and my doctor's office was closed. I could not breath through my nose, had post nasal drip that choked me. I was very wheezy, doctor gave me a breathing treatment with a nebulizer for 10 minutes that lasted for 3 hr. He also prescribed albuteral air chamber. This treatment lasted only 30 minutes. I we.Patient was receiving HCT, Lipitor..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 11. Swelling, redness, heat at injection site a few hours after immunization. Hives pt took Benadryl to reduce symptoms. Reported adverse effect to Pharmacy the next day.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AR, USA. Female patient, child 4 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 13. Large local reaction with papulo-macular erythematous area with 8cm X 8cm on R upper thigh with STS and R thigh diameter (31 cm) L thigh diameter (30cm), increased STS noted after 12 hrs s/p shot. Fever to 104 after 12 hrs s/p shot.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 56 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Body aches, high fever, chills.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 29. Pain, redness, induration at injection site. Pain mediates entire arm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AL, USA. Female patient, 22 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 10. Reports He ETOH abuse and low immune system. On 3/10 he requested following TD, Flu, Pneumonia vaccine, even though he is only 22 YR old. On Sat 3/11, client reports awakening with red, swollen, tender left arm with limited ROM. Around 2pm, noted fever 102.4, and feeling achy all over. Saw DR who prescribed Z Pac 5day and Ibuprofen. 3/14 Still C/O some tenderness, and swelling able to move arm better, but still not full ROM..Paient had Non specific SX: cough, weakness.Patient was receiving Steterra, IBP, Tylenol PRN.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 19. Red swollen warm painful redness 8 inches in length and 3.5 inches in width pt. does state site is looking better than it did last noc. informed pt. to take otc benadryl and ice to site. if worsen to report back asap..Paient had YES, PRESSURE IN BILAT. EARS LIGHTHEADED UNSTEADY WHEN AMB..Patient was receiving FOSAMAX 70 MG, CA 1200-1500MG/D, MVI. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 19. Received phone call at 4:30pm. Stated child was seen in office today for reaction to vaccine received in Right Deltoid (Pneumovax). Stated red, swollen area around injection site, no fever, warm erythema with mild edema on right upper arm, no infection noted. Stated was a local reaction and mom was advised to watch area for cellulitis and to return to office in 2-3 days if no better..Paient has the following illness history - Hearing deficit.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 12. Pt recieved pneumovax on 4/12/06 and was feeling fine at the time. Also had lab testing routinely done that day-CMP,Lipid, TSH, T4,CBC. Labs and vaccine ordered. Pt. returned on 4/13 complaining of shortness of breath, chest pain, fatigue and fever overnight-evaluated by me. Vital signs were normal and exam unremarkable that day and was reassured- EKG normal. Given durabac samples for pain and told to rest and drink fluids. also had labs from day before checked and had lft elevation but otherwise OK and tol.Paient has the following illness history - Trigeminal Neuralgia, Hypothyroidism.Patient was receiving lipitor 20 mg qd, Tegretol 200 mg qid, Neurontin 800 mg qid, Synthroid 50 mcg qd, MVI, Calcium.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 17. On 4/17/2006 at 4:15pm, following day mildly painful, 2 day later painful and red, today 4/20/06, still red and swollen 16x22cm..Paient has the following illness history - Seasonal Allergies. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient, child 20.7 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 12. Immediately after giving the second injection, PPV23 patient became flaccid, started crying and put head back. She turned cyanotic around mouth eyes and nose. Was brought directly to EMS where O2 was started (around 4:45pm) and epinephrine 01 MES of 1:1000 SQ..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. 04/19/2006 pt presented to center with temp 102.3 and left upper arm swollen, warm, erythematous. 4/20/2006 area if erythema increased. Pt admitted to hosp..Paient had Hx of cough x 2 days.Paient has the following illness history - HgB SS disease.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 19. Pt received injection 4/19. Had pain in arm at site. Woke up 4/20 with erythema from elbow to shoulder. Mild swelling right elbow above injection site..Paient had Sinusitis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female who was vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently, the patient experienced loss of sensation and use of her arm, numb paralysis which lasted for several days and weeks. The physician did not know if this was caused by the vaccine or the administration of the vaccine. At the time of the report, the patient was recovering. Loss of sensation and use of her arm, numb, paralysis were considered to be disabling. Additio.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 20. Temp 101, right area pain, radiating from shoulder to fingers day after injection, chilling, slightly swollen, hot to touch at injection site. MD advised Benadryl OTC 25mg BID, warm compresses to site. After Tylenol ore Ibuprofen PRN pain, Pt was not able to take Benadryl..Paient had Colitis.Paient has the following illness history - Dysrhythmia, cardiac.Patient was receiving Actonel, Adacel, Folic Acid, Imuran. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 21. Child was recommended to receive Pneumococcal vaccine per immunologist child received PCV instead of PPV..Paient has the following illness history - Bipolar disorder..Patient was receiving Benadryl, Lithium, Adderall. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 22 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 08. Information has been received from the mother of a 22 year old hospitalized female with sickle cell anemia and no allergies who on 4/8/2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine, for sickle cell anemia. Concomitant therapy included dexamethasone (manufacturer unknown) and acetaminophen oxycodone hydrochloride (Percocet). It was noted that the patient was hospitalized for her sickle cell anemia. On 4/8/2006 she was released after receiving the pneumococcal 23v polysaccharide v.Paient has the following illness history - Sickle cell anemia, Hospitalization..Patient was receiving Percocet, Decadron tablets..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Resident received Pneumovax 0.5cc IM injection on 4/3/2006 in right upper arm. Area of 20cm x 27cm reported to be red, swollen, warm to touch. Resident complained of pain in area. Reaction noted by nurse 4/5/06..Paient has the following illness history - Allergies PCN, Cephalosporins. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Resident received Pneumovax on 4/3/06 0.5cc IM in right deltoid. 7cm x 7cm area of injection became red, warm, swollen and resident complained of pain in area. Reaction reported on 4/5/06 by nurse.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Resident received Pneumovax on 4/3/06 0.5cc IM injection. Area of injection became red, swollen and hard 16cm x 15cm. Resident complained of pain. Right arm/elbow. Reaction reported by nurse on 4/5/06.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 03. Resident received Pneumovax 04/03/06 0.5cc IM injection in left upper arm on 4/5/06, area observed 13cm x 14cm was red, swollen. Resident complained of soreness in area. Reaction reported by nurse on 4/5/06.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 12. 12-24 hours after vaccination, pt was sent to Extended care for pain, swelling in armpit and arm down to elbow, light headedness and a sore somewhat hoarse throat. TX Depo Medrol 80mg IM, Benadryl 50mg PO, Tylenol 1000mg PO Triamcinolone 0.1% cream topically..Paient has the following illness history - Allergic to PCN.Patient was receiving Premarin, Provera.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Local reaction, not feeling well.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 10. 4/10 received inj right deltoid about 11:00am 4/10 pm right arm swollen around site, skin hard, painful. 4/11 am increased swelling radiating to elbow at inside of arm, very painful. 4/11 pm entire arm bright red, blisters noted around inj site, pain radiating to wrist. 4/12 appt at appt RX Keflex 500mg QID x 10d. 4/14 pain gone, redness diminished no new blisters denied other s/s. 4/19 all above s/s gone..Paient had UTI.Paient has the following illness history - Allergy, Laminectomy, Seizure disorder, HTN, Osteoporosis, Hyperlipidemia.Patient was receiving Aleve, ASA, Calcium, Atenolol, Lipitor, Avapro, Fosamax, MTV.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 20. Had DPT and Pneumovax on 4/20/06 within 24 hours developed pain, swelling, redness at site of Pneumovax and temp 103.7, fever lasted until 4/24..Paient has the following illness history - Hypertension.Patient was receiving Cozaar, Thamterse, Ambien. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Left upper arm pain, swelling, redness. Pain radiating to distal arm, head, fingers. Ice and ibuprofen helped relieve discomfort. Swelling and redness resolved at office visit 4/19 9AM. Still left upper arm soreness but improving..Paient has the following illness history - Augmentin-Jaundice. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 20. C/o arm being swollen, red, achy, warm to touch. Tx: ice, Tylenol prn. Zyrtec 10mg 1 daily x 5 days..Paient has the following illness history - CAD, Neuropathy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Redness, swelling of left arm..Paient has the following illness history - IBS, Osteoporosis.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 21. Child was recommended to receive "pneumococcal vaccine" per Immunologist. Child received PCV instead of PPV..Paient had cerumenosis.Paient has the following illness history - Bipolar disorder.Patient was receiving Benadryl, vitamins, Adderall. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 45 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 20. Pt reported symptoms of pain,tenderness and swelling in left upper arm at injection site. Pt rated pain at 8/10. She complained of feeling ill-after resting felt better. During follow up visit with doctor, her temperature was 97.1 F. Doctor's impression was that she was having a severe local reaction. Doctor wrote a prescription for Lortab for pain if needed..Paient has the following illness history - Diabetes, Synalgos allergy, hypothroidism, allergic rhinitis.Patient was receiving Aspirin, Claritin, Glipizide, Lantus, Levoxyl, Lisinopril, Multivitamin, Vitamin C. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 93 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 21. Pt stated she was unable to raise left arm when taking her shirt off and had instant pain over the left anterior portion of her shoulder. She had immediate nausea and did vomit. Small movements produced pain at time of follow up visit. She stated the pain seem to be traveling up her neck and down through her back at times. She was advised by NP to take Aleve one tab twice daily. She was also given Darvocet N 100. Also advised to use Tylenol 2 tabs for breakthrough pain as she needs to..Patient was receiving Aspirin, Atenolol, Enalapril, Lovastatin, Norvasc, Plavix.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 26. Pt complained of red and swollen left deltoid. Site of Pneumovax injection on 4/26/06..Paient had Recheck HTN visit.Patient was receiving Lipitor, Lexapro, Lisinopril. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 24. Back pain, muscle aches, headache, abd. discomfort, upset stomach, chills, edema at site with redness, warmth, anorexia and insomnia. Had surgery scheduled for 4/25/2006 and was cancelled. Was started on Cephalexen 500 mg. twice daily for 10 days..Paient had Sore throat.Paient has the following illness history - Diabetes, hypothyroidism, HTN, Ostium Secundum Atrial Septal Defect.Patient was receiving Furosemide 20 mg daily Diovan 320 mg daily, Norvasc 10 mg daily Toprol XL 200 mg daily Prevacid 30 mg daily Metformin 500 mg daily Levothyroxine 50 mcg daily ASA 81 mg daily. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient, child 20.1 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 24. Fever to 104.5 late same day of vaccine. Emesis and persistent fever to 101.0 since (2 days) 8cm area red, indurated skin left thigh IM site..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pneumovax 0.5CC IM LD was administered 12/28/05 at 1515. 12/29/05 she presented at ER saying a few hours after shot she noticed redness in injection area. It was accompanied by severe pain radiating to the left shoulder and upper back. 5/16/06 -22 page DC summary and medical notes from hospital stay 12/29-12/31-2005 at Lourdes Medical Center-Pneumovax on 12/28/05-presented to ED on 12/28/05, approximately 2 hours after injection with c/o swelling and pain in left arm and shoulder, the site of the vaccine, w.Paient has the following illness history - CAD, hyperlipidemia, hypothyroid.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 25. Pt received vaccination 4/25/06. Pt called office next morning c/o arm swollen and cannot bend. Pt came in for exam..Paient has the following illness history - DM, HTN.Patient was receiving nystatin powder, Milarais 24mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 01. @ days after injection of pneumococcal vaccine, she developed a reddened area about 3" in diameter, some soreness, and slight swelling of area. She is to use ice to area and Tylenol..Paient has the following illness history - Acute Renal Failure; Hearing loss; Allergic Rhinitis; Breast Cancer; Hyperlipidema; Menopause; DVT; Celft palate; Basal cell carcinoma; Supraventricular tachycardia; Pulmonary embolus; ARDS..Patient was receiving Vitamin C; Sudafed; Nasonex; and Alavert.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 32 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 28. Pneumovax 0.5cc 4/28/2006-4/29/2006 mid-day (+) fevers, diarrhea L deltoid red, painful. Unable to lift arm. ER-temperature 103-LP done-Keflex 500 po qid x 10 days, Motrin prn. Seen in clinic 5/1/06..Paient had HIV; Acute pharyngitis.Patient was receiving PPD 0.1cc-Parke Davis-23081-LFA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 24 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 01. Pneumovax vaccine 0.5 to right deltoid on 5/1/06 12pm pt noted pain at infection site that evening and warmth no fever and erythema deltoid, right axilla. returned to clinic 5/2. Cephalexin 500 QID 10d, Codeine PRN..Paient had HIV, Bipolar.Paient has the following illness history - HIV, Cleft palate, Cleft Lip..Patient was receiving PPD.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 01. See vaccine schedule below. 48 hours after receiving YF and other vaccines on 5/1/06, and 4 hours after receiving Pneumovax and Menomune on 5/3/06, she developed shaking chills, and shoulder pain. Today I received a phone message that she is hospitalized with fever 103 and stiff neck..Patient was receiving Lipitor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Red rash on shoulder/arm/chest/back about 20 x 30cm, starting from injection site (TD)..Paient had CPE.Patient was receiving Levoxyl; Fosamax.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 16. ERYTHEMA, PRURITIS RIGHT ARM SITE OF INJECTION, FEVER, COUGH. gIVEN 10 DAY COURSE AUGMENTIN.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 01. Swelling, redness, warmth right deltoid area. Discomfort, tenderness at site low-grade fever. Advised cold pack, Tylenol prn. Given 1000mg Tylenol po in office..Paient has the following illness history - HTN; AF; Hyperlipidemia; Osteoarthritis; Colon Polyps; Bilateral knee replacement.Patient was receiving lisinopril; Crestor; Warfarin; Digitek. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 26. Within 3 hours of vaccine administration she felt inflammation at site of injection. By the next morning, inflammation with heat and firmness in area covered an 18 X 15cm oval area of L upper outer arm with some tenderness at site of edema, slight tenderness..Paient had UTI.Paient has the following illness history - HTN; Onychomycosis; hyperglycemia; abnormal lft's; arthritis..Patient was receiving Bactrim DS bid x 7d (4/26/06)' DynaCira CR 10gm; HCTZ QD. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 05. SX began 05/03/06 pm after injection site a small bump, arm red from shoulder to elbow, warm to touch, not itching. At that point pts wife stated he had Pneumovax 1/05, Pt did not remember..Paient had Cough.Patient was receiving Diazepam. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 17 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 05. Spiking fevers to 103.9, 6 inches of erythema at inoculation site photo available..Paient has the following illness history - Acne, HX Adenoid resection..Patient was receiving PPD.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 10. Dizziness and swelling for 2 weeks..Paient has the following illness history - Diabetes type 2, Hypertriglyceridemia, eye lesion..Patient was receiving Advicor, Glucotrol, Move free with Glucosamine and chondroitin, Flaxseed, Alcarnatine, Omega vitamin MSM, Folic acid, Allerest, Coricidin, Aspirin..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 25. Right arm violous edema, sharply demarcated involving lateral arm, no ulcers, no deficits nerve sense or motor deficit..Paient had burning, chills, redness right arm.Patient was receiving Lipitor 10mg, ASA 81mg, Imdur 60mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 03. 3-4 hrs after injection, pt developed a lot of pain followed by redness and swelling that evening along with chills. c/o deep ache down her left arm to left hand the next morning. Will use ice, Tylenol, Benadryl.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 02. Following day patient reported red, hot arm with red streaks under arm. Notified local MD placed on antibiotics given cortisone shot..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 31. On 3/31/06, at Outpatient Clinic, I recieved a Pneumovax Injection. I had moderate pain in left knee and had not slept adequately in two months.(normal knee deterioration-no accident relation) That day; I told my assigned physician that I needed help with my knee pain. His primary concern was general health care and re-assignment of Rx to hospital protocal. As a typical 'new' patient; I was told (by Staff nurse) after Dr. consultation, that the Pneumonia vaccination was 'a good idea' and I was supposed to h.Paient had Knee Pain; Chest congestion..Paient has the following illness history - Lung damage due to prior surgery from surgery in 1994 for head injury. Lumbar surgery 3/06..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 43 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 27. Pt administered pneumococcal vaccine in the morning on 4/27/06. Several hours later, in the afternoon, pt noted redness, swelling and pain at injection site that was also spreading to axilla. By evening pain had become so bad patient found it difficult to move affected arm. On 4/28/06 pain, redness and swelling continued to worsen and patient had low grade fever. Patient took aspirin 325mg in the morning and evening with no symptom relief. On 4/29/09 again took aspirin 325mg twice daily and began to hav. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 25. Information has been received concerning a 68 year old female with rheumatoid arthritis, osteoporosis and pain who on 11/25/2005 was vaccinated (route unknown) with a dose of pneumococcal 23v polysaccharide vaccine (lot # unknown) and a jab of influenza virus vaccine unspecified. Concomitant therapy included diclofenac, leflunomide, tramadol HC1 (Tramadolor), cholecaloiferol, risedronate sodium (Actonel) and etanercept Enbrel. It was reported that a patient was a participant in a study. In the evening of 11.Paient has the following illness history - Rheumatoid arthritis, Osteoporosis, Pain.Patient was receiving Cholecaloiferol, Diclofenac, Enbrel, Leflunomide, Actonel, Tramadolor. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 57 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 20. 04/20/2006 received injection 4/21/06 site had soft tissue swelling, warm and hard to touch. Site was erythematous as well..Patient was receiving Allergy injection.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from UT, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 08. Patient presented to this Immunization Clinic on 8 May 2006 at 1300 hours stating PA-C had advised her to receive a Pneumonia Vaccine. Therefore, patient was vaccinated with Pneumovax(adult formulation)0.5ml given SQ over the right deltoid without any reaction noted at time of vaccination. Patient contacted this Immunization Clinic on 10 May 2006 stating she had localized redness, swelling, and heat at the injection site on her right arm and was advised to see a provider for further evaluation. Patient p.Paient had Patient was prescribed a Zithromaz Z-Pak on 8 May 06 by PA-C..Paient has the following illness history - Danazol.Patient was receiving Patient had PPD (TB skin test) 5 Test Units administered to left foreaarm on 1 May 2006 with results read on 3 May 2006 from left forearm as zero milimeters = negative. No other reactions noted at that time. Proventil 90 mcg Inhaler Sig:2.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 08. FEVER 101.6, VOMITING, REDNESS AND PAIN INJECTION SITE.Patient was receiving ALBUTEROL. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 09. Several hours after vaccine was administered, pt developed a red indurated rectangular area that was tender to touch at the site of the injection. Patient called office and MD instructed her to watch for worsening factors (i.e. fever), use Benadryl prn, Hydrocortisone cream prn, and ice. Instructed pt that symptoms should subside in a few days and that it is most likely an allergic reaction and not to get the pneumovax in the future..Paient has the following illness history - Novocaine.Patient was receiving Synthroid 125mcg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 25. Pain from shoulder to elbow, fever, chills, loose bowels, SOB, restless, decreased sleep, increase BP, fatigue. TX Aleve PRN pain, Avelox 400mg #5 x 5 days. Clarinex 5mg QD..Paient has the following illness history - Hypercholesterol, BPH, decreased WBC, decreased Platelets, seasonal allergies..Patient was receiving Lipitor, Lunesta, Nasonex, Udaminsp, Allegra..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from HI, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 05. Swelling and pain in arm just distal to injection unable to move arm for 2 days due to pain. Swelling and pain slowly resolving without treatment. pt has rheumatoid arthritis..Paient had Allergies Sinuses.Paient has the following illness history - Rheumatoid arthritis, allergic rhinitis..Patient was receiving PPD, Lexapro, Tums, Vit D,. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 15 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 09. Painful, red, hot to touch. When woke up Weds am 5/10/06 Pt states is not as sore today appears to be getting better.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 03. 05-03-06 Pneumococcal vaccine adm. 05-05-06 Pt. presents to clinic with s/s and diagnosis cellulitis at INJ site and surrounding area extending down to wrist. Pt had Levaquin treatment x10days with three office follow up visits before s/s resolved 05/15/06..Paient has the following illness history - Betadine.Patient was receiving Calcium, multi vit, Lipitor, Ecotrin ASA, Levoxyl, Fosamax, Nasacort.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 11. Right arm swelling, erythema, pain upper arm. Came in next day-dx allergic reaction. Given script for Prednisone 20mg bidx3days. When called to check on patient the next week-patient never filled script-thought it would upset her stomach. States arm is fine now..Paient had s/p strep pneumonia 3/06.Paient has the following illness history - Coumadin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 16. 05-16-06 Pneumococcal vaccine adm. 05-17-06 Pt. presents to clinic with approx 9x14cm erythema and feverish area surrrounding INJ site and distal left arm. Pt was treated with Keflex and Prednisone and instructed to return to physician if s/s didn't subside..Paient has the following illness history - zetia, pcn, sulfa, aciphex, ditropan, ultram, neurontin.Patient was receiving omnicor, zantac, singulair, lasix, nasocort, buspar, citracal, micalcin, premarin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2004, 26. Info has been received from a physician, via a company representative, concerning a 98 year old male who "two years ago", on 4/26/04, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. "Two weeks ago" on 4/26/06, the pt died due to non-pneumococcal cause. It was reported that the pt was hospitalized or had prolonged hospitalization and that the experience was life threatening. The non-pneumococcal cause of death was considered to be immediately life-threatening. Additional info has been. Patient died on -0/00/2006.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received via another company from a rheumatologist concerning an approx 84 yr old female with osteoarthritis concerning an approx 84 yr old female with osteoarthritis who in 2006 was vaccinated with pneumococcal 23v polysaccharide vaccine by a general physician. Subsequently, in 2006, the pt presented at emergency dept and was admitted with severe swelling and pain in arm. The pt had high temp of 38C degree. The fluid from the arm was drained and tested. The results showed severe inflam.Paient has the following illness history - Osteoarthritis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 16. Redness/pain at injection site began 8 hrs after injection, vomiting after 42 hrs..Paient has the following illness history - Titanium, Neosporin.Patient was receiving Keflex 500mg.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, child 10.4 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2003, 30. Information has been received from a RN concerning a 16 month old female who on 30Jul03 was vaccinated SC with a first dose of 0.5ml varicella virus vaccine live. Concomitant vaccinations given on that same day included a fourth dose of pneumococcal 23v polysaccharide vaccine (manf unspecified) and a fourth dose of diphtheria (+) pertussis vaccine (unspecified) (+) tetanus toxoid (manf unk). Almost immediately after the injection the pt experienced hives and redness around the injection site. Unspecified me.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 15. Pneumovax given on 5/15/06 right deltoid. 5/16 pt came to MD with right arm erythema and edema at inj site, despite use of acetominophine and ice packs x5. MD and Allergy MD saw patient and prescribed prednisone 60mg qd. 5/17 the patient returned with increased swelling and erythema to upper arm extending to elbow, erythema to shoulder and side of neck. Pt face is flushed and states she "does not feel well". No temp, chills or sweats. Pt stated she did take prednisone as prescribed. pt admitted to hospi.Paient has the following illness history - HTN, Allergic Rhinitis, Hx Colon CA with colon resection, Congenital Nystagmus, questionable TIAs.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 82 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 15. Patient reported redness, swelling and warmth at injection site. Warm moist heat to area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 04. Pt received Pneumovax 23 during hospital admission. Leucocytoclastic vasculitis developed after injection. Generalized erythematous nodules and papules were seen..Paient has the following illness history - Patient has a history of COPD and hyperlipidemia patient has NKDA..Patient was receiving Ciprofloxacin 200 mg IV q12b, Oxycodone/ APAP 5/325 PO q4prn. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 15. Severe Swelling of l upper extremity..Patient was receiving Fosamax.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 84 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 27. Both arms and shoulder froze after shots. Pt doesn't have full function of arms/shoulders. Experience pain and discomfort..Patient was receiving Aspirin/APAP/Codeine. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 22. Patient given Pneumovax IM in left deltoid on 5/22/06. Returned to clinic on 5/24/06 and observed a 5" area of warm erythematous skin around upper arm, approx. 1 inch below the injection site to the distal humerus. Tender to touch. Doctor instructed patient to use warm compresses and Advil 200 mg q 12hrs..Paient had Hepatocellular Carcinoma.Paient has the following illness history - Diabetes mellitus.Patient was receiving Atenolol, Lisinopril, Metaformin, Glyburide, Lantus, Asprin, Gabapentin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 19. Admitted to hospital on 5/21/06. States received "Pneumonia Shot" on 5/19/06. Right upper arm swollen and reddened, entire upper on upon admission. Diagnosis, cellulitis. Treated pt with Levaquin. Called Pharmacy for vaccine used there..Paient had Acute MI, Angiogram done..Paient has the following illness history - Allergies: Penicillin, Tetracycline, Sulfa; Hx MI..Patient was receiving Plavix, Nitroglycerin, Lipitor, Lopressor, Aspirin, Lisinopril, Evista, Synthroid.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 23. (OMIC). Pt received Pneumovax 0.5cc IM during general visit on 2/23/06. Pt was counseled on benefits and potential side effects associated w this immunization. At this time the pt also instructed to report any s/s ET acute distress, SOB, or rash, vaccine given in left deltoid on 2/23/06. On the 24th, the pt presented to the clinic as a walk in stating that his left arm was swollen, hot and sore. When examined upper arm was noted to be 1.5 times the pts normal size, with tenderness upon movement. The pt was.Paient has the following illness history - GERD, Hyperlipidemia, OA, COPD.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 07. Pt administered Pneumovax PPV 23 vaccine 0.5mL SC x 1. Pt experienced local reactions outside of normal. Pt experienced severe redness and pain at inj site. Malaise and increased temp reported. Temp was not recorded..Paient has the following illness history - Admitted for acute MI.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 06. Pt administered Pneumovax 0.5mL SC x 1. Pt experienced local reactions outside of normal. Pt experienced malaise in addition to severe redness and pain at injection site. Temp was not recorded..Paient has the following illness history - Pt admitted to hospital for chest pain and CHF.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 30 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 12. Information has been received from a health professional concerning a 30 year old female with asthma who on 5/12/2006 was vaccinated IM with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651320/1008P). On about 5/15/2006, the patient was seen in the office with an infected arm. She was admitted to the hospital that day for a possible staph infection. Laboratory diagnostic studies included blood and other test done in the hospital. At the time of this report, she was still in the hospital rec.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 22. Pt received Pneumovax 23 left deltoid, 5/22/06 at 4pm, within 1 hour swelling in left shoulder radiating to neck and down to antic cubital Fossa of left elbow, advised NSAID with Rocephin.Paient has the following illness history - All sulfa.Patient was receiving B12, Ogen.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 16. Cellulitis to left upper arm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 12. Pt received pneumococcal vaccine, developed reaction, swelling at the site, pain and induration..Paient had Admitted for colic, abdominal pain, syncope and collapse, pain, vertigo.Patient was receiving 2/11-2/14/06 Aztreonam IV, Hepatin, Lansoprazole, Meclizine, Vanco IV, Morphine, Naproxen. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 12. Admitted 5/10/06 discharged 5/17/06. Received pneumococcal vaccine (routine). Developed L arm rash, swollen arm. Treated with Tylenol, Keflex PO, warm compresses..Paient had abdominal pain, h/o rectal bleeding.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 24. FOUR HOURS AFTER THE SHOT HAD SOB, FEVER OF 103 DEGREES. DID NOT GO TO THE ER DUE TO THE COST. BETTER THE NEXT DAY. fEVER WENT DOWN. ALL SYMPTOMS GONE BY THE FOLLOWING DAY..Paient had NO.Paient has the following illness history - NO. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 22. Pt states the day after receiving the Influenza & Pneumococcal vaciines his Rt shoulder started to hurt with stiffness & the pain/stiffness started to progress down into his hips & knees. He has difficulty opening his Lt hand when he wakes up in the morning. He states he has a little arthritis in the Lt shoulder & "spurs" here & there" but his physician is not able to find the cause of the joint problems..Paient has the following illness history - Pt reported joint problems today 5/30/2006..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ME, USA. Female patient, 16 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 24. Patient developed fever and chills after receiving vaccinations. Area of injection developed a red erythema area. Patient admitted to hospital for suspicion of cellulitis and started on intravenous antibiotics..Paient has the following illness history - Pt two years post-liver transplant.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 22. Swelling pain right arm.Paient has the following illness history - Sulfa. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 18. Intense pain in arm, could not move arm, difficulty breathing. Morphine for Pain, Medrol..Paient has the following illness history - Emphysema (COPD).Patient was receiving Percocet, Keflex.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 16. One week after vaccination patient had severe polyarticular arthritis, and generalized weakness, was unable to get out of bed for several days. Had hand swelling, pain and stiffness lasting several weeks. All symptoms resolved after a short course of systemic steroids. Rheumotlogic workup yielded only mild DJD..Paient has the following illness history - Hypertension Fatty liver disease. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 18 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 31. Patient received Pneumovax at the clinic on 5/31/06. Developed redness and swelling at the injection site. Emergency room visits x 4 (given Rocephin x 2, Rx for Keflex and later Augmentin). Admitted to hospital on 6/4/06 for IV antibiotics, started on Clindamycin and Zosyn. Later Zosyn discontinued and Vancomycin initiated..Paient has the following illness history - Sulfa.Patient was receiving Birth Control Pills.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 28. Information has been received from a physician concerning a 74 year old female with reportedly no adverse drug reaction or allergy, who on 4/28/2006 the patient experienced deep vein thrombosis DVT and was admitted to the hospital. It was reported that the patient had blood work performed. The patient was given intravenous IV heparin. It was reported, that the patient was on enoxaparin sodium Lovenox therapy until the patients warfarin sodium Coumadin became therapeutic. Additional information has been requ.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 27 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 02. Per patient- Temp got as high as 102 F on 6/3/06. He called in to after hours nurse line on 6/3/06 and spoke with MD, who recommended taking Tylenol prn. He called in to clinic 6/5 for a work excuse letter and we had him come in to clinic to check his injection sites. Right arm was benign. Left upper arm was red, hot and swollen. Patient was sweaty and warm, but afebrile. He had taken Tylenol approximately 2 hours prior. MD examined him. Recommended using ibuprofen and acetaminophen to control continued fev.Paient has the following illness history - HIV. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 16. Arthus-Hypersensitivity reaction-severe swelling at arm and shoulder. Required surgical I & D. Onset about 2-6 hours. 06/22/2006-12 page medical records received from North Memorial Health Care, to include H&P and DC summary for hospitalization 2/19-2/22/06. Chief complaint: left shoulder pain. Receiving immunization and indicated that at the time of the injection she felt the shot hit something and had tingling immediately afterwards and pain. RX at office with Z-Pak for sinusitis. Pain increased, sought r.Paient has the following illness history - hypertension sinusitis glaucoma arthritis eczema.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 17. Pt developed redness and swelling in L arm, 4 hrs after receiving a Pneumovax. She has not had any fever. Pt was given an injection of Benadryl and of Kenalog. She was sent home with a RX for Benadryl and Keflex..Patient was receiving HTN meds. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 13. Arm pain, rash, redness, chills, streaking to axilla, infection, treated with ibuprofen and Augmentin.Paient has the following illness history - Asthma Allergies: Codeine, Iodine.Patient was receiving Advair, Albuterol, Singulair.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 04. Patient received three IM immunizations at once. Patient immediately reached for his throat due to apparent laryngeal spasm at approximately 12:00. Oxygen administered immediately, 25mg IV diphenhydramine given. Epinephrine not required. Discharged to home after abservation period. Later that night 05/05/06 @ 02:48 patient presented to the ED with fever to 102, vomiting for 90 minutes. Diphenhydramine and prednisone given in ED at approximately 04:43. Patient discharged from ED with Epipen, prednisone pres.Paient had ITP Aspleenic since 1997.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SD, USA. Female patient, 31 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 23. 05/25/06 at 1310 pt went to the Emergency Room for eval of Right Arm (deloid) where tetanus and pneumovax given on 05/23/06. Patient complained of onset fever on 05/24/06 evening. Site appeared to be erythema, warm to the touch, but muscle tissue soft otherwise with limited ROM secondary to pain per ER report. Sensation intact, motor intact, no vascular compromise and tendon function normal per ER report. Patient clinical impression was 1)Soft tissue localized reaction 2nd to immunization. 2)fever 2nd t.Paient has the following illness history - Ancef, Morphine, Diamox, PCN, Sulfa.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 03. After injection noted red, swollen L arm/shoulder. Severe induration/erythema involves most of upper arm..Patient was receiving Atenolol, Pravachol.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 17 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 02. Swelling, redness, hives localized to immunization site, pain radiating to back reaction progressed later on 6/4/ to fever, vomiting and chest pain prompting hospital admission.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 24 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 06. Within 24 hours, 1cm red induration lesion at injection site with 2 other lesions on same arm. One 4cm; the other 1cm. All in deltoid region..Paient has the following illness history - Asthma; NKDA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 24. Left arm red, muscle pain and swelling at injection site. Treatment: observe site..Paient has the following illness history - Hyperlipidemia; hearing loss; BPH; Hypertension; colon polyps; lumbar HNP; chronic fatigues; HCM; Cellulitis; CPE; Hand injury; Knee pain; pharyngitis acute.Patient was receiving Toprol XL 25mg 1 tab qd; Prinivil 40mg 1 tab qd; Diclofenac sodium 50mg 1 tab bid use prn for arthritis pain, avoid chronic daily use; Epi-pen; aspirin 81mg 1qd.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 31. Cellulitis developed with red, hot and firm areas at and adjacent to injection site. Started on antibiotic, antihistamine, anti-inflammatory and ice packs. Upper left arm 3" X 6" into axilla..Paient has the following illness history - HTN; Depression; GERD; MI; Shingles; Kidney Stone.Patient was receiving Lunesta; Toprol; Cytotec; Naprosyn; HCTZ; Nexium; Paxil; Fiorinal; ///; calcium. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 29. Approximately 36 hours after receiving pneumococcal vaccine patient developed edema, redness, and pain to left upper arm in deltoid region. Arm x-rayed; no fracture found..Paient has the following illness history - NKDA; PMH: History of Pancytopenia; Cirrhosis; Coronary artery disease; Chronic obstructive pulmonary disease; history of heart failure and resides in a nursing home.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 15. This pt had pneumonia vaccine 11/22/1989 with no reactions. She had /// again 5/15/06 and within 24 hours developed swelling of upper arm in area where she received it. The arm still swelling, 1 week later and there is some residual redness of upper arm as of 6/7/06..Paient has the following illness history - Sarcoidosis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 09. Diarrhea, vomiting, unable to breathe. I was sick for almost 2 weeks. As of today 6/8/06 I'm still coughing.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 07. Five days after injection of Adacel, c/o itching at site, red and hard area about the size of 50 cent piece. Advised to use Benadryl, cold compresses and Tylenol prn..Paient had Annual physical.Paient has the following illness history - Hyperlipidemia; right carpel tunnel syndrome..Patient was receiving Lipitor; ibuprofen; chondroitin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 13 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 14. Presented to Emergency Center later in the day of immunization complaining of right arm pain & swelling. Patient admitted to hospital for sickle cell anemia with hypoxia (O2 sat to 80%). Acetaminophen, morphine,empirically started on antibiotics, ketorolac. "Edema was possibly secondary to a reaction to Pneumovax.".Paient had Sickle Cell Anemia.Paient has the following illness history - NKDA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 88 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 30. Left upper arm with moderate redness and edema..Paient had acute abdomen.Paient has the following illness history - CODEINE, OXYCODONE ALLERGY.Patient was receiving famotidine, pantoprazole, hydrochlorothiazide, diltiazem, sertraline, valsartan, alprazolam, potassium chloride, fleet enema, psyllium laxative. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 31. Pt's L arm became swollen, red and tender. She states symptoms appeared about 24 hrs after vaccine. Tx: Benadryl and symptoms resolved..Paient had Ankle edema bilateral.Paient has the following illness history - Iodine, Sulfa, PCN, michdentin.Patient was receiving Lisinopril 10mg; Synthroid 25mg; Lipitor 20mg; aspirin 81mg. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 09. Patient received 1/2 dose Td due to local reaction in 1996. She experienced elevated temperature (100) numbness all over, worse in legs, rash evening of vaccine; presented to ER 6-10-06. No treatment; symptoms resolved..Paient had no.Paient has the following illness history - allergic to codeine; hypertension; osteopenia;osteoarthritis, esophagitis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 13. MD reported that patient received vaccination within 2 years of previous shot and had diffuse immunological reaction to left arm with red swollen tender hot area, "immunological memory". 6/16 arm better; less red, less swollen; positive antineutrophil cytoplasmic antibody.Paient had non q-wave MI; coronary artery disease, atrial fib.Paient has the following illness history - history allergy to codeine, penicillin, sulfa. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a 66 year old female consumer with history of reaction to [loratadine] (CLARITIN) and IgA who 8 years ago was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine. There was no concomitant medication. Subsequently, three and a half years ago, the patient reportedly was not immune and experienced pneumonia. She reportedly received two other doses of pneumococcal 23v polysaccharide vaccine after she was hospitalized. At the time of the report, the patient.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 09. The day after she received vaccination, she started developing erythema and swelling on the site of injection, which became tender, and started spreading slowly over deltoid area. When seen 3 days after vaccination, had cellulitis developed on right deltoid area, 3 fluctuation/abscess. I do not believe this was a reaction of vaccine per se, as any injection can break skin and become a site of entry to S. aureus infection..Paient had Allergic rhinitis.Paient has the following illness history - Allergic rhinitis; overweight.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 21. Cellulitis - large area of local reaction - arm. Seen in ER 3 times. She saw me on 12/27 when it was resolving..Paient has the following illness history - Celebrex; Vioxx.Patient was receiving Enalapril; Piroxicam.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 56 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 05. Swelling under right axilla. No temp. Tx: Antihistamines.Paient has the following illness history - Allergic rhinitis.Patient was receiving Synthroid; Allegra. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 12. Left arm cellulitis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DC, USA. Female patient, 17 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 14. Within 30 minutes of administration, pt developed localized swelling, erythema, ecchymosis and pain at administration site. (Vaccine was given SQ/IM due to her diagnisis of ITP.).Paient had ITP.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 12. Tender L Deltoid eschar with 1cm central skin necrosis. That slowly healed over 6 weeks without need for medications or surgical debridement or grafting..Paient has the following illness history - Penicillin.Patient was receiving Not relavent. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 84 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 24. Angioneurotic edema cellulitis approximately 6 cm in diameter..Paient has the following illness history - Discharge summary states vertigo, hypertension, renal insufficiency, cataracts. msv. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 14. Redness, swelling, fever, knobs under skin. Swelling goes down after aspirin and ice applied. Swelling returns after aspirin wears off. Started 15 days after shot. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 26. Patient developed swelling, redness, and pain on the same arm the vaccine was administered in. This developed ~ 24 hours after administration. Site of swelling and site of vaccination different..Paient had DVT, UTI.Paient has the following illness history - HTN, h/o CVA, CAD, seizure disorder.Patient was receiving IV Heparin, Vytorin, Levaquin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 23. Red and sore with infection Pneumovax 2.5 days achy, temp, sweating.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 26. Redness at injection site (by patient description), swelling, temp to 103 F, no itching, no wheeze..Paient has the following illness history - Asthma.Patient was receiving Advair; Albuterol; Singulair; Flonase; Spirina. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WV, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 19. Red, swollen arm day after Pneumovax administered. Prednisone and Keflex prescribed..Paient has the following illness history - Lung cancer, HTN, Hyperlipidemia, Asthma.Patient was receiving Ibuprofen, ranitidine, formoterol, flunisolide, simvastatin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WV, USA. Female patient, 57 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 19. Red, swollen arm day after Pneumovax. Presented to ER two days after Pneumovax. Treatment unknown..Paient has the following illness history - CAD, smoker, osteoarthritis, elevated PSA, Hyperlipidemia, HTN, Angina.Patient was receiving oxycodone, ranitidine, lactulose, diazepam, aspirin, atorvastatin, nitroglycerin, pentoxifylline, terazosin, finasteride, nitrofurantoin, colestipol.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 27. Patient's husband called for his wife two days after having received the vaccine with c/o redness, swelling, and pain at the injection. She also had chills with no fever, and a splotchy rash on the affected arm to her elbow.It was described as being much worse than any vaccine she had recieved. Arm felt heavy and had a lot of pain when moving it. Symptoms had gotten a little better today so they opted not to have evaluation by provider. She will continue to monitor the area, apply compresses, and take oral.Paient had No illness but had a swollen ankle she was evaluated for..Paient has the following illness history - No known allergies. Pt has aortic valve disease and hyperlipidemia..Patient was receiving Pt is currently taking, verapamil, lipitor, premarin.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, child 20.8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 13. Leg swelled up 6 cm hot area, refusal to walk, extreme local pain requiring narcotics.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, child 20.8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Pt's leg swelled up and he refused to walk.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 04. Information has been received from an LPN concerning a 65 year old female patient with a urinary tract infection (UTI), rheumatoid arthritis, hyperlipidemia, GERD, COPD, and no known allergies and a recent history of hospitalization for right flank pain (diagnosed with UTI) who on 05/04/2006 or 05/05/2006 before being discharged from hospital was vaccinated IM in the deltoid with a dos of pneumococcal 23v polysaccharide vaccine Concomitant therapy included atorvastatin calcium (Lipitor) and ciprofloxacin hy.Paient had UTI; COPD; GERD; Rheumatoid arthritis; Hyperlipidemia.Paient has the following illness history - Medical History: Hospitalization. Concurrent conditions: UTI; COPD; GERD; Rheumatoid arthritis; Hyperlipidemia.Patient was receiving Lipitor; Cipro.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a health authority concerning a 36 year old male who on 11/10/2005 was vaccinated intramuscularly in the arm with a dose of pneumococcal 23v polysaccharide vaccine (lot #648713/1336N, batch #hv24420). Concomitant suspect therapy given intramuscularly in the same arm included a dose of influenza virus split virion 3v vaccine inactivated (Enzira) (batch #02701). That same day the patient experienced a severe systemic reaction. The patient felt unwell (fatigue) and feverish w. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 16 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 05. Paleness, weakness, rapid heart rate, dizziness, general malaise. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 27. Red, swollen area left deltoid.Paient had Cough.Paient has the following illness history - Hypothyroidism, hyperlipidemia, hypertension, osteopenia..Patient was receiving Synthroid, Diovan, ASA, HTZ, MVI, Calcium, Lipitor. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 27. Pt in for complete physical on 06/27/06 and a pnemovax was administered. Pt called on 6/29/06 & c/o redness, swelling, and discomfort at injection site as well as a fever. Pt instructed to use tylenol or ibuprofen as needed and to call if symptoms worsened or did not improve..Paient had Pt described redness, swelling, and discomfort at injection site accompanied by a fever..Paient has the following illness history - asthma/ copd hypothyroidism carotid stenosis pud/ crohn's disease hyperlipidemia osteopenia.Patient was receiving actonel 35mg q wk asacol 400mg 3 tabs bid synthroid 50mcg q day lipitor 20mg q day nexium 40mg q day singulair 10mg q day advair 250/50 2 puffs bid asa 81mg q day multi-vitamin q day zyrtec d prn albuterol prn glucosamine chondro. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 11. The day after vaccination (6/12), there was redness and warmth at the site of injection. The nurse marked it to assess swelling. The patient was afebrile and able to move the arm with no limits. On 6/13, swelling and warmth was increased, so IV cefazolin was started due to suspected cellulitis. The patient received 2 days of cefazolin and was discharged from the hospital 6/15. The reaction was improved..Paient had C diff diarrhea.Paient has the following illness history - C. difficile diarrhea, s/p bilateral knee arthroplasty, hypertension, hypercholesterolemia, anxiety.Patient was receiving vancomycin 125mg po qid, metoprolol 50mg bid, enoxaparin 40mg sq daily, atorvastatin 20mg daily. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 07. Information has been received from a physician concerning a 62 year old male patient with left hemiplegia and a history of stroke several years ago who on 06/07/2006 was vaccinated IM in the the left upper arm with his second dose of pneumococcal 23v polysaccharide vaccine (lot #650835/0966P, batch #nb29850). A few hours post vaccination the patient developed an injection site reaction with redness and warmth. In the evening the symptoms worsened and he developed swelling of the whole arm down to the finger.Paient had Hemiplegia.Paient has the following illness history - Stroke; hemiplegia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 28. Swelling of arm, pain, rash as well as swelling of her throat. ER 6/28.Tx with ?? and Benadryl. Treated with Keflex 500 mg QID for 1 week begining 6/30..Paient had No.Paient has the following illness history - Diabetes Type 2 Hypertension.Patient was receiving avandia 8 mg ASA 81 mg HCTZ 12.5 mg Zestril 20 mg.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 26 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 05. Ten minutes after injection patient complained of severe itching. Dime sized redness noted at injection site. Patient was provided with an ice pack and instructed to use some Benadryl..Paient has the following illness history - Allergies: Morpine, Dilantin, Depakote, Nickel, Latex, Paper tape.Patient was receiving Humalog, HCTZ, Lantus, Levothroid, Lipitor, Lisinopril, Lortab, Naproxen, Trazadone. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 21. Rash developed around injection site. Hot to touch, raised. Rapidly developed (with in one hour of injection)..Paient has the following illness history - ADD.Patient was receiving Adderall XR. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 21. Discomfort, redness and swelling in upper arm. Treated with ice and elevation. Seen by physician..Patient was receiving Multivitamin, Metformin and ASA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 21. Redness, swelling, RU extremity down to medical elbow area. No axillary adenopathy. Trt: ice packs, elevation, antihistamines. Seen by Dr..Paient had Chapped lips (cheilitis).Paient has the following illness history - PCN, Sulfa.Patient was receiving Claritin, HCTZ, Levoxyl, Estradiol, Ambien.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 26. Patient complained of nausea, vomiting, fever (100.1), swelling and redness at sit of injection (left deltoid) IM. Adacel..Paient had No.Paient has the following illness history - II Diabetic, ED, Hyperlipidemia, fatigue.Patient was receiving ASA, lantus Insulin, Cialis, Lipitor, Androgel. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, swelling, pain in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 22 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Redness, swelling, warmth, pain in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Redness, warmth, swelling, pain in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 44 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 33 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 31 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in left upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 39 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in left upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 57 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 45 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, swelling, pain in right upper axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 45 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 38 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 26. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 26. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 32 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 30 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 37 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Left blank on form.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Redness/warmth/pain/swelling in axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 34 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper A axillary area. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 36 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in right upper arm axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper A axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 30 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper A axillary area.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 03. Pneumovax and DT Mon July 2, 2006 had DT several times past that July 3-4-5-6,2006. Fever 102, myalgias, arthralgias, unwell, pain lt arm site of Pneumovax..Paient has the following illness history - Breast cancer, asthma, acid reflux. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 22. Pt called several hours after the administration on 2/22/06 c/o pain and difficulty moving of left arm. Symptoms were at the highest level the first 3 days after immunization and she states today 7/11/06 that she has steadily improved since. Has recovered for the most part, presenting 7/11/06 with vague discomfort in the lower aspect of left arm, 3 to 4 inches above elbow.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 11. The patient experienced a full body arthritic reaction with joint aches in the knees and shoulders most prominent..Paient had Type 2 DM, hyperlipidemia, hypertension.Paient has the following illness history - see number 18.Patient was receiving MVI, metformin, asa, lipitor. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 07. Patient received Pneumovax on 6/7/06 to right deltoid. Patient returned 6/8/06 complaining swollen right deltoid . She was given Benadryl and Tylenol..Paient has the following illness history - Allergy to Iodine History of HSV type 2, GERD, DJD.Patient was receiving Verapamil, Prevacid, Amitriptyline, Nasacort, Albuterol, Azmacort, Vicodin, Cyclobenzapril, Methocarbamol, Acyclovir.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 10. Rash right arm, muscle pain (arms, legs), neck pain, fever and loss of appetite..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 28 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 21. Patient received Td shot and PPV23 on 06/21/2006. Today she states that her arm is sill swollen from the PPV23. On examination, the patient has developed cellulitis to the left deltoid (site of PPV23 vaccination).. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 16. Information has been received from a general practitioner concerning a 66 year old female with a history of pituitary adenoma, diabetes insipidus, pituitary hormone deficiency, pancreatitis, chronic obstructive pulmonary disease, allergic rhinoconjunctivitis and nephrolithiasis who on 16 June 2006, was vaccinated (route unknown) in the left upper arm with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 650833/0882P, Batch # NC72130). About twelve hours later, she developed severe swelling of the wh.Paient has the following illness history - Pituitary adenoma; Diabetes insipidus; Pituitary hormone deficiency; Pancreatitis; Chronic obstructive pulmonary disease; Allergic rhinoconjuctivitis; Nephrolithiasis.Patient was receiving Ciprofloxacin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 09. Patient present to clinic on 2/10/06 with "20 x 16 cm red elevated sore" Swelling started 2-3 hours after injection. Given prescription of Keflex 500 mg qid x 7 days and ibuprofin 800 mg tid. On 2/13/06 patient returned for follow up. Per chart note, "inner elbow continues with swelling, upper arm with decreased swelling, discolored yellow around injection site, pain decreased..Paient has the following illness history - Psoriasis; Hypothyroidism;Depression; Hypertension; Sarcoidosis..Patient was receiving Celexa 10 mg;Levothyroxine 75 mcg; Estradiol 1 mg;Calcium, Vitamin C, Zinc, and Vitamin E..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 27. Significant pain, erythema and induration in area (anterior and medial) around left deltoid. Significant streaking of tissue with well demarcated erythema, but no axillary node involvement. Fevers with temperature of 101 F. Symptoms began at 12 hours post administration and were still present on days. Treated with Ibuprofen (600 mg, QID) and antibiotics for possible cellulitis (Cefpodudine 400, BID x 7 OMS).Paient had A1 HIV, HTN.Paient has the following illness history - A1 HIV.Patient was receiving Lisinopril, Alprazolam, HCTZ.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Pneumococcal vaccine polyvalent Pneumovax 23, 0.5ml single dose vials. The expiration date is ambiguous. Lot number 0751P. It is depicted on the vial as 07Jun06. Interpreted as expiring June 6 2007 and June 7 2006.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 27. A 35-year-old female patient received an injection of pneumococcal vaccine on 06/27/06. On 06/28/06, at 0300 in the morning, 13 hours after the pneumococcal vaccine was administered, the patient complained of severe muscular pain in the right shoulder at the site of injection. The patient had not previously complained of any pain. Tylenol was administered to the patient as a rescue medication for the pain. No laboratory or diagnostic testing was done.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Hives left eye very swollen, rash on face, neck lasted a week. Went to DR for diagnosis and got Prednisone for 5 days and used over counter Benadryl..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 06. Pt developed erythema macular around the injection site one after the shot. Pt did not developed fever no hives. Area was slightly swollen. Pt was treated with Zyrtec improving. Pt was in the clinic today 7/17/06. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 20 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 17. Very pronounced local reaction. 4-5 inch diameter red, swollen, painful, hot area at location of injection. Red area expanded to about 5-6 inch diameter today. No improvement..Paient has the following illness history - Splenectomy years ago, allergic to PCN, sulfa, Doxycycline..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from LA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 19. Received TC from pts mother on 07/19/2006 at 3:30 pm. States pts right arm swollen. Instructed to apply cold compresses and take to ER and to call 911 it has problems breathing..Paient has the following illness history - Sickle Cell Disease.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 28 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 18. Pneumovax vaccination occurred 7/18/06 at 4pm. There was immediate pain with injection of Pneumovax. Pain worsened as the day progressed and peaked for next 48 hours. Injection was administered in left shoulder. All of left upper extremity was painful/tender to palpation. Erythema and edema of left deltoid occurred appx 12 hours later. Fever started appx 30 hours after injection with a max temp of 101deg F. I was evaluated by another physician at another clinic and was started on Avelox 400mg one tab.Paient had Was visiting facility for dermatology referral..Paient has the following illness history - Hx of Asthma, seasonal allergies, back pain, R shoulder SLAP lesion, bilateral lower extremity- exercise induced compartment syndrome, depression..Patient was receiving Advil, Tylenol.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Initial report received on 13Jul06 from another manf who had originally received the report from a healthcare professional. A 69 yr old female pt with a past medical history of allergy to Penicillin (hives), and who had a current work related injury of left leg contusion with probable hematoma, had received an intra muscular dose of Fluzone 2005-2006, lot number U1912AA and a first IM dose of Pneumovax 23, lot number 650649/0790P, on 07Nov05 at 16:30PM. The sites of administration were not reported for eith.Paient had At the time of vaccination the patient had a work related injury of left leg contusion with probable hematoma..Paient has the following illness history - The patient has a past medical history of allergy to Penicillin that causes hives..Patient was receiving Tylenol; Antibiotics ("Keter"); Prednisone.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OK, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 12. Malaise, swelling, throbbing to 3 inches below the right elbow, radiating to inner right arm, painful to touch. 10-13-05 started Benadryl and Aleve every 4-6 hours. 10-17-05 swelling and inflammation gone but aching remains. Will continue Aleve. 10-19-05 tenderness only at injection site..Paient had No.Paient has the following illness history - Shellfish, MSG, alcohol Auto immune liver problem Arthritis.Patient was receiving Urso, Premarin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OK, USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Client stated she woke up Sat morning with red welts on arm, nausea, shortness of breath.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OK, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 01. Redness and swelling below immunization site.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OK, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2004, 26. Client complain of severe pain under right arm-axilla unable to move arm above 45 degree angle. Pain sometimes radiate down arm to hand. Upper inner arm is warm to touch. Referred to Doctor, he diagnose lymph node infection patient put on Bextra 20mg daily.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2005, 28. Information has been received from a pharmacist concerning a 71 year old white female with no relevant medical history reported who at 06:10 on 28-APR-2005 was vaccinated subcutaneously in the left arm with a first dose of pneumococcal 23v polysaccharide vaccine. It was reported that the patient had pneumonia at the time of vaccination. At 12:00 on 28-APR-2005, the patient developed redness, warmth and swelling at the injection site. Subsequently, the patient recovered. The reporter felt that the patient's.Paient had Pneumonia. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 57 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 29. Initial and follow-up information has been received from a registered nurse and a physician concerning a 57 year old white female patient with chronic obstructive pulmonary disease, reactive airway disease, hypertension, hyperlipidemia, pneumoconiosis and allergies to penicillin, erythromycin, prochlorperazine, and oxycodone (+) aspirin who at 03:50 on 29-JUN-2005 was vaccinated IM in the right deltoid with a first 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (Lot# 649692/0371P). Concomitant thera.Paient has the following illness history - chronic obstructive pulmonary disease, reactive airway disease, hypertension, hyperlipidemia, pneumoconiosis and allergies to penicillin, erythromycin, prochlorperazine, and oxycodone (+) aspirin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2000, 03. Information has been received from a certified medical assistant concerning a 69 year old patient with high blood pressure, GERD, IBS, and lots of allergies, who on 5/3/00 and on 8/22/05 was vaccinated with a first and second dose (lot # 647661/0055R) of pneumococcal 23v polysaccharide vaccine, respectively. After the first dose, on 5/3/00, the patient developed a 4x6cm red area on left arm and was diagnosed with cellulitis. After the second dose the patient developed a swollen red area at site of injection.Paient has the following illness history - Blood pressure high; Gastroesophageal reflux disease; Irritable bowel syndrome; Hypersensitivity.Patient was receiving Prevacid.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 13. Information has been received from a health care worker concerning a patient who on 13-SEP-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 649981/0704P or 650451/0750P). On 15-SEP-2005 the patient was seen by a physician, after developing a local reaction described as a large swollen painful area in left arm at site of injection down to forearm. The patient was placed on Keflex and Domboro soaks. At the time of the report the patient was in the process of treatment. No prod.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 30. Information has been received from a registered nurse concerning a 32 year old male who on 30-SEP-2005 was vaccinated IM with 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (lot # 650649/0790P). On approximately 30-SEP-2005, the patient reported that he went to an urgent care facility due to a severe localized reaction. He was diagnosed with cellulitis and placed on cephalexin (Keflex). A product quality complaint was not involved. Cellulitis was determined to be an other important medical event (OM.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 20. Information has been received from a registered nurse concerning a 51 year old female who on 20-SEP-2005 was vaccinated SC with a 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (lot # 650649/0790P). On an unspecified date in approximately September 2005, the patient went back to her physician and was diagnosed with localized allergic urticaria and was placed on methylprednisolone (Medrol) dose pack. A product quality complaint was not involved. Localized allergic urticaria was determined to be an ot.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a licensed practical nurse concerning a 68 yr old female pt with an allergy to PCN and codeine and a past medical history of carcinoma of the uterus, GERD, and lumbar spinal stenosis, who on 28Sep05 was vaccinated in the left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 650084/0605P). There were no other concomitant vaccination administered at the same time. On the day of vaccination with pneumococcal 23v polysaccharide vaccine, 28Sep05, the pt reported.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 04. Information has been received from a RN pharmacist concerning a 53 yr old female with a sulfa allergy who on 04Oct05 was vaccinated IM in the deltoid with her second 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650649/0790P, also reported as lot 650648/0967P). It was reported in follow up information that the pt developed soreness, redness and tenderness at the injection site and into her chest area on 04Oct05 at 8PM. She required medical intervention and was diagnosed with cellulitis and was.Paient has the following illness history - Sulfonamide allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 11. Information has been received from a physician concerning a 47yr old female with sulfa allergy and diabetes who on 11Oct05 was vaccinated (left deltoid) with 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Within 24 hrs, on 12Oct05, the pt called the office and complained of pain at the injection site. On 13Oct05 the pt developed headache, hot, induration and swelling at injection site. The pt was treated with acetaminophen (Tylenol) and ibuprofen (unspecified). As of 14Oct05, the.Paient has the following illness history - Sulfonamide allergy; diabetes. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a RN concerning a pt with a history of pulmonary disease who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 0650643/0790P). The registered nurse reported that the pt developed redness, swelling and heat in the injection site arm after vaccination, during the past 3 months. The pt received oral antibiotics. At the time of the report, it was unk if the pt recovered. The RN felt that redness, swelling and heat in the pt's injection site arm was considered to.Paient has the following illness history - Lung disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 12. Initial and follow-up information has been received from a pharmacist concerning a 76 year old male who on 12-OCT-2005 was vaccinated intramuscularly, with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot # 651539/0607R). It was reported that this was the first dose of pneumococcal 23v polysaccharide vaccine that the patient had received. On 12-OCT-2005, the patient was also vaccinated intramuscularly in the left arm with 0.5 ml dose of influenza virus vaccine (unspecified). On 13-OCT-2005, the p.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a health professional concerning an adult patient who, in the last month, in approximately October 2005, was vaccinated IM with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot # 649914/0578P). In approximately October 2005, in the last 30 days, the patient experienced cellulitis at the injection site and was treated in the hospital with IV antibiotics, recovered and was released. It was noted that the patient recovered within 3-7 days post vaccination. It was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 16. Information has been received from a health professional concerning an adult pt who less than 2 days ago on approx 16Oct05 was vaccinated IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. (lot 649914/0578P). In Oct 2005 the pt experienced an injection site reaction including redness, swelling and local pain at the site. The pt was treated with diphenhydramine hcl (Benadryl). At the time of this report, the pt was still recovering. It was also noted that this was a revaccination and the pt had.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning an adult pt who in the last 30 days, approx Oct 2005, was vaccinated IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot649914/0578P). In approx Oct 2005, over the last 30 days, the pt experienced an injection site reaction including redness, swelling and pain and was treated with diphenhydramine hc1 (Benadryl). The pt recovered in 3-7 days. It was also noted that this was a revaccination and the pt had at least one and pos.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 1997, 05. Initial information and follow up information has been received from a licensed practical nurse and medical records concerning a overweight 68 year old female who wears corrective lenses and has allergies itching to amoxicillin (-) clavulanate potassium Augmentin, grass and trees, hypertension (controlled), bilateral lower extremity edema (controlled. Physiologic flow murmur, coronary artery disease, hypothyroidism (recently decreased levothyroxine sodium dose because of TSH suppression), GERD, degenerative.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning one of four patients with a history of pulmonary disease who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 0550549/0790P). The registered nurse reported that the patient developed redness, swelling and heat in the injection site arm after vaccination, during the past 3 months. The patient received intravenous antibiotics in an outpatient setting. At the time of the report, it was unknown if the patient recovered. The registe.Paient has the following illness history - Lung disorder..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a pharmacist concerning an adult patient (age and gender not reported) with unknown medical history and unknown allergies, who in early Oct 2005, was vaccianted intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 644220/1119M) which had expired on 4/9/04. It was reported that the patient developed redness, swelling at the injection site and general malaise 24 hours post vaccination, was treated with cephalexin Keflex, and recovered fully in ab.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a registered nurse concerning a 54 year old female who on 10/24/05 at 4:30 pm was vaccinated with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 647661/0055R), in the right deltoid. Subsequently, she called the physician complaining of pain at injection site. The patient was seen in the office on 10/26/05 for cellulitis to right shoulder, induration, erythema in linear area below injection site and running medially around anterior aspect of shoulder and into.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a certified medical assistant concerning an adult (age and gender not reported) patient who in approximately Oct 2005 (over the last month), was vaccinated intramuscularly with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently, on an unspecified date, the patient developed an injection site reaction to include soreness, warmth, erythema and swelling. The patient was treated with antibiotics and on an unspecified date recovered fully..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 04. Information has been received from a registered nurse concerning a 77 year old male with unspecified medical history who on 11/4/2005 was vaccinated with Pneumococcal 23v polysaccharide vaccine (0.5 ml) (lot 650329/0747P), intramuscularly in the right arm. Concomitant therapy included unspecified medication. Subsequently the patient had a swollen, red, right arm, no fever. The patient was seen in the doctors office. The patient was diagnosed with cellulitis and was treated with oral antibiotics, The patient.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 09. Information has been received from a respiratory therapist concerning a female age not provided, who on 11/9/05 was vaccinated IM into the left arm with 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). The patient also received influenza virus vaccine unspecified on the opposite arm. On approximately 11/9/05, the patient developed hot, painful and swelling about size of half dollar at injection site. The physician ordered 50mg of diphenhydramine hydrochloride Benadryl PO and 30 mg p. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a licensed practical nurse concerning an elderly female patient who is a diabetic and has a history of mastectomy who on approximately 20-OCT-2005 "three weeks ago" was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #649914/0578P). "Within 24 hours of dosing" the patient experienced cellulitis. It was noted that if she would have waited a few more days before contacting the physician's office, would have required hospitalization. It was noted that s.Paient has the following illness history - Mastectomy, Diabetes..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a registered nurse concerning a 54 year old female with unspecified medical history who on 11/7/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine 0.5 ml (lot 650329/0747P) Concomitant therapy included unspecified medication. Subsequently, the patient developed a swollen, red arm. The patient was seen in the doctors office. The patient was diagnosed with cellulitis and was treated with oral antibiotics. The patient was reportedly doing well. The reporting nurse.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a 77 year old female with unspecified medical history who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot #650329/0747P) (0.5ml), intramuscularly. Concomitant therapy included unspecified medication. Subsequently, the patient experienced cellulitis. The patient was seen in the emergency room and was treated with antibiotics. The patient was reportedly "doing well". The reporting nurse considered cellulitis to be disabling. It.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a respiratory therapist concerning 49 year old black female educator (164 lb, 66") with no known drug allergies and sarcoidosis who on 07NOV-2005 was vaccinated intramuscularly with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). The patient also received influenza virus vaccine (unspecified) on the opposite arm. On 07-NOV-2005, the patient developed erythema, hot, itching and swelling about size of "half dollar" at injection site. The physici.Paient has the following illness history - Concurrent conditions: Sarcoidosis. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 37 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Information has been received from a licensed practical nurse concerning a 37 year old white non drinking (also reported to use alcohol regularly, 2-3/day), male, chef, with no known allergies, who lives with his wife, performs his own activities of daily living and is independent, with a past surgical history of an open reduction with an internal fixation of the right lower leg, who has reflux disease, multiple sclerosis for the past two years, inflammatory acne, migraines, joint pain in the pelvic and thi.Paient has the following illness history - Multiple sclerosis; open reduction of fracture with internal fixation. Gastrooesophageal reflux disease; smoker; acne; migraine; arthralgia..Patient was receiving Avonex; Prevacid; tetracycline hydrochloride 500mg.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a registered nurse concerning a 32 year old female with asthma and type I diabetes mellitus who in 11/05 was vaccianted subcutaneously with 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). It was reported that the patient had been vaccinated with the first dose of Pneumococcal 23v polysaccharide vaccine. The registered nurse reported that the next day the patient developed a local reaction involving pain and difficulty moving her arm, which was dia.Paient had Asthma; Type I diabetes mellitus.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a registered nurse concerning a 69 year old female with a penicillin allergy hives who on 11/7/2005 at 1630 was vaccinated intramuscularly with her first dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Concomitant vaccine therapy included a dose of influenza virus split virion 3v vaccine inactivated Fluzone given intramuscularly in the other arm lot U1912AA. At the time of vaccination the patient had a left leg contusion with a probable hematoma (work r.Paient had Contusion of lower leg.Paient has the following illness history - Hives, penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 17. Information has been received from a registered nurse concerning a 75 year old female patient, with a history of vaccination (route unknown) by another facility with her first dose of Pneumococcal 23v polysaccharide vaccine (manufacturer unknown) >5 years ago and unknown drug reactions allergies, who on 11/17/05 was vaccinated intramuscularly in the left deltoid with a 0.5ml booster dose of Pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Concomitant therapy included metoprolol succinate (Toprol.Patient was receiving Aspirin; Avapro; Prevacid; Synthroid; Toprol XL tablets; Zocor; Vitamins; Ambien.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 29. Information has been received from a physicians assistant concerning a 72 year old male with polycythaemia (stable in past 5 years), no allergies, and folliculitis of the face and neck. On 11/29/2005 the patient was hospitalized for a change in mental status and a seizure. It is part of the hospitals protocol to offer a patient the vaccine if they have not had one. The patient had never had one so that same day he was vaccinated intramuscularly with a first 0.5 ml dose of Pneumococcal 23v polysaccharide vac.Paient had Convulsion, mental status changes.Paient has the following illness history - Polycythaemia, hospitalisation, folliculitis..Patient was receiving Aspirin; Plavix; Doxycycline; Dilantin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 56 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a health professional concerning a 56 yr old female pt with allergies to codeine derivatives, penicillins and tetracyclines who on 04Nov05 (also reported as 05Dec05) was vaccinated IM in the left deltoid with a dose of pneumococcal 23v polysaccharide vaccine (lot 650541/1004P) (also reported as 650542/1005P). Concomitant therapy included influenza virus vaccine (unspecified). There was no illness at the time of vaccination. The pt had a local reaction at the injection site.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning two patients who were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650454/0751P). Subsequently, the patients developed injection site swelling and fever. The patients are being treated with acetaminophen Tylenol and application of ice pack. No other information was available regarding the adverse event or the patients outcomes. There was no product quality complaint reported. The reporter considered the patients adver.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered pharmacist concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy that day included influenza virus vaccine (unspecified). Subsequently the patient experienced cellulitis in the arm that the pneumococcal 23v polysaccharide vaccine was given. Unspecified medical attention sought..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 16. Information has been received from a registered nurse concerning a 52 year old female with exercise induced asthma and allergies to penicillin and sulfonamide who on 11/16/05 at 2:30pm was vaccinated IM, into the left deltoid, with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651328/1046P). Concomitant therapy included influenza vaccine (lot U1827AA) given IM into the right deltoid. On 11/16/05, shortly after the vaccination, the patient developed redness, warmth, swelling and pain at left.Paient has the following illness history - Asthma exercise induced, Penicillin allergy, Sulfonamide allergy..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Initial and follow up information has been received from a office manager of a physician's office concerning a male pt, who was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine and subsequently experienced cellulitis in his arm after receiving the vaccination. The office manager reported the pt had been in the ER for another reason; however, he received the dose of pneumococcal 23v polysaccharide vaccine, due to the state law that requires hospitals to offer it before a pt leaves the.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a registered nurse concerning a 12 year old African American female with allergy to penicillin and sulfa who on 10/31/05 was vaccinated a first dose of pneumococcal 23v polysaccharide vaccine (0.5ml) (lot # 651318/1006P), IM in the left arm. There was no illness at the time of vaccination. On 11/2/05, the patient presented to the office with injection site pain, swelling, and tenderness of the left arm. It was also reported that two days post immunization the patient devel.Paient had Sulfonamide allergy; Penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning a female pt who was vaccinated with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot649695/0512P) and within 72 hrs she developed cellulitis at the injection site. The pt sought medical attention and was treated with antibiotics. The pt recovered. There was no product quality complaint reported. The reporter considered cellulitis at injection site to be an other important medical event (OMIC) and disabling. Additional infor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a health professional concerning a 52 year old immunocompromised female with rheumatoid arthritis who on 12/08/05 was vaccinated SC in the right arm with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Concomitant therapy the same day included influenza virus vaccine (unspecified) and tuberculin given in the left arm. On 12/10/05 the patient presented with cellulitis of her right arm. She was treated with antibiotics and has recovered. There was.Paient has the following illness history - Rheumatoid arthritis, Immunosuppression.Patient was receiving Tuberculin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning a female patient who was vaccianted with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P) and within 72 hours she developed cellulitis at the injection site. The patient sought medical attention and was treated with antibiotics. The patient recovered. There was no product quality complaint reported. The reporter considered cellulitis at injection site to be an other important medical event (OMIC) and disabling.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 04. Information has been received from a registered nurse concerning a 77 year old female with hypertension, diverticulitis, osteoporosis, arthritis, and a sulfa allergy who at 1:15pm on 1/4/06 was vaccianted intramuscularly in the left arm with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). Concomitant therapy included alprazolam Xanax, amlodipine besylate Norvasc, Telmisartan Micardis, ranitidine HCL Zantac, risedronate sodium Actonel, vitamins and acetaminophen Tylenol. Approxim.Paient had Hypertension; Diverticulitis; Osteoporosis; Sulfonamide allergy; Arthritis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 13. Information has been received from a pharmacist concerning a 62 year old male, with ampicillin allergy, sulfamethoxazole allergy, and simvastatin (manufacturer unknown) allergy, who on 1/13/06 was vaccinated intramuscularly in the left deltoid with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). ON 1/15/06 the patient was presented to the ER and diagnosed with cellulitis. The patient was treated with clindamycin manufacturer unknown and released. The patients present status was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 13. Information has been received from a pharmacist concerning a 62 year old male who on 1/13/06 was vaccinated intramuscularly in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). On 1/15/06 the patient was presented to the ER and diagnosed with cellulitis. The patient was treated with Ibuprofen Motrin and released. The patients present status was reported as unknown. The pharmacist is requesting a lot check. The patient's experience was considered to be an impor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 24. Information has been received from a healthcare worker/office manager concerning a 74 year old female, with unknown medical history and unknown drug reaction/allergies, who on 1/24/06 was vaccinated intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651330/1048P). About 4 hours post vaccination, on 1/24/06, the patient developed swelling and redness near the injection site. She was treated at a local ER with some form of steroids and released. The patients present status was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient with a history of pulmonary disease who was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 0650649/0790P). The registered nurse reported that the patient developed redness, swelling and heat in the injection site arm after vaccination, during the past 3 months. The patient received oral antibiotics. At the time of the report, it was unknown if the patient recovered. The registered nurse felt that redness, swelling and h.Paient has the following illness history - Lung disorder..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient with a history of pulmonary disease who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot # 0650649/0790P). The registered nurse reported that the patient developed redness, swelling and heat in the injection site arm after vaccination, during the past 3 months. The patient received oral antibiotics. At the time of the report, it was unknown of the patient recovered. The registered nurse felt that redness, swelling and.Paient has the following illness history - Lung disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a pharmacist concerning an adult patient (age and gender not reported) with unknown medical history and unknown allergies, who in early October 2005, was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot # 644220/1119M) which had expired on 4/9/04. It was reported that the patient developed redness, swelling at the injection site and general malaise 24 hours post vaccination, was treated with cephalexin, and recovered fully in about one week..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a certified medical assistant concerning an adult (age and gender not reported) pt who in approximately Oct 2005 (over the last month), was vaccinated IM with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). Subsequently, on an unspecified date, the pt developed an injection site reaction to include soreness, warmth, erythema and swelling. The patient was treated with antibiotics and an on unspecified date recovered fully. The patient experienced.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a certified medical assistant concerning an adult (age and gender not reported) patient who in approximately in October 2005 ("over the last month"), was vaccinated intramuscularly with a 0.5 mL dose pneumococcal 23 v polysaccharide vaccine (Lot # 649695/0512P). Subsequently, on an unspecified date, the patient developed an injection site reaction to include soreness, warmth, erythema and swelling. the patient was treated with antibiotics and on an unspecified date recover.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 24. Information has been received from a licensed practical nurse concerning a female with an allergy to the flu vaccine who on 24May06 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 653284/0002P). That same day, post immunization, the pt experienced an anaphylactic reaction and was hospitalized. She was treated with epinephrine and diphenhydramine (Benadryl). Subsequently, the pt recovered. Anaphylactic reaction was considered to be an other important medical event (OMIC) a.Paient has the following illness history - Allergy to vaccine.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 45 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2006, 05. Initial information (via a company rep) and follow up information has been received from a physician, concerning a 45 yr old white female, with no known medical history and no known drug reactions/allergies reported, who on 05May06 was vaccinated SC in the right arm with a first dose of pneumococcal 23v polysaccharide vaccine (650644/0004F). Concomitant therapy included vancomycin. It was previously reported that on 05May06 after receiving the immunization the pt developed cellulitis. It was reported that t.Paient had Fever.Patient was receiving Vancomycin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 17. Information has been received from a RN concerning a 69 yr old white female who on 17Apr06, was vaccinated IM with a 0.5mL first dose of pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). Several hours post vaccination, the pt developed pain at the injection site. The pt's arm was very sore to the point of having trouble lifting the arm. The pt might have also developed redness and swelling at the injection site. The pt was treated with a triamcinolone acetonide (Kenalog) injection to get relief. S.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 14. Injected limb mobility decreased; injection site erythema; injection site pain; injection site swelling. Information has been received from a registered nurse concerning a 66 year old white female who on 12-DEC-2005 was vaccinated intramuscularly with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650660/0748P). Several hours post vaccination the patient developed pain at the injection site. The patient's arm was very sore to the point of having trouble lifting the arm. The patient might have.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 08. Information has been received from a RN concerning a 71 yr old white male who on 08Apr06 was vaccinated IM with a 0.5mL second dose of pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). Several hours post vaccination, the pt developed pain at the injection site. The pt's arm was very sore to the point of having trouble lifting the arm. The pt might have also developed redness and swelling at the injection site. On 09Apr06, the pt was treated with a triamcinolone acetonide (Kenalog) injection to get.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 13. Information has been received from a physician concerning a 63 yr old male physician, with unk medical history, who on 13Apr06 was vaccinated (route unk) with a dose of pneumococcal 23v polysaccharide vaccine (lot 651328/1046P). There was no concomitant medication. On 13Apr06 the pt developed cellulitis. The pt was treated with antibiotics (unspecified). No product quality complaint was involved. The reporting physician requested a lot check. Cellulitis was considered to be disabling and other important med.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 01. Initial and follow up information has been received from a medical assistant, via a company rep, concerning an 80 yr old white retired male, with glucose intolerance, hyperlipidemia, herpes zoster virus, and a history of abdominal aortic aneurysm, AAA, who on 01Aug05, was vaccinated SC with a first dose of pneumococcal 23v polysaccharide vaccine (lot 649694/0386P). Initially the nurse reported that, on an unspecified date, the pt developed cellulitis of the arm after having been vaccinated with pneumococcal.Paient has the following illness history - Abdominal aortic aneurysm; glucose intolerance; hyperlipidaemia; herpes virus infection.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist, via a company rep, concerning a female (age unk) who in Apr 2006, was vaccinated (route unk) with a dose of pneumococcal 23v polysaccharide vaccine (lot unk). It was reported that after receiving a dose of pneumococcal 23v polysaccharide vaccine the pt had to be admitted to the hospital because of a fever. The fever developed within 23 hrs of receiving the vaccine. It was reported that the pt had a low grade fever before vaccination and she was being observed.Paient had Medical observation; slight fever; upper respiratory tract congestion. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 59 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 03. Initial and follow up information has been received from a RN concerning a 59 yr old female pt (198 pounds) with a sulfa allergy, who on 03Mar06, was vaccinated IM into the right deltoid with a 0.5ml first dose of pneumococcal 23v polysaccharide vaccine (651320/1008P). Subsequently, the pt's right deltoid was swollen, red and warm to touch at the injection site. The pt also experienced injection site pain. The pt was treated with cephalexin (Keflex) 500mg BID for 7 days. Subsequently, the pt recovered. No p.Paient has the following illness history - Sulfonamide allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 09. Initial and follow up information has been received from a RN concerning a 71 yr old white male pt who on 09Mar06 was vaccinated IM into the right deltoid with a 0.5ml first dose of pneumococcal 23v polysaccharide vaccine (651320/1008P). On 09Mar06 in the evening, the pt experienced swelling, redness and pain in the right arm at the injection site. The pt also developed cellulitis and injection site local heat. The pt was treated with cephalexin (Keflex) 500mg every four hours for 10 days and diphenhydramin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 22. Initial and follow up information has been received from a medical assistant concerning an 66 yr old white male painter, with an allergy to aspirin, hypertension, back pain, and non insulin dependent diabetes, who on 22Mar06 was vaccinated IM in the right arm with a first 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651320/1008P). There was no concomitant medication. In the evening of the injection, on 22Mar06, the pt's right arm became painful and swollen. It became worse the next day. It was. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 87 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 20. Information has been received from a health professional concerning an 87 yr old Caucasian male with diabetes neuropathy, non insulin dependent diabetes mellitus, aspirin allergy and hypertension who on 20Mar06 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (0.5ml) (lot651320/1008P), IM, in the right arm. There was no concomitant medication. There was no illness at the time of vaccination. One day after injection the pt developed soreness at the site of injection. An exam revea.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 10. Initial and follow up information have been received from a RN concerning a 72 yr old white male pt who on 10Feb06 was vaccinated IM into the left deltoid with a 0.5ml first dose of pneumococcal 23v polysaccharide vaccine (lot 651321/1036P). On 11Feb06, the pt developed left upper arm redness to the elbow. Within the last 6 weeks, the pt experienced an injection site reaction to include swelling, local heat and pain. The pt was treated with cephalexin (Keflex) 500mg, four times daily for 10 days, acetaminop.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 01. Information has been received from a registered nurse concerning an adult (age and gender unknown) patient who within the last six months, on an unknown date, was vaccinated (route unknown) with a 0.5mL dose pneumococcal 23v polysaccharide vaccine (lot # 650329/0747P). Subsequently, within the last six months on an unspecified date, the patient developed an injection site reaction which included pain, redness, swelling, and local heat. The patient also developed cellulitis and was treated with antibiotics..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 14. Information has been received from a registered nurse concerning a 75 year old female with no known allergies who on 9/14/2005 at 3:30 pm was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine 0.5ml IM lot 647661/0055R, in the right deltoid. Concomitant therapy that day included influenza virus split virion 3v vaccine inactivated lot U1772AA, in the left deltoid. Subsequently within 24 hours, the patient developed an adverse reaction on right arm. The patient experienced redness at injection.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 03. Information has been received from a physician concerning a 58 yr old female who on 03Oct05 was vaccinated IM with a 0.5mL first dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant vaccination on the same day in the other arm included a dose of influenza virus whole virion 3v vaccine inactivated (Fluzone). On 03Oct05, within 1.5 hrs of vaccination, the pt experienced a very sore arm. Unspecified medical attention was sought. No treatment was required. Additional information has b.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 11. Information has been received from a health professional concerning a 86 year old female with asthma, chronic obstructive pulmonary disease, dust allergy, pollen allergy and mold allergy who on 10/11/2005, between 11:00 and 16:00, was vaccinated IM in the right deltoid with a 0.5ml second dose of Pneumococcal 23v polysaccharide vaccine (lot 646501/0497N). Concomitant therapy included a dose in the left arm of influenza vaccine unspecified. On 10/12/2005 the patient presented to the doctor office. She had a.Paient has the following illness history - Asthma, Chronic obstructive pulmonary disease, house dust allergy, pollen allergy, mycotic allergy..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 13. Information has been received from a 70 year old female with depression, acid reflux, a broken left arm and no allergies who on 10/13/2005, was vaccinated SC in the right arm with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650331/0749P) last dose reportedly received 10 years prior. Concomitant vaccinations on that same day included a dose in the right arm of influenza virus vaccine (unspecified). Other concomitant therapy included esomeprazole magnesium (Nexium), tolterodine tartrate (Detr.Paient has the following illness history - Depression, Acid reflux Oesophageal, arm fracture..Patient was receiving Nexium, Zoloft, Detrol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 82 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a pharmacist concerning an 82 yr old white female hospital inpt with a penicillin allergy who on 20Oct05 at 14:30pm was vaccinated IM in the left deltoid with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651524/0605R). Concomitant vaccination at the same time included an IM dose in the right deltoid of influenza virus split virion 3v vaccine inactivated (Fluarix) (lotAFLUA123BC). Concomitant therapy included levothyroxine Na (Synthroid), Mg oxide (Mag ox 40.Paient had Cardiac failure congestive; hematocrit low; haemoglobin low; rectal bleeding.Paient has the following illness history - Hospitalization; penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 21. Information has been received from a health professional concerning a female pt who on 21Oct05 was vaccinated IM in the right deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy at the same site in the right deltoid included a dose of influenza virus vaccine (unspecified). On 22Oct05 the pt complained redness and soreness at the site. Unspecified medical attention was sought. The pt is recovering. Follow up information indicated that the pt has recovered. No additional.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Information has been received from a pharmacist concerning a 65 yr old male with an enlarged prostate and a history of benign prostatic hyperplasia who on 17Oct05 was vaccinated with a 0.5mL IM dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). Suspect vaccination that day included a dose of influenza virus vaccine (unspecified). Concomitant therapy included morniflumate (Flomax). The pt complained the same evening that he difficulty voiding. It was reported that the pt had enlargement of t.Paient had Enlarged prostate.Paient has the following illness history - Benign prostatic hyperplasia.Patient was receiving Flomax (Morniflumate). Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female adult who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included a dose of influenza virus vaccine (unspecified). Subsequently, the pt experienced neck pain. Unspecified medical attention was sought. There was no additional information regarding the pt's present status. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 36 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 10. Information has been received from a RN concerning a 36 yr old male who on 10Oct05 was vaccinated IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot650327/0792P). Concomitant therapy included a dose of influenza virus vaccine (unspecified). On 10Oct05 later that day, the pt experienced a severe localized reaction with soreness, redness, and bruising from the deltoid to the elbow, headache and a fever to 101 deg F. It was noted that the pt also experienced 5 minute episodes of nausea, dyspn.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a licensed practical nurse concerning a 66 yr old female pt with allergies to meperidine hydrochloride (Demerol), codeine, and procaine hydrochloride (Novocain), degenerative joint disease, hormone deficiency and dyspepsia who on 25Oct05 was vaccinated IM into the upper left deltoid with a second dose pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). Concomitant therapy given IM into the left deltoid included a third dose of influenza virus whole virion 3v vaccin.Patient was receiving Prevacid; Prilosec.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a RN concerning a 63 yr old male with a history of pneumonia last year. On an unspecified date, the pt was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). Concomitant suspect therapy included an unspecified influenza virus vaccine administered into the opposite arm. On an unspecified date, the pt developed redness, swelling, and tenderness up to the shoulder for several days. The pt sought unspecified medical attention. It was.Paient has the following illness history - Pneumonia.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 11. Information has been received from a RN concerning a 59 yr old male with neck squamous cell carcinoma, metastases to lung and a history of left upper lobe lobectomy. On 11Oct05 the pt was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). Concomitant suspect therapy included an unspecified influenza virus vaccine. On an unspecified date, the pt complained of a scratchy throat and cough after vaccination. On 14Oct05 the pt was treated for wheezing and a worsening o.Paient has the following illness history - Surgery, squamous cell carcinoma; Metastases to lung; dyspnea..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NJ, USA. Female patient, 44 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a healthcare worker concerning a 44 yr old female pt with asthma and environmental allergies who on 25Oct05 was vaccinated IM with her first dose of pneumococcal 23v polysaccharide vaccine (lot 649912/0529P). Concomitant therapy included fluticasone propionate (+) salmeterol xinafoate (Advair), tiotropium bromide (Spiriva), montelukast sodium, and albuterol. On 26Oct05 the pt developed redness at injection site (not specified). On 27Oct05 she was seen in the office with bl.Paient has the following illness history - Asthma; environmental allergy.Patient was receiving Albuterol, Advair, Singulair, Spiriva.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Cellulitis; Fatigue Information has been received from a physician concerning a 37 year old female with sulfa allergy and a history of migraine who on 24-OCT-2005 at 5:00 PM was vaccinated with pneumococcal 23v polysaccharide vaccine (lot #651318/1006P), in the left arm upper arm. On 24-OCT-2005 the patient's left arm became swollen with pain, heat and fever (40 C). The patient took diphenhydramine HCL (Benadryl), "which helped a little." On 27-OCT-2005 she was seen by the doctor and she was given an antibi.Paient has the following illness history - Migraine Sulfonamide allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 19. Swelling; Pain; Erythema; Skin warm Information has been received from a Certified Medical Assistant (CMA) concerning a 63 year old female with allergy to tetanus vaccine, depress and acid reflux (esophageal) and a history of hysterectomy, sinus operation and kidney stone who on 19-OCT-1-2005 was vaccination with 0.5ml pneumococcal 23v polysaccharide vaccine (lot #650454/0751P) subcutaneously. Concomitant therapy included lansoprazole (Prevacid), venlafaxine HCL (Effexor) and imatinibmesylate (Gleevec). On.Paient has the following illness history - Hysterectomy, sinus operation, kidney stone Allergy to vaccine; depression; gastroesophageal reflux disease; blood pressure high..Patient was receiving Gleevec Prevacid Effexor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 29. Injection site reaction Information has been received from a registered nurse concerning a patient who on 29-OCT-2005 was vaccinated intramuscularly with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot #651329/1047P). Concomitant therapy included influenza virus vaccine (unspecified). Eight to twelve hours later the patient developed a local injection site reaction. Unspecified medical attention was sought. It was reported that the patient was recovering. No product quality complaint was involv.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Incision site cellulitis; pain; vomiting Information has been received from a registered nurse concerning a patient in their 60's who in approximately October 2005 was vaccinated intramuscularly with a 0.5ml of pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same time included influenza virus vaccine (unspecified) (both vaccines were administered at separate sites and via separate syringes). Subsequently the patient developed a site reaction of cellulitis, vomiting and described thei.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Dizziness;Fatigue;Inappropriate Schedule of drug administration; amnesia Information has been received from a registered nurse concerning her friend an 82 year old female patient with memory loss who on approximately 25-OCT-2005 ("about a week ago") was vaccinated (route unknown) with a second dose pneumococcal 23v polysaccharide vaccine (Lot # and Batch # unknown). It was reported that the patient also received the influenza virus vaccine (unspecified). The patient was complaining of exhaustion, dizziness,.Paient has the following illness history - Memory loss; immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 02. Information has been received from a physician concerning a male who on 02-NOV-2005 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy that day in the sane arm included influenza virus vaccine (unspecified). The first vaccination was given three months ago and second was given by mistake. On 02-NOV-2005 the patient experienced pain at the injection site. Follow up reported that the patient "did not have reaction" Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Edema peripheral; burning sensation; discomfort; urticaria; erythema Information has been received from a registered nurse concerning a 71 year old white male with a penicillin allergy who on 25-OCT-2005 was vaccinated in the right deltoid muscle pneumococcal 23v polysaccharide vaccine (lot #549989/0579P). Concomitant therapy that same day included a vaccination in the left deltoid muscle with influenza virus split virion 3v vaccine inactivated (Fluzone) (influenza virus split virion 3v vaccine inactivated).Paient has the following illness history - Penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning an adult patient who within the lst week (approximately November 2005) was vaccinated SC with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine therapy administered on the same day included a dose of influenza virus vaccine (unspecified). The physician reported that within the last week (approximately November 2005) the patient developed redness only, at the injection site. It was mentioned that the patient may have been gi.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 23. Information has been received from a female consumer who on 23-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot reported as "1406P". Concomitant therapy that day in the same arm included influenza virus vaccine (unspecified). She reported that she became quite ill beginning the day after receiving the shots, on 24-OCT-2005. The patient's physician confirmed that she experienced a severe reaction to the vaccination. The patient ended up missing a full week of work and a. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Initial and follow up information has been received from a health professional concerning a 68 year old white female, with hypertension, hypercholesterolemia, penicillin allergy, venous insufficiency and peripheral vascular disorder who on 08-NOV-2005 was vaccinated intramuscularly in the left deltoid with a second dose (0.5 ml) of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P) and at the same time was vaccinated intramuscularly in the right deltoid with a second dose of influenza virus SAg 3v.Paient has the following illness history - Concurrent conditions: hypertension, hypercholesterolemia, penicillin allergy, venous insufficiency, peripheral vascular disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a health professional concerning a 74 year old female with allergies to acetaminophen (+) hydrocodone bitartrate (LORTAB) and acetaminophen (+) codeine phosphate (TYLENOL 3) who on 26-OCT-2005 was vaccinated intramuscular in the right deltoid with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccines that day included the influenza vaccine (unspecified). There was no illness at the time of vaccination. On 26-OCT-2005 she had a severe local reaction on.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 74 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Follow up information has been received from a licensed practical nurse concerning a 74 year old male patient, with hypertension, hyperlipidemia, erectile dysfunction ("ED"), and unknown drug reactions/allergies who on 08-NOV-2005 was vaccinated intramuscularly in the left deltoid with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. It was also reported that the patient received a second dose of influenza virus vaccine (AVENTIS) intramuscularly in the right deltoid on the same day. The patient s.Paient has the following illness history - Concurrent conditions: Hypertension, Hyperlipidemia, Erectile dysfunction.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Information has been received from a registered nurse concerning a 3 year old male with asthma who on 08-nov-2005 was vaccinated subcutaneous in right arm with a dose of pneumococcal 23v polysaccharide vaccine. The patient was given a flu shot (unspecified) in the same arm as pneumococcal 23v polysaccharide vaccine. On 08-nov-2005, 6 hours after the vaccination, the patient developed a cellulitis reaction, 103 F fever, erythema and pain. The pain was reported as recovered. There was no product quality c.Paient has the following illness history - Concurrent conditions: asthma. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient in approximately October 2005, was vaccinated intramuscularly with 0.5 ml of pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same time included influenza virus vaccine (unspecified)(both vaccines were administered at separate sites and via separate syringes). Subsequently the patient developed an injection site reaction. The arm was red and swollen and was described as being "cellulitis like", however the p.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient who in approximately October 2005, was vaccinated intramuscularly with 0.5 ml of pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same time included influenza virus vaccine (unspecified) (both vaccines were administered at separate sites and via separate syringes). Subsequently the patient developed an injection site reaction. No further details pertaining to the site reaction were available. Unspecified me.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 44 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a certified medical assistant (CMA) concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently the patient experienced swelling, pain at injection site and hot skin to touch. The outcome of the events was not reported. In follow up, the certified medical assistant reported that this patient had not developed hotness of swelling as originally reported. The 44 year old female with diabetes mellitus, an allergy to codeine and hyperc. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a certified medical assistant (CMA) concerning a 65 year old patient who on 28-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy included tetanus toxoid and influenza virus vaccine (unspecified). Subsequently the patient experienced swelling, pain at injection site, hot skin to touch, red and warm to touch at injection site, and achiness all over. The outcome of the events was not reported. Follow up information has been received.Paient has the following illness history - Medical History: myocardial infarction Concurrent conditions: coronary artery disease, diabetes mellitus, hypertension.Patient was receiving aspirin, LIPITOR, glipizide, lisinopril, metoprolol, ACTOS. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a certified medical assistant (CMA) concerning a 70 year old patient who on 28-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included influenza virus vaccine (unspecified). Subsequently, the patient experienced pain at injection site, hot skin to touch, swelling, achiness all over, and red and warm to touch at injection site. The outcome of the events was not reported. Follow up information has been received from a p. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a 58 year old female with hypothyroidism an allergy to sulfa, who on 31-OCT-2005 was vaccinated subcutaneous in the right arm with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine therapy administered on 31-OCT-2005 included a dose of influenza virus vaccine (unspecified) administered in the left arm. Other concomitant medication included levothyroxine Na (SYNTHROID). The patient reported that the next day, on 01-NOV-2005 she experienced a s.Paient has the following illness history - Concurrent conditions: hypothyroidism, Sulfonamide allergy.Patient was receiving SYNTHROID. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 09. Information has been received from a license practical nurse concerning a 52 year old female daycare provider with sulfa allergy and no medical history, who on 09-NOV-2005, at 16:45, was vaccinated intramuscular into the right deltoid with a first 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. On 09-NOV-2005, the patient was vaccinated intramuscular with a third dose of influenza virus split virion 3v vaccine inactivated (FLUZONE). Concomitant therapy included levothyroxine Na (LEVOXYL). There wa.Paient has the following illness history - Concurrent conditions: Sulfonamide allergy.Patient was receiving LEVOXYL. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Edema peripheral; fatigue; pain; erythema Information has been received from a physician and a registered nurse concerning a 73 year old retired white male with no allergies or medical history who on 31-OCT-2005 was vaccinated IM in the left deltoid with a second 0.5ml dose of pneumococcal 23v polysaccharide vaccine (Lot #649914/0578F). Concomitant therapy included psyllium husk (Metamucil), aspirin daily, Vitamin B12 injection monthly, and a dose of influenza virus vaccine (unspecified) given in the right.Patient was receiving aspirin cyanocobalamin Metamucil.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Injection site pain; Swelling Initial and follow up information has been received from a licensed practical nurse concerning a 60 year old white female with arrhythmia. hormone replacement therapy, no known allergies an a prior immunization with pneumococcal 23v polysaccharide vaccine in 2000. On 26-OCT-2005, the patient was vaccinated intramuscularly into the left arm with pneumococcal 23v polysaccharide vaccine (Lot #651526/0604R). On that same day in the AM the patient was vaccinated intramuscularly into.Patient was receiving Lanoxin Premarin verapamil. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Injection Site Pain Information has been received from a health professional concerning a 62 year old white retired female with hyperparathyroidism and no known allergies who on the morning of 27-OCT2005 was vaccinated IM into the left deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot #651523/0604R). Concomitant therapy given IM in the morning into right deltoid included a dose of influenza virus whole virion 3v vaccine inactivated (Fluzone) (influenza virus whole virion3v vaccine in.Paient has the following illness history - hyperparathyroidism. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Swelling Information has been received from a nurse concerning a patient who on an unspecified date was vaccinated IM in the arm with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included an unspecified influenza virus vaccine given in the same arm. Subsequently, the patient developed swelling. Medical attention was sought. Subsequently, the patient recovered. No further information is available..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 17 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Injection site reaction; pain; erythema; skim warm; swelling. Information has been received from a licensed practical nurse concerning a 17 year old (also reported as 14 year old) white male with diabetes mellitus juvenile onset who on 07-NOV-2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine in the left deltoid (650649/0790P), intramuscularly in the left deltoid. Concomitant therapy that day included a first dose of influenza virus split virion 3v vaccine inactivated (Fluzone).Paient has the following illness history - Diabetes mellitus juvenile onset.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Injection site reaction; chills; myalgia Information has been received from a physician concerning a 61 year old male with diabetes who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy three days prior to the pneumococcal 23v polysaccharide vaccine included a dose of influenza virus vaccine (unspecified). Subsequently the patient experienced a severe injection site reaction with chills and myalgia. It was noted that the patient recovered on an unknown date. Unspecif.Paient has the following illness history - Diabetes.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Erythema; pain in extremity; edema; peripheral Information has been received from a health professional concerning a 61 year old white female with degenerative joint disease, hormone deficient, hyperparathyroidism, codeine and "sodium pent" allergy who on 25-OCT-2005 later in the PM was vaccinated IM in the right deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (Lot #651523/0604R). Concomitant therapy included a IM dose in the left deltoid of influenza virus split virion 3v vaccine inact. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Pyrexia; erythema Information has been received from a registered nurse concerning a 8 year old female with asthma who in late October 2005 was vaccinated SQ in right arm with a dose of pneumococcal 23v polysaccharide vaccine (lot #not provided). The patient was given a flu shot (unspecified) in the same arm as pneumococcal 23v polysaccharide vaccine. Twelve hours post vaccination the patient developed a 103 F fever and erythema. The fever persisted for 12 hours. The patient was reported as recovered. There.Paient has the following illness history - Asthma. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MT, USA. Female patient, 53 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Pain in extremity; erythema; edema peripheral Information has been received from a licensed practical nurse concerning a 53 year old white female with a tetanus allergy and clindamycin allergy, who on 25-OCT-2005 was vaccinated IM into the right arm with a fifth dose of pneumococcal 23v polysaccharide vaccine (lot #651526/0604R). Concomitant therapy given IM into the left arm included a second dose of influenza virus whole virion 3v vaccine inactivated (Fluzone) (influenza virus whole virion 3v vaccine inac.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 18 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 01. Injection site pain; injection site erythema Information has been received from a registered nurse concerning an 18 year old male with asthma who on 01-DEC-2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (Lot #651318/1006P). Concomitant therapy given into the other arm included a dose of influenza virus vaccine (unspecified) (no reaction noted). On 01-DEC-2005 (previously report as 04-DEC-2005) the patient was seen in the doctor's office with an injection site reaction descr.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 86 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 10. Information has been received from a pharmacist concerning an 86 yr old female inpt with a diagnosis of cardiac arrhythmia who on 10Dec05 was vaccinated IM in the arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 651572/0741R) as a routine immunization during hospital stay. Concomitant therapy included warfarin sodium (Coumadin), atorvastatin calcium (Lipitor), isosorbide mononitrate (IMDUR), tolterodine tartrate (Detrol LA), diltiazem hydrochloride (Cardizem CD), and an unspecified influenza.Paient has the following illness history - Arrythmia; hospitalization.Patient was receiving Lipitor, Cardizem CD, IMDUR, Detrol LA, Coumadin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a RN concerning an 58 yr old male with asthma who on 05Dec05 was vaccinated IM into the right deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). Concomitant therapy given into the other arm included a dose of influenza virus vaccine (unspecified) (no reaction noted). That night, the pt experienced an injection site reaction described as pain with tenderness, swelling and redness. On 06Dec05, the pt was seen in the doctor's office. The.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 19. Information has been received from a medical assistant via a company rep concerning a male physician who on approx 19Nov05 was vaccinated IM into the arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same time in the same arm included a dose of influenza virus vaccine (unspecified). Subsequently, on approx 19Nov05, the pt was very ill for two days and experienced body aches, fever and severe site reaction involving a rash, soreness and swelling down his entire.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 23. Information has been received from a RN concerning a 72 yr old male who on 23Nov05 was vaccinated IM in the arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot unspecified). Secondary suspect vaccinations included a dose of influenza virus vaccine (unspecified) given in the same arm as the pneumococcal 23v polysaccharide vaccine. On 23Nov05 the pt developed swelling and itching at the injection site. Unspecified medical attention was sought and the pt was given over the counter medications.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a 55 yr old white retired female with no allergies who in approx Oct 2005, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot not reported). Concomitant suspect therapy included a dose of influenza virus vaccine (unspecified) administered at the same time into the same arm. On 26Oct05 the pt developed redness from the shoulder to elbow, swollen tender, axilla glands, and throbbing pain. It was reported that the pt stated that.Paient has the following illness history - Immunization. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 03. Initial and follow up information has been received from a pharmacist concerning a 68 yr old white male with shellfish allergy who on 03Oct05 was vaccinated at 5:30PM IM into the left deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650331/0749P) and at the same time vaccinated IM into the right deltoid with a dose of influenza virus split virion 3v vaccine inactivated (Fluzone). Concomitant therapy included clopidogrel bisulfate (Plavix), ramipril (Altace) and rosuvastatin calcium.Paient has the following illness history - Shellfish allergy.Patient was receiving Plavix, Altace, Crestor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 25. Information has been received from a RN concerning a male pt (18 to 20 yrs of age) who on 25Jan06 was vaccinated SC in the left tricep with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649696/0490P). Concomitant therapy included influenza virus 3v reassortant vaccine live intranasal (Flumist), hep A virus vaccine inactivated (+) hep B virus vaccine rHBsAg (yeast) (Twinrix), meningococcal ACYW conj vaccine (dip toxoid) (Menactra), MMR vaccine, penicillin G benazathine (Bicillin) and tuberculi.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a RN pharmacist concerning a pt who was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy that day included influenza virus vaccine (unspecified). Subsequently the pt experienced cellulitis in the arm that the pneumococcal 23v polysaccharide vaccine was given. Unspecified medical attention was sought..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, child 00.9 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2005, 11. Information has been received from a health professional concerning an 11 month old Asian female with no medical history or allergies who on 11May05, at 10:30AM, was accidentally vaccinated in the left thigh with a first dose of pneumococcal 23v polysaccharide vaccine (lot 650644/0887P). Concomitant vaccine that day, at 10:30AM, included a second dose in the right thigh of Hib conj vaccine (tet toxoid) (Acthib) (lot UE392AA). There was no illness at the time of vaccination. The child has manifested no addit.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning an adult pt who in approx Feb 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). In approx Feb 2005, the pt experienced injection site reactions described as swelling, soreness, warmth, erythema and induration. Unspecified medical attention was sought. It was noted that the pt was treated with levofloxacin (Levaquin). Subsequently, the pt recovered. A lot check will be performed. No product qualit.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on May 2005, 19. Information has been received from a 69 yr old female with elevated triglycerides and depression who on 19May05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine in the left arm (route not reported). Concomitant therapy included cetirizine hydrochloride (Zyrtec), fenofibrate (Tricor) and amitriptyline hydrochloride. On 19May05 the pt developed injection site reaction with swelling down and under the upper arm. The pt reported "It looked like an octopus, swollen red, hot and sore". The pt.Paient has the following illness history - Serum triglycerides increased; depression.Patient was receiving Elavil, Zyrtec, Tricor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 07. Information has been received from a physician concerning a 77 yr old female pt who on 07Jun05 was vaccinated IM with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). On 07Jun05 in the evening, the pt developed arm, redness, pain and warmth. On 08Jun05, the pt also experienced fever and chills. The pt was treated with ice, cephalexin (Keflex), and acetaminophen (Tylenol). The pt's outcome was unk. The physician indicated that he would like an investigation into that lot #. T.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 08. Information has been received from a medical technologist concerning a male pt who on 08Jun05 or 09Jun05 was vaccinated with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). It was noted that the pt had injection site reactions. On approx 09Jun05, the pt called the doctor's office because he experienced temp to 103 deg F, chills, nausea, weakness, redness, swelling, and soreness of the arm to the elbow. It was noted that he was taking ibuprofen (Motrin) and or acetaminophen.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 07. Information has been received from a registered nurse concerning a female who on 6/7/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (0.5 ml lot 650454/0751P), intramuscularly. On 6/7/05 the patients vaccinated arm became red and warm to touch. She developed a raised area on the arm 38 mm x 45mm. She experienced some discomfort. It was not known if this was her first dose or a booster dose. The symptoms resolved on their own in a few days. Unspecified medical attention was sought. N.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 02. Information has been received from a registered nurse concerning a 14 year old female with respiratory issues, immunodeficiency and an allergy to amoxicillin + clavulanate potassium Augmentin and Sulfamethoxazole + trimethoprim Bactrim who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650084/0605P). Concomitant therapy included an unspecified respiratory medication. It was reported that the patient received a previous dose of Pneumococcal 23v polysaccharide vaccine in 2004. On 6.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2005, 25. Information has been received from a pharmacist concerning a 70 year old female patient with a sulfa allergy, who on 4/25/05 at 13:00 was vaccinated subcutaneously in the RUQ with a 0.5 ml first dose of Pneumococcal 23v polysaccharide vaccine. Illness at the time of vaccination included a urinary tract infection and dehydration. At 20:00, the patient developed injection site redness, erythema, swelling and soreness. Unspecified medical attention was sought. The patient was treated with warm compresses. No.Paient had Dehydration, Urinary tract infection.Paient has the following illness history - Sulfonamide allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 26 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2005, 13. Information has been received from a health care worker concerning a 26 year old female with no medical history or allergies reported. On 1/13/05 the patient was vaccianted with the first dose of Pneumococcal 23v polysaccharide vaccine. There were no concomitant medication reported. On 1/14/05 the patient developed redness, swelling and burning of injection site. The patient sought unspecified medical attention. The events subsided in a few days and no treatment was required. Additional information has been.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 14. Initial and follow up information has been received from a registered nurse and a physician concerning a 52 year old male (previously reported as 51 years old) with no adverse events following prior vaccinations reported. On 6/14/05 at 4pm, the patient was vaccinated intramuscularly with Pneumococcal 23v polysaccharide vaccine (lot 649913/0577P). The patient had asthma at the time of vaccination. On 6/15/2005 in the PM, within 24 hours, the patient developed swelling and erythema of the left arm (previously.Paient had Asthma.Paient has the following illness history - Immunisation.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2004, 01. Information has been received from a 41 year old female registered nurse with asthma and unspecified allergies. In June 2004, the nurse was vaccinated with Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included an unspecified therapy Naacort fexofenadine hydrochloride + pseudoephedrine hydrochloride Allergra D, Fluticasone propionate Flovent, and lansoprazole Prevacid. In June 04, the nurse developed arm swelling when she received the Pneumococcal 23v polysaccharide vaccine. The nurse reporte.Paient has the following illness history - Asthma, hypersensitivity..Patient was receiving Allergra D, Flovent, Prevacid.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 01. Information has been received from a medical technologist concerning a female patient who on 4/1/05 was vaccinated with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 647661/005R). It was noted that the patient had injection site reaction. On 6/6/05, the patient was seen in the doctors office with a red and hot arm. It was noted that she was taking Ibuprofen Motrin and or acetaminophen Tylenol. Unspecified medical attention was sought. The patients outcome was unknown. It was noted that the pa.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 22. Initial and follow up information has been received from a medical assistant and a physician concerning a 65 year old female violin teacher who is well nourished, well developed, and well groomed and has a good build, with allergies to erythromycin (rash), penicillin (swelling), and sulfa drugs (rash), non smoker, and a history of De Quevain's tenosynovitis, Dupuytren's contracture (right fifth digit), a mammogram 6/10/05, colonoscopy 8/2003 not complete, and a core biopsy 9/04 and non contributory family.Paient has the following illness history - Rash, swelling, colonoscopy, De Quervain's tenosynovitis, Dupuytren's contracture, biopsy, egg allergy, non smoker, allergic reaction to antibiotics, penicillin allergy, sulfonamide allergy..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 23. Information has been received from a physician and a company representative concerning an 88 year old female patient with a history of hypertension and no reported allergies who on 6/23/05 with vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine lot 647661/0055R. There was no concomitant medication. Subsequently, on an unspecified date, the patient developed redness, soreness, swelling and then hardness at the injection sight that caused a great deal of pain. The company representative also re.Paient has the following illness history - Hypertension.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning an adult female patient (age not reported) who several weeks ago, on an unspecified date, was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot unknown). The patient reported to the nurse by phone that she developed an injection site reaction that included redness and local pain lasting about 2 weeks. It was reported that the patient sought unspecified medical attention. At the time of the report he patient outcome was u.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 09. Information has been received from a registered nurse concerning a 5 year old female with respiratory issues who on 6/9/05 was vaccinated wit a dose of Pneumococcal 23v polysaccharide vaccine lot 650082/0691P. Concomitant therapy included an unspecified respiratory medication. On 6/10/05 the patient developed an injection site reaction. The nurse reported that on 6/10/05 the patient developed fever (measurement not reported), hives, rash and redness at the injection site. The patient was treated with cefdin.Paient has the following illness history - Respiratory disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2004, 01. Information has been received from a 50 year old male registered nurse, who in 10/04, was vaccinated with the first dose of Pneumococcal 23v polysaccharide vaccine. Twenty four hours after the injection, he developed flu like symptoms, soreness and a fever. The nurse reported that the fever lasted about a day. The nurse did not seek medical attention. At the time of this report, the nurse had recovered from the events. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 18. Initial and follow up information has been received from an office manager for the physician and a physician concerning a 70 year old female with no known adverse drug reactions, no known allergies and no pertinent medical history reported. On 7/18/05 the patient was vaccianted with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine lot 650327/0792P. There were no concomitant medications reported. The same day, following vaccination, the patient developed pain and redness at the injection site, was war.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 06. Initial and follow up information has been received from a registered nurse via a company representative concerning a 54 year old female patient with an unknown medical history how on 7/6/05 at 8:30am was vaccinated in the left deltoid with a dose of Pneumococcal 23v polysaccharide vaccine lot 650457/0973P. On 7/6/05 previously reported as 7/7/05, at 9:00pm, the patient developed a bad pain in the shoulder/arm and chills. It was reported that the reaction was red and swollen and was pronounced in the arm wh. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 28. Initial and follow up information has been received from a physician concerning a 63 year old female admissions representative with no known drug allergies who on the morning of 7/28/05 wad inadvertently vaccinated IM in the left deltoid with a second 0.5ml dose of Pneumococcal 23v polysaccharide vaccine 650452/0753P. Concomitant therapy included simvastatin, lisinopril, aspirin, acebutolol, Brompheniramine maleate pseudoephedrine Lorane, hydrochlorothiazide manufacturer unknown, and glucosamine. Subsequent.Paient has the following illness history - Immunisation.Patient was receiving simvastatin, lisinopril, aspirin, acebutolol, Brompheniramine maleate pseudoephedrine Lorane, hydrochlorothiazide. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 25. Information has been received from a female who on 7/25/05 was vaccinated in the left deltoid with a second dose of Pneumococcal 23v polysaccharide vaccine. On 7/25/05, the patient developed soreness at the injection site. The pt subsequently developed swelling and erythema 7cm by 3cm on the inner aspect of the left bicep. The pt did not seek medical attention for the experience. At the time of this report, the patients soreness at the injection site and swelling and erythema on the inner aspect of the left. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 06. Information has been received from a physician concerning a 67 year old who on 06-Jun-2005 was vaccinated intramuscularly with a first 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). On 06-JUN-2005, the patient's arm was swollen and warmth. The patient was treated with ice packs and elevation. The physician requested an investigation into the lot number. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory, The.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 06. Information has been received from a physician concerning a 70 year old female who on 06-JUN-2005 was vaccinated intramuscularly with a first 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). On 07-JUN-2005, the patient's arm was swollen with cellulitis. The patient was treated with amoxicillin (+) clavolanate potassium (AUGMENTIN). On 09-JUN-2005, the patient developed a fever and pain in the right hip when walking. The physician requested an investigation into the lot number..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 02. Information has been received from a health professional concerning a 78 year old male on 02-JUN-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Subsequently, the patient experienced a sore and red arm. Unspecified medical attention was sought. The patient's outcome was unknown. No product quality complaint was involved. The physician requested an investigation into the lot number. The records of testing prior to release of this lot have been checked by Q.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 86 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 19. Initial and follow up information has been received from an office manager for the physician and a physician concerning an 86 year old male with no known adverse drug reactions, no know allergies and no pertinent medical history reported. On 7/19/05, in th Am the pt was vaccinated in the left arm with the first 0.5ml dose of Pneumococcal 23v polysaccharide vaccine lot 650327/0792P. There were no concomitant medications reported. That same day, following vaccination in the AM, the pt developed pain and redne.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 20. Initial and follow up information has been received from an office manager for the physician and a physician concerning a 65 year old retired female with no known adverse drug reactions, no known allergies and no pertinent medical history reported. On 20-Jul-2005, in the morning, the patient was vaccinated in the left arm with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). There were no no concomitant medications reported. That same day, following vaccination in the morning,.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 27. Initial and follow up information has been received from an office manager for the physician and a physician concerning a 65 year old retired female with no known adverse drug reactions, no known allergies and no pertinent medical history reported. On the morning of 27-JUL-2005, the patient was vaccinated into the right arm with a 0.5 ml, first dose of pneumococcal 23v polysaccharide vaccine (lot650453-0791P). There were no concomitant medications reported. That same day, following vaccination, the patie.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 13. Information has been received from a health care worker concerning a 77 year old female with cholesterol, acid reflux, an unspecified "heart condition" and no allergies reported. On 13-JUN-2005 the patient was vaccinated with the first dose of pneumococcal 23v vaccine (lot 647661-0055R). Concomitant therapy included esomeprazole magnesium (NEXIUM), atorvastin calcium (LIPITOR) clopidogrel bisulfate (PLAVIX) and aspirin. On 14-JUN-2005 the patient developed redness, swelling an burning of injection site a.Paient has the following illness history - Concurrent conditions: cholesterol high, acid reflux (esophageal), cardiac disorder.Patient was receiving aspirin, LIPITOR, PLAVIX, NEXIUM.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2004, 01. Information has been received from a health care worker concerning a 70 year old female with high cholesterol, seasonal allergies, no food or drug allergies and a history of a prior immunization with pneumococcal 23v vaccine in 2000. On 01-NOV-2004 the patient was vaccinated with the second dose of pneumococcal 23v vaccine. Concomitant therapy included risedronate sodium (ACTONEL), aspirin, unspecified vitamins, atorvastatin calcium (LIPITOR) and triamcinolone acetomise (NASOCORT). On 02-NOV-2004 the pa.Paient has the following illness history - medical history: immunization, concurrent conditions: cholesterol high, seasonal allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 01. Information has been received from a certified medical assistant concerning a 63 year old white male with gastroesophageal reflux disease, chronic obstructive pulmonary disease and chronic bronchitis who on 01-AUG-2005 at 16:38 was vaccinated intramuscularly into the left arm with a second dose of pneumococcal 23v vaccine (lot 649694/0386P). On 02-AUG-2005, the patient's left arm was sore,"felt hard" and was not warm to the touch. The patient stated that he just doesn't fell well. The patient experienced.Paient has the following illness history - concurrent conditions: gastroesophageal reflux disease, chronic obstructive pulmonary disease, bronchitis chronic.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 29. Information has been received from a physician concerning a 73 year old white female with penicillin allergy and hospitalized for a minor unspecified GYN procedure and a history of splenectomy (due to lymphoma)and knee replacement who on 29-JUL-2005 (before discharge from hospital) was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included estradiol (ESTRACE) and medroxyprogesterone acetate (PROVERA). On 30-JUL-2005 the patient developed a fever of over 102 F.Paient has the following illness history - Medical history: surgical procedure, knee arthroplasty, splenectomy, lymphoma Concurrent conditions: Hospitalization, Penicillin allergy.Patient was receiving ESTRACE, PROVERA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from e registered nurse concerning a female in her 50's clinically compromised with no drug allergies who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly). There was no concomitant medication. Subsequently the patient experienced puffy swelling from under ears to and including hands. Ibuprofen (ADVIL) was given for the redness and swelling. The patient recovered. It was noted that the patient had no history of reactions to an.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from e registered nurse concerning a female in her 50's clinically compromised with no drug allergies who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly). There was no concomitant medication. Subsequently the patient experienced puffy swelling from under ears to and including hands. Ibuprofen (ADVIL) was given for the redness and swelling. The patient recovered. It was noted that the patient had no history of reactions to an.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2003, 20. Information has been received from a physician concerning a 71-year-old white male who on 23-OCT-2003 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. There was no illness at the time of vaccination. Concomitant therapy included aspirin, atorvastatin calcium (LIPITOR), glimepiride (AMARYL) and amlodipine besylate (NORVASC). Subsequently, the patient developed a high fever, body aches and flu like symptoms. It was later discovered that the patient had received pneumococcal 23v polys.Patient was receiving NORVASC, aspirin, LIPITOR, AMARYL.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, child 00.7 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 08. Information has been received from a registered nurse concerning an eight month old "healthy" male patient who on 08-AUG-2005 was vaccinated with an expired dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly) (lot 647363/0944N), in the left vastus lateralis, instead pneumococcal 4 6B 9v 14 18C 19F conj vaccine. There was no concomitant medication. The nurse reported that a follow up call was placed to mother of the child who stated child seemed fine and no adverse event. However, t. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 17. Initial and follow up information has been received from a physician concerning a 72 yr old white, retired, female who on 17Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot650370/0740P) into the left deltoid. On 17Aug05 the pt developed pain and swelling at the injection site. Follow up information reported that the pt also developed and erythematous rash at the injection site. Unspecified medical attention was sought. At the time of the follow up report, the pt had recovere.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 16. Information has been received from a RN concerning a 58 yr old female physician who on 16Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 6499989/0579P), IM in the left deltoid. On 16Aug05 the pt developed severe pain, redness and swelling in left arm. There was severe swelling, redness and a large blister noted at the injection site the following AM. The symptoms began a few hrs after receiving the injection. The physician recovered. It was also reported that another adult p. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 18. Information has been received from a RN concerning her daughter a 24 yr old female with Crohn's disease and asthma who on 18Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included polypharmacy. On 18Aug05 the pt developed intense swelling at the injection site and her entire body was aching. It was unk if medical attention was sought or if laboratory diagnostic tests were performed. She was treated with acetaminophen (Tylenol) and was recovering. There was n.Paient has the following illness history - Crohn's disease; asthma. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from DC, USA. Female patient, 21 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 09. Information has been received from a RN concerning a 21 yr old female pt who on 09Aug05 at 10:15AM was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 6499989/0579P), IM in the left arm. On 09Aug05 the pt developed severe pain and swelling in left arm, then developed febrile illness with decreased WBC and increased alk phosphate. The pt recovered. It was also reported that another adult pt had an adverse experience after being vaccinated with pneumococcal 23v polysaccharide vaccine (W. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female nurse who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, she experienced a local injection site reaction and achiness. It was noted that she was not able to go to work the day following her immunization. Unspecified medical attention was sought. The pt's outcome was unk. No product quality complaint was involved. Additional information is not expected..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 18. Information has been received from a 75 yr old female with cancer and a history of urinary tract bacteria, splenectomy and no allergies, who on approx 18Aug05 last week was vaccinated SC with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included (Leboxyl), esomeprazole magnesium (Nexium), (Prevachol) and pancreatic enzymes. Last week, the pt developed vomiting and diarrhea. Unspecified medical attention was sought. No lab diagnostic studies were performed. The consumer reported tha.Paient has the following illness history - Urinary tract infection; splenectomy, cancer..Patient was receiving Nexium.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 22. Information has been received from a physician concerning a 70 yr old female family friend who on 22Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On 23Aug03, the pt's arm was swollen almost to her elbow. The physician said, it looked like angioedema. No treatment was needed. At the time of this report, the pt was recovering. It was noted that the reporting physician was a family friend and the pt was vaccinated at another doctor's office. No product quality complaint was invol.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on June 2005, 25. Information has been received from a registered pharmacist concerning a 67 yr old male who was hospitalized for cholecystitis and was post op cholecystectomy who on 25Jun05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649978/0709P). On approx 25Jun05, the pt developed a localized skin reaction, fever, and cellulitis. The pt was treated with IV antibiotics for the cellulitis. It was noted that the pt has a previous unspecified reaction to a tetanus toxoid vaccination. S.Paient has the following illness history - Vaccination adverse reaction, hospitalization, cholecystectomy; cholecystitis..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 18. Information has been received from a registered pharmacist concerning a 73 yr old female who was hospitalized for dehydration who on 18Aug05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine. On approx 18Aug05, the pt developed a localized skin reaction, fever, and cellulitis and was treated with ice packs. The pt was not treated with antibiotics for the cellulitis. Subsequently, the pt recovered. The pharmacist did not believe that the adverse events prolonged the pt's hospital.Paient has the following illness history - Dehydration; hospitalization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 14. Information has been received from a registered pharmacist concerning a 78 yr old male who was hospitalized for a knee replacement who on 14Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649978/0709P). On approx 14Jul05, the pt developed a localized skin reaction, fever and cellulitis. The pt was treated with IV antibiotics for the cellulitis. Subsequently, the pt recovered. The pharmacist did not believe that the adverse events prolonged the pt's hospitalization a.Paient has the following illness history - Hospitalization; knee arthroplasty.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 28. Information has been received from a registered pharmacist concerning an 86 yr old male who was hospitalized for a knee replacement who on 28Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649978/0709P). On approx 28Jul05, the pt developed a localized skin reaction, fever and cellulitis. The pt was treated with oral cephalexin (Keflex) for the cellulitis. Subsequently, the pt recovered. The pharmacist did not believe that the adverse events prolonged the pt's hospit.Paient has the following illness history - Hospitalization, knee arthroplasty.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 28. Information has been received from a registered pharmacist concerning an 73 yr old female who was hospitalized for a knee replacement who on 28Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649978/0709P). On approx 28Jul05, the pt developed a localized skin reaction, fever and cellulitis. The pt was not treated with antibiotics for the cellulitis. Subsequently, the pt recovered. The pharmacist did not believe that the adverse events prolonged the pt's hospitalizat.Paient has the following illness history - Hospitalization; knee arthroplasty.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant concerning an adult pt who was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5ml) (IM). Subsequently, the pt experienced injection site reaction with injection site redness, warmth and soreness within a day of vaccination. Unspecified medical attention was sought. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 27. Information has been received from a physician concerning a 61 yr old female with chronic obstructive pulmonary disease who on 27Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On 28Aug05 the pt developed redness and swelling at the injection site. On 29Aug05 the pt was recovering from the redness and swelling at the injection site when she developed a fever of 103 deg F. Unspecified medical attention was sought. At the time of the report, the pt was recovering from the fever. A.Paient has the following illness history - Chronic obstructive pulmonary disease..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 26. Information has been received from a 57 yr old female with hypertension and drug hypersensitivity to cephalexin (Keflex) who on 26Aug05 was vaccinated IM in the left arm with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included atenolol (Atenol), omeprazole (Prilosec) and nizatidine (Axid). Subsequently on 26Aug05 the pt experienced pain at injection site (left arm), dizziness, difficulty walking and red blotches in upper part of her left arm. Unspecified medical attention was sou.Patient was receiving Atenol, Axid, Prilosec.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning a pt in their mid 60's who was vaccinated IM into the deltoid muscle with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (649914/0578P). On approx 19Jul05 over this past week, the pt experienced localized redness and localized swelling that looked like cellulitis from the deltoid area down to the elbow and inner arm. The pt was seen in the clinic and was treated with cephalexin (Keflex). In about 4 days, the reaction res.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a female consumer who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine administered at the same time included a dose of tetanus toxoid. Concomitant therapy included prednisone. Subsequently the pt experienced chronic pain. The pt's chronic pain persisted. Additional information is not expected..Patient was receiving Prednisone. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning an adult male who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt experienced a severe reaction of his arm. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 26. Information has been received from a 73 yr old male with hypertension who otherwise experienced good health and had no allergies who on 26Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included hydrochlorothiazide (+) telmisartan (Micardis HCT) and simvastatin. On 27Aug05 the pt developed red blotches near the injection site. Unspecified medical attention was sought. At the time of the report the pt's red blotches were still present. There was no product qua.Paient has the following illness history - Hypertension.Patient was receiving Micardis HCT, Zocor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 31. Information has been received from a healthcare professional concerning a 63 yr old male who on 31Aug05 was vaccinated SC with a 0.5ml dose pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). On approx 31Aug05 the pt experienced erythema and soreness at the injection site. Unspecified medical attention was sought. The pt recovered without treatment within 48 hrs. The reporter would like to know if there have been any other problems with this lot number. The records of testing prior to release of thi.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 01. Information had been received from a certified medical assistant concerning a 79 year old female with chronic obstructive pulmonary disease and chronic respiratory acidosis, who on 8/1/05 at 15:00 was vaccinated IM into the left arm with a second dose of Pneumococcal 23v polysaccharide vaccine lot 649694/0386P. On 8/2/05, the patient experienced a local site reaction of redness, tenderness and edema. The pt stated that her arm was sore, she had some swelling and had a low grade fever. That day the pt was br.Paient has the following illness history - Chronic obstructive pulmonary disease, respiratory acidosis..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 06. Information has been received from a medical assistant concerning an 80 year old male with hypertension and hypercholesterolemia, and with no known drug allergies, who on 9/6/05 at 15:00pm was vaccinated IM in the left arm with a third dose of Pneumococcal 23v polysaccharide vaccine lot 647661/0055R. There was no illness at the time of vaccination. The pt was noted to have been administered the first and second doses of Pneumococcal 23v polysaccharide vaccine in Nov 1997 and Dec 2001. Subsequently, on 9/6/0.Paient has the following illness history - Hypertension, Cholesterol high.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 01. Information has been received from a female who, in Sept 2005 was vaccianted with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently within a day of vaccine administration, she had a local reaction that included 2 red bands around her arm at the injection site. She also had lymph node involvement on the arm the injection was given. It was reported that the injection was given high on the arm, possible at the joint. The duration of symptoms was about 2-3 days. At the time of the report the patie. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 31. Information has been received from a healthcare professional concerning a 73 year old female who on 8/31/05 was vaccinated subcutaneously with a 0.5ml dose Pneumococcal 23v polysaccharide vaccine lot 649914/0578P. On approximately 8/31/05 the pt experienced erythema and soreness at the inject site. Unspecified medical attention was sought. The pt recovered without treatment within 48 hours. The reporter would like to know if there have been any other problems with this lot number. The records of testing pri.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 30. Information has been received from a healthcare professional concerning a 45 year old female who on 8/30/05 was vaccinated subcutaneously with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine lot 649914/0578P. On approximately 8/31/05 the patient experienced erythema and soreness at the injection site. Unspecified medical attention was sought. The patient recovered without treatment within 48 hours. The reporter would like to know if there have been any other problems with this lot number. The record.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 03. Information has been received from a medical assistant concerning a 78 year old retired female with hypertension, hypercholesterolemia, COPD, and a sulfa allergy who on 8/3/05 at 9:30am was vaccianted IM in the left arm with a first 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). There was no illness at the time of vaccination. Subsequently the pt experienced burning at site of injection and pain at site of injection. Follow up information received from a medical assistant indicate.Paient has the following illness history - Hypertension, Sulfonamide allergy, chronic obstructive pulmonary disease, cholesterol high.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 06. Information has been received from a physician concerning a 73 year old female with an allergy to sulfa drugs and a history of hip replacement who on 9/6/05 was vaccinated with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included gabapentin (Neurontin) and alendronate sodium MSD. It was reported that on 9/6/05, shortly after being vaccinated, the patients arm began itching. She also experienced redness, swelling, and extreme pain in her arm from her elbow to her shoulder, Sh.Patient was receiving Fosamax, Neurotin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 82 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a registered nurse concerning an 82 year old female with no medical history or no known allergies who on the morning of 9/7/05 was vaccinated IM in the right deltoid with the first dose of Pneumococcal 23v polysaccharide vaccine (lot 649111/0287P). There was no concomitant therapy or illness at the time of vaccination. The RN reported that on 9/7/05, the pt developed what was described as a possible allergic reaction. The pt was noted to have developed a red swollen arm. O.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a registered nurse concerning a 58 year old female with asthma and cardiac arrhythmia who the morning of 9/7/05 was vaccinated in the left deltoid with an IM 0.5ml first dose of Pneumococcal 23v polysaccharide vaccine (lot 650457/0973P). Concomitant vaccination that morning included a SC first dose of meningococcal ACYW polysaccharide vaccine (Menomune AlClYlW-135) (lot UE4804A) in the left arm. There was no illness at the time of vaccination. On 9/14/05 the patient called.Paient has the following illness history - Asthma, Arrhythmia.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 14. Information has been received from a registered pharmacist concerning a 70 year old male who on 9/14/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine 0.5ml (lot 651523/0604R), IM. On 9/14/05 the pt experienced immediate local reaction with redness, swelling, and tenderness. The swelling progressed the length of the left arm (where the injection was given) and down the lateral chest wall on the left side. The pt did not have any itching but said the area ached. It was noted that the pt received.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 15. Information has been received from a nurse concerning a pt who on 15Sep05 was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5ml) (lot 649981/0704P or 650451/0750P), IM. Subsequently, on 16Sep05, the pt called the office complaining of local reaction described as large swollen, reddened, hot area in left arm from deltoid down to elbow. Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 06. Information has been received from a nurse concerning a pt who on 06Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5ml), IM (lot 649981/0704P or 650451/0750P). On 07Sep05 the pt complained of hard firm area at site with swelling and more swelling at the elbow than the vaccination site. Ice was prescribed to area and acetaminophen (Tylenol). The nurse stated that the pt had improved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 22. Information has been received from a physician concerning a 58 yr old male with many health problems who on 22Aug05 was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy included multiple mediations. In Aug 2005, the pt experienced urticaria and a papular rash that became more macular. The rash persisted for 3 weeks. It started at the injection site and spread over the trunk and other arm with no facial involvement. There were no respiratory problems or other symptoms. Unspecified.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a pt (age and gender not reported) with unk medical history and unk allergies who in approx Dec 2004 (winter 2004) was vaccinated IM in the arm with pneumococcal 23v polysaccharide vaccine (lot unk). Subsequently, the pt developed severe local injection site reactions in the same arm the injection was given but below the actual site of injection. It was reported that the pt recovered on an unk date. The pt sought unspecified medical attention. There.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a RN concerning a 48yr old female who on 07Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5ml) (IM) (lot 550453/0791P). Subsequently, within two days, the pt experienced injection site redness, mild swelling and arthralgia. The pt was treated with ice, ibuprofen (Tylenol) and ibuprofen, as needed. No product quality complaint involved. It was also reported that another pt had an adverse reaction following vaccination with pneumococcal 23v po.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 19. Information has been received from a certified medical assistant (CMA) concerning a 65 yr old white female with an unk medical history and unk allergies who on 19Sep05 at 17:00 was vaccinated IM, left deltoid with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). On the night of 19Sep05 (previously reported as within 48 hrs of being vaccinated), the pt developed redness and swelling at the injection. The pt had a mild pain and she took ibuprofen (Advil). She also felt low grade fever. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 21. Initial and follow up information has been received from a medical assistant concerning a 65 yr old white female with a resolving vesicular rash, cardiac disorder, and an allergy to Tolech who on 21Sep05, at approx 9:30AM, was vaccinated IM in the left deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). It was reported that the pt was vaccinated with a prior dose of pneumococcal 23v polysaccharide vaccine on 10Sep68 (approved for market 07Jul83). Concomitant therapy incl.Paient has the following illness history - Immunization; hypersensitivity; cardiac disorder; rash vesicular.Patient was receiving Fosamax, aspirin, atenolol; Aciphex.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 11. Information has been received from a certified medical assistant (CMA) concerning a 72 yr old white male (198lb, 74") with coronary artery disease, increased blood pressure and no illness at time of vaccination and a history of pneumonia (May 20050 and unk allergies who on 11Jul05 was vaccinated IM, left deltoid, with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). On 12Jul05 (previously reported as within 48 hrs of being vaccinated), the pt developed pain and redness over the vacc.Paient has the following illness history - Pneumonia; Coronary artery disease; blood pressure increased. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a male pt who in 1999 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, in 1999, the pt developed an injection site reaction with redness and induration after vaccination. Unspecified medical attention was sought. Subsequently, the pt recovered. No other information was provided. There was no product quality complaint. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 23. Information has been received from a nurse practitioner concerning a 68 yr old Hispanic female with diabetes mellitus and dizziness who on 23Sep05 was vaccinated IM in the right arm with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 650087/0815P, also reported as 650083/0746P). Concomitant therapy included atorvastatin calcium (Lipitor), trandolapril (Mavik), meclizine, estrogens, esterified (+) methyltestosterone (Estratest), vitamins (Centrum), aspirin, and rabeprazole NA (Aciphex). On 24Se.Paient has the following illness history - Diabetes mellitus; dizziness..Patient was receiving aspirin, Lipitor, Estratest, meclizine, Centrum, Aciphex, Mavik. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 21. Information has been received from health professional concerning a 71 yr old male, with atrial fibrillation, diabetes, hypertension and cholesterolemia, and no known allergies, who on 21Sep05 was vaccinated with a SC dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant therapy included warfarin sodium (Coumadin). It was reported that on 23Sep05 the pt's entire arm, that had received the injection, had redness, swelling, pain, and was warm to the touch. The swelling was past the e.Paient has the following illness history - Atrial fibrillation; diabetes; hypertension; cholesterol high.Patient was receiving Coumadin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning an 81 year old female who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650331/0749P). On approx 9/27/05 the pt experienced swelling, tenderness, and redness at the injection site. The pt was treated warm compresses and antihistamines. The symptoms resolved. The outcome was reported as recovered. No further information was available. There was no product quality complaint. Additional information has been re.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 29. Information has been received from a healthcare professional concerning a 62 year old female with diabetes, and allergies to sulfonamides and codeine who at the end of Sept 2005 was vaccinated IM with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included metformin HCL (Glucophage), Levothyroxine NA (Synthroid), venlafaxine HCL (Efferxor), atorvastatin CA (Lipitor), Benazepril HCL (Lotensin), estrogens, conjugated (Premarin) and medroxyprogesterone acetate (Provera). The healt.Patient was receiving Lipitor, Lotensin, Premarin, Synthroid, Provera, Glucophage, Effexor..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a health professional concerning an 85 year old female with atrial fibrillation, hypertension and osteoporosis who on 9/28/05 was vaccinated with an IM dose in the deltoid of Pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant therapy included warfarin sodium Coumadin for the treatment of atrial fibrillation. It was reported that the patient was seen in the physicians office on 9/29/05 since her shoulder to elbow, of the arm that received the injection,.Paient has the following illness history - Atrial Fibrillation, Hypertension, Osteoporosis..Patient was receiving Coumadin.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning an approx 64 year old male with an allergy to penicillin and no other past medical history who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650331/0749P). Concomitant therapy included dexamethasone and prochlorperazine maleate Compazine. Subsequently, the pt developed painful welts at the injection site. He went to the ER, but was not admitted. He was given moxifloxacin hydrochloride Avelox as treatment. No lab.Paient has the following illness history - Penicillin Allergy..Patient was receiving Decadron Tablets, Compazine.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a license practical nurse concerning an 66-year-old female who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650331/0749P). On approximately 27-SEP-2005 the patient experienced swelling, tenderness, and redness at the injection site. The patient was treated warm compress and antihistamines. The symptoms resolved. The outcome was reported as recovered. No further information was available. There was no product quality complaint. Additiona.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 17. Information has been received from a physician concerning an older female who on 17-AUG-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). On 17-AUG-2005 the patient developed pain and swelling at the injection site. Unspecified medical attention was sought. The patient's pain and swelling at injection site persisted. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 03. Information has been received from a pharmacist concerning a female in her 50"s who on approximately 03-SEP-2005 began self administrating pneumococcal 23v polysaccharide vaccine daily (duration not reported). Subsequently, the patient experienced dizziness. The patient was seen in the clinic and was asked to bring the bottle of medication to the clinic. On 03-OCT-2005 the patient returned to the clinic and brought 9 empty vials of pneumococcal 23v polysaccharide vaccine. The pharmacist indicated that t.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 27 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 27. Information has been received from a certified medical assistant concerning a 27 year old female who on 27-SEP-2005 was vaccinated with pneumococcal23v polysaccharide vaccine (lot 650648/0967P), 0.5 ml, one dose. On 29-SEP-2005 the patient reported pain, swelling, redness and warmth at the injection site. As of 03-OCT-2005 the patient was recovering from her experiences. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 47 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 29. Initial and follow up information has been received from a pharmacist and physician's assistant concerning a 47 year old unemployed black female with an allergy to penicillin noted as rash. On 29-SEP-2005, at 9:00 am, the patient was vaccinated intramuscularly in the left deltoid arm with the first dose of pneumococcal 23v polysaccharide vaccine (lot 649979/0531P). There were no illness at the time of vaccination. Subsequently the patient experienced an injection site reaction with an indurated red area.Paient has the following illness history - concurrent condition: penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 20. Initial and follow up information has been received from a medial assistant concerning a 58 year old white male with benign prostatic hyperplasia (BPH), elevated cholesterol, "onychotic" toe nails, sciatica and an allergy to sulfa, rosuvastatin calcium (CRESTOR), cefuroxime axetil (CEFTIN), trees, grass, mold and dust who on 20-SEP-2005, AT APPROXIAMTELY 10:30 am was vaccinated intramuscularly in the left deltoid with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). Concomitant.Patient was receiving saw palmetto, LAMISIL.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning a 60-year-old male who in the last 10 days (approximately September 2005) was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). It was reported that within one day of the vaccination ( approximately September 2005), the patient developed an injection site reaction. He also developed a whole body rash, red pettichiae on both arms and chest, malaise, fever, and the injection site was hard and tender.Paient has the following illness history - Medical History: Immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist and physician's assistant concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 649979/0531P). Subsequently the patient experienced an injection site reaction with an indurated red area five times the size of the injection site, swelling, inflammation, nausea and fever. The patient was treated with ibuprofen (MOTRIN). As OF 04-oct-2005, the patient was recovering from injection site reaction site reaction with an indurate.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 21. Information has been received from a certified medical assistant concerning a 67 yr old white male who at 09:00 on 21Sep05 was vaccinated IM in the right deltoid with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0592P). It was reported that the pt had since developed pain, redness, swelling, and warmth at and around the injection site. On 23Sep05, the pt developed an allergic reaction with some erythema around elbow area. The pt saw the physician and was treated with gatifloxacin (Teq.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information ahs been received from a healthcare pharmacy student concerning an approx 87 year old male with no know allergies and history of cold agglutination disease who within the year approx 2005 was vaccianted with a dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included prednisone. On 8/16/05 the pt had a titer which showed a response to only 6 serotypes. There was no other information available regarding the pts adverse event. The adverse event did not improve and the pt is not.Paient has the following illness history - Cold agglutinins positive..Patient was receiving Prednisone.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 04. Information has been received from a pharmacist concerning adult female who on 04-OCT-2005 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 651524/0605R). It was noted that the patient received her first dose prior to age 65. On 04-OCT-2005, immediately after vaccination, the patient's entire upper arm was red and warm to touch. It covered the entire upper arm with no defined border. Unspecified medical attention was sought and the patient was instructed to use ice packs.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a health professional concerning an approximately 64-year-old female with no known allergies who on 28-SEP-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650331-0749P). Subsequently, in September 2005 the patient developed swelling from her shoulder to her elbow. She was given antibiotics. It was unknown if the patient was on other medications, and the patient's status at the time of the report was unknown as well. Additional informatio.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 06. Information has been received from a 79 year old female consumer with emphysema who on 06-OCT-2005 was vaccinated (route unknown) with a dose of pneumococcal 23v polysaccharide vaccine (lot number unknown). On 06-OCT-2005 the patient experienced rash after getting injection. The patient mention that the rash started below the injection site and spread down the arm. The caller indicated that by the next day, 07-OCT-2005, the rash was gone and only some discoloration was left. At the time of the report it. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 61 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 05. Information has been received from a registered nurse concerning a 61 year old female patient with seizure disorder, chronic anemia, gastroesophageal reflux disease , aguegenic myeloid metaplasia and seasonal allergy who on 05-OCT-2005 was vaccinated intramuscularly in her left arm with a first dose of pneumococcal 23v polysaccharide vaccine. There was no concomitant medication. On 06-OCT-2005 the patient developed cellulitis at an area other than injection site. The cellulitis developed in her left arm.Paient has the following illness history - Concurrent conditions: convulsion disorder, anemia, gastroesophageal reflux disease, myeloid metaplasia, seasonal allergy. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 04. Initial and follow up information has been received from a physician, the husband of a 69 yr old female pt with no known medical history and no known drug reaction or allergies reported, who on 04Oct05 was vaccinated (route unk) in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot unk). On 05Oct05 the pt developed an injection site, cellulitis like reaction, characterized by erythema, tenderness, swelling and pain. It was also reported that the pt experienced warmth. The pt was t. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 06. Information has been received from a pharmacist concerning an 88 year old female who on 06-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). Subsequently, the patient developed large raised welts at the site. No prescription drug treatment was required. The patient's outcome was unknown. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 08. Information has been received from a pharmacist concerning a 70 year old female who on 08-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). On 08-OCT-2005, the patient developed large raised welts at the site of injection. It was noted that hydrocortisone cream was ordered to reduce the welt in this patient. At the time of this report, the patient's outcome was unknown. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 08. Information has been received from a physician concerning a 37 year old male patient with an unknown medical history, who on 10/08/2005, was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine 651329/1047P), one year after his first vaccination, which was in October 2004. It was noted that the patient requested the vaccine even through he had been vaccinated one year earlier. The vaccine was administered by the medical assistant with a physician order. One day after the vaccination, on. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OR, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 07. Information has been received from a 64-year-old female with asthma and no drug allergies who on 07-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. There was no illness at the time of vaccination. Concomitant therapy included fluticasone propionate (FLOVENT), ALBUTEROL, montelukast Na, and thyroid. On 07-OCT-2005, after vaccination, the patient's right arm swelled up to three times the normal size at the injection site area. The patient also developed pain and redness in.Paient has the following illness history - Concurrent conditions: asthma.Patient was receiving ALBUTEROL, FLOVENT, SINGULAIR, thyroid. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 06. Information has been received from a pharmacist technician concerning a patient (age and sex not specified) who on 06-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). On 06-OCT-2005 , within 24 hours, the patient developed an injection site reaction of swelling and redness. The patient sought unspecified medical attention. It was reported they have requested a check of lot 650456/0974p. At the time of this report, the outcome of the events were unknown. The recor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist purchaser concerning a senior citizen patient ( age and gender not specified) who was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650452/0753P) in a senior center during an immunization clinic. On an unspecified date" recently", the patient developed "severe pain at the injection site", so much so that the patient " could not sleep at night". It was also reported that the patient had "swelling present". It.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 42 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 26. Information has been received from a health professional concerning a 41 year old Caucasian male patient with cerumen impaction and otalgia and no known allergies who on 26-SEP-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (intramuscularly) (0.5 ml) (lot 649694/0386P). On 27-Sept-2005 at 8:00 am the patient experienced pain, redness of 6 centimeter by 4 centimeter at local site where vaccine was administered. The patient also had "shooting pain up and down the arm, right arm a.Paient has the following illness history - Concurrent conditions: cerumen impaction, ear pain.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 18. redness and tenderness at site of injection, fever and headache started about 24 hours after vaccine received. Pt is started on Keflex..Paient had Whip worms.Paient has the following illness history - NKDA, ADD, Obesity, Chronic rhinitis.Patient was receiving Strattera, Mebendazole. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 14. Information has been received from a health professional concerning an 83 yr old male who on 14Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot 650649/0790P). On 14Sep05 the pt complained of upper arm swelling and redness at the injection site, fever and chills. The pt took over the counter medication. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 08. Information has been received from a pharmacy tech concerning a pt (age and sex not specified) who on 08Oct05 was vaccinated with pneumococcal 23v polysaccharide vaccine (650456/0974P). On 08Oct05, within 24 hrs, the pt developed an injection site reaction of swelling and redness. The pt sought unspecified medical attention. It was reported they have requested a check of medical attention. It was reported, they have requested a check of Lot 650456/0974P. At the time of this report, the outcome of the events.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning an adult female who was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 651524/0605R). It was noted that the pt received her first dose prior to age 65. Subsequently, the pt's arm had redness, and warm, and was tender. It was noted to be band like. Unspecified medical attention was sought and the pt was instructed to use ice packs for comfort. The pt was recovering. A product quality complaint was not involved. Addition.Patient was taken to emergency room. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female pt in her sixties who in approx Oct 2005, was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine. On approx 05Oct05, the pt developed upper shoulder swelling, redness and tenderness. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning a pt (age and gender not reported) with unk medical history and unk allergies who on an unspecified date was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot unk). Subsequently, the pt developed cellulitis as a result of the vaccination. It was also reported that the pt was treated with antibiotics (unspecified) and recovered from cellulitis on an unspecified date. The reporter felt that the pt's cellulitis was re.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a health professional concerning an 82 yr old female who on 28Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot650649/0790P). On 28Sep05 the pt complained of redness, swelling, and warmth at the injection site and fever. The pt took over the counter medication. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a 79 year old female on 29-SEP-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). On 29-SEP-2005 the patient complained of swelling and redness at the injection site and fever. The patient took over the counter medication. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 02. Information has been received from certified medical assistants concerning a 51 yr old white male (281.5lb, 6'4") factory worker with allergies to aspirin and NSAID (not specified) who on 02Oct05 (also reported as 12Oct05), at 16:15, was vaccinated IM, into deltoid muscle, with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649981/0709P). On the next morning (also reported within the next several hours), at 7:30AM, the pt developed angioedema of face and head (also reported as swelling of his fa. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female child (age not provided) with asthma who was initially vaccinated (date not provided) with a dose of pneumococcal 23v polysaccharide vaccine (lot 651318/1006). Subsequently the patient developed marked, painful redness and swelling at the site of injection. The patient's outcome was not reported. There was no product quality complaint involved. The physician also provided information regarding another patient's experiences with pneumococ.Paient has the following illness history - Concurrent conditions: Asthma. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacy purchaser concerning a senior citizen patient (age and gender not specified) who on an unspecified date was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650452/0753P) in a senior center during an immunization clinic. On an unspecified date. "recently", the patient developed "severe pain at the injection site", so much so the patient "could not sleep at night". It was also reported that the patient had "swelling.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 07. Information has been received from a physician concerning an adult patient who " over the last week", on approximately 07-OCT-2005, was vaccinated with 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). It was reported that the patient developed a severe local reaction at the injection site including, redness, swelling, and pain. It was reported that the patient recovered or was recovering. Unspecified medical attention was sought. The reporter expressed concern abo.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a 64 year old female with chronic obstruction pulmonary disease, emphysema, arthritis, diabetes and cardiac failure congestive who was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy included " too many" medications (therapy unspecified). Subsequently the patient experienced injection site reaction. The patient's outcome was not reported. The patient also reported her experiences while on therapy with ezetimibe. Additional information has.Paient has the following illness history - Concurrent conditions: chronic obstructive pulmonary disease, emphysema, arthritis, diabetes, cardiac failure congestive. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 12. Information has been received from a 69 year old female with lupus and allergic to sulfa who on 12-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine. The patient reported that she received a flu vaccine at the same time that she received the pneumococcal 23v polysaccharide vaccine. On 12-OCT-2005 the patient reported that she felt " dizzy, weak, and generally debilitated" after receiving pneumococcal 23v polysaccharide vaccine. The patient did not seek medical attention. Laboratory di.Paient has the following illness history - Concurrent conditions: lupus erythematosus, sulfonamide allergy. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 70 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 14. Information has been received from a 70 year old female with high cholesterol, hypertension, glaucoma,and penicillin allergy who on 14-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5 ml), subcutaneously. Concomitant therapy included atorvastatin calcium (LIPITOR), valsartan ( DIOVAN), amlodipine besylate (NORVASC) and atenolol. On 14-OCT-2005, "later that night" the patient experienced severe pain in the region of the injection and red blotches on arm. The next day she had a ras.Paient has the following illness history - Concurrent conditions: cholesterol high, hypertension, glaucoma, penicillin allergy.Patient was receiving NORVASC, atenolol, LIPITOR, DIOVAN.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 07. Information has been received from a physician concerning an adult patient who " over the last week", on approximately 07-OCT-2005, was vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). It was reported that the patient developed a severe local reaction at the injection site including, redness, swelling, and pain. The patient was seen at the emergency room. It was reported that the patient had recovered or was recovering. The reporter expressed con.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 07. Information has been received from a physician concerning an adult patient who "over the last week" on approximately 07-OCT-2005 was vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine. (lot 650453/0791P). It was reported that the patient developed a severe local reaction at the injection site including, redness, swelling and pain. The patient was seen at the emergency room. The patient also developed hives and was treated with diphenhydramine hydrochloride (BENADRYL),.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Information has been received from a physician concerning an adult patient who on 17-OCT-2005 was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). On 17-OCT-2005 the patient developed an injection site reaction including redness and swelling , and the area was itchy. Unspecified medical attention was sought. Outcome was reported as recovering. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 41 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 16. Information has been received from a consumer concerning her 41 year old daughter with a history of cancer who on 16-OCT-2005 was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (Lot 650453/0791P). Concomitant therapy included an unspecified cancer therapy. It was reported that on 16-OCT-2005 the patient's arm had swelled and that she had red welts covering her arm near the injection site. The patient's mother also reported that her arm" hurts very much" near the injecti.Paient has the following illness history - Medical History: cancer. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning a 60 year old male who in approximately 1995 was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. In approximately 1995 the patient developed an injection site reaction with redness, swelling and pain. Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a physician concerning a 69 year old white male with a codeine allergy who on 18-OCT-2005 at 7:10 pm was vaccinated intramuscularly in the right deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). Concomitant vaccination on 25-OCT-2005 intramuscularly seventh dose in the left deltoid of influenza virus split virion 3v vaccine inactivated (lot U1B33BA). It was reported that it had been 9 years since the patient received his first dose.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 13. Information has been received from a registered nurse concerning a 48 year old male with asthma and no known allergies. On 10/13/05 the pt was vaccinated IM with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). Concomitant therapy included unspecified therapy two unnamed inhalers. On 10/14/05 the pt developed a localized reaction of arm with swelling, redness an skin was warm to touch. The pt was treated with diphenhydramine hydrochloride Benadryl. It was reported that it was unkn.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacy technician concerning a male pt who was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). Subsequently the pt experienced a local site reaction post vaccination. The pt called the office on approximately 10/12/05 to report a red, raised, warm area at the injection site, and feeling of fatigue. Unspecified medical attention was sought. The outcome was reported as recovered. There was no product quality complaint. Addit.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 14. Information has been received from a health professional concerning a 65 year old female with no pertinent medical history who on 10/14/05 was vaccinated intramuscularly in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). there was no concomitant medication. There was no illness at the time of vaccination. Following vaccination (date not specified) the pt experienced upper arm swelling to the elbow, redness at the injection site and skin was warm to touch at.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 19. Information has been received from a certified medical assistant concerning an 84 year old female with an allergy to penicillin, vancomycin and gentamicin. On 10/19/05, the pt was vaccianted with Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included metoprolol succinate Toprol XL tablets, alendronate sodium and cyclobenzaprine HCL. On 10/19/05, the pt developed from the injection site to the elbow, her arm was red, swollen and very warm. The pt sought unspecified medical attention. There wer.Patient was receiving Fosamax, Flexeril, Toprol XL tablets.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Information had been received from a pharmacist concerning a 66 year old female with an allergy to codeine who on 10/17/05 was vaccinated IM in the left arm with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). It was reported that the pt came into the pharmacy yesterday, 10/19/05, and complained of a swollen left arm at the injection site. It was reported that the adverse event onset was within 72 hours. Unspecified medical attention was sought. The patient was treated with oral.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 84 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from an 84 year old female with hypertension and an allergy to cephalexin Keflex who on 10/18/05 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included amlodipine besylate Norvasc. On 10/18/05, the pts arm became very sore and red. The flab on the underside of her arm also became very swollen. No medical attention was sought and no diagnostic lab test were performed. At the time of the report, the pt had not recovered. A pro.Patient was receiving Norvasc. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female in her 30's with an undefined illness who was initially vaccinated (date not provided) with a dose of Pneumococcal 23v polysaccharide vaccine(lot 651318/1006). Subsequently the pt developed pain, redness and swelling at the site of injection. No treatment was ordered. The pts outcome was not reported. There was no product quality complaint involved. The physician also provided information regarding another pts experiences with Pneumococcal 2.Paient had sickness. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a 68 year old female with a history of multiple allergies and one time vaccination with Pneumococcal 23v polysaccharide vaccine who was vaccinated (date not provided) with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1005). Subsequently the pt developed pain, redness and swelling at the injection site extending into axillary region and posterior cervical area on same side. The pt was treated with cephalexin (Keflex). The pts outcome.Paient has the following illness history - Hypersensitivity, Immunisation. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a health professional concerning an approx 80 year old pt who in Oct 2005 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. In Oct 2005, the pt experienced cellulitis and was hospitalized. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 15. Information has been received from a pharmacist concerning a 75 year old female with an allergy to penicillin and sulfa drugs, and no other medical history who on 10/15/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (kit 647661/0055R). Concomitant therapy included levothyroxine NA Synthroid, escitalopram oxalate Lexapro, Loratadine Lorazepam, rabeprazole sodium Aciphex and zolpidem tartrate Ambien. On 10/15/2005 the pt developed a huge red knot at the injection site which was accom.Patient was receiving Lexapro, Synthroid, Lorazepam, Aciphex, Ambien.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 05. Information has been received from a pharmacy technician concerning a male pt who on approx 10/5/05 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine vaccine lot 650083/0749P). Subsequently, in Oct 2005, the pt experienced a local site reaction post vaccination. The pt called the office to report a red, raised, warm and achy area at the injection site. He was treated with cold compresses and acetaminophen Tylenol as needed. Unspecified medical attention was sought. The outcome w.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 05. Information has been received from a pharmacy technician concerning a female pt who on approx 10/5/05 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). Subsequently, in Oct 2005, the pt experienced a local site reaction post vaccination. the pt called the office to report a red, raised, warm, and achy area at injection site. He was treated with cold compresses and acetaminophen Tylenol as needed. Unspecified medical attention was sought. The outcome was repor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a health professional concerning an 85 year old female with hypertension and hypohydremia and no allergies who on 10/20/2005 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included enalapril maleate. On 10/21/05 the pt stated that the site was swollen and red down to the elbow on the back side of the arm. The pt saw the physician on 10/22/05 where the condition was observed and verified. there were no labs or diagnostics.Patient was receiving Enalapril Maleate.Patient was taken to emergency room. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a certified medical assistant CMA and a registered Nurse concerning an over 65 adult male with no pertinent medical history or allergies who on 10/20/05 was vaccinated IM with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). the day after the injection, on 10/21/05, the pt experienced swelling, redness, induration, warmth and pain at the injection site. The swelling was described as almost like cellulitis. Unspecified medical attention was sought.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 19. Information has been received from a health professional concerning a 72 year old female with penicillin allergy, sulfonamide allergy and dexamethasone allergy who on 10/19/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). On 10/19/05, the pt experienced raised red hot area at the injection site. Unspecified antibiotics were started on 10/21/05. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine and had a local reaction. No other information was provided. Additional information is not expected.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a physician concerning a pt who was vaccinated with a first and second dose of Pneumococcal 23v polysaccharide vaccine, the first in 1995 and the second on 10/24/05 (lot 650302/1039P, 0.5ml, IM). On 10/25/05 the pt was diagnosed with cellulitis of the arm. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a public health nurse concerning an adult female pt who was vaccinated with a second dose of Pneumococcal 23v polysaccharide vaccine. It was noted that the date of the first dose is unknown. Subsequently the pt experienced redness and severe swelling at the injection site, which resolved with no treatment. The adverse event improved and the pt recovered. No further information was available regarding the adverse event. There was no product quality complaint reported. The p.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a health professional concerning a 31 year old female who on 10/18/2005 was vaccianted with a 0.5ml dose IM in the left deltoid of Pneumococcal 23v polysaccharide vaccine, (lot 640453/0791P). Concomitant therapy included atorvastatin calcium Lipitor. That night, on 10/18/2005, the pt experienced a red and swollen left arm and she had pain in her shoulder blade and arm pit. The symptoms subsided on their own and she received no treatment. No medical attention was sought. Th.Patient was receiving Lipitor. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, child 20.1 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a certified medical assistant concerning a 25 month old male with no medical history and no drug allergies who on 10/18/05 in the AM was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine 0.5ml IM lot 649695/0512P, in the right thigh. There was no concomitant medication. On 10/19/05 the patient experienced a red, tender and swollen at injection site. It was also reported as patient got a severe erythematous 6cm circular region at injection site. The pt was t.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a health professional concerning an adult female who on 24OCT05 was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 659697/1038P). On 24Oct05 the pt experienced a swollen arm and pain at the injection site. She was seen by the physician and was ordered acetaminophen (Tylenol). At the time of this report, the pt was recovering. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 22. Information has been received from a RN concerning a 39 yr old female with a history of pneumonia 2 yrs in a row. On 22Oct05 the pt was vaccinated IM in the left deltoid with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). That same day, the pt developed redness, swelling at site, and a fever noted as 102.5. The pt sought unspecified medical attention. It was reported that there was no treatment. The fever resolved itself (date unk). At the time of the report, the pt had recovere.Paient has the following illness history - Pneumonia.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a physician concerning a 54 yr old Caucasian male pt with sarcoidosis, thrombocy, and no known drug reactions/allergies, who on 24Oct2005 was vaccinated SC with a first dose pneumococcal 23v polysaccharide vaccine. There was no concomitant medication. On 24Oct05 the pt developed a local reaction. The left tricep and upper arm of the pt had warmth and erythema. It was reported that the doctor gave the pt a shot of methylprednisone sodium succinate (Solumedrol) and gave cefd.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a RN concerning a male (age not specified) who on approx 26Oct05, the past 48 hrs, was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On approx 26Oct05, the past 48 hrs, the pt developed a significant injection site reaction and cellulitis from armpit to wrist. It was also reported that symptoms started within 12 to 24 hrs of receiving the vaccine. The pt sought unspecified medical attention. There were no lab diagnostic studies.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Information has been received from a healthcare worker concerning a 76 yr old female with hypertension. On 27Oct05 the pt was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot649913/0577P). Concomitant therapy included unspecified therapy reported as several other medications. On 27Oct05 the pt developed swelling at the injection site and area surrounding the injection site. The pt sought unspecified medical attention. At the time of this report, the pt was recovering from the.Paient has the following illness history - Hypertension.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a licensed practical nurse concerning an adult female pt with unk medical history and unk drug reactions/allergies, who on 24Oct05 was vaccinated in the right deltoid IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot649979/0531P). The pt called the office within 4 hrs complaining of redness, warmth to injection site, body aches and vomiting. She was ordered promethazine hydrochloride (Phenergan) by mouth. Subsequently, within 24 hrs vomiting and body aches.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 13. Information has been received from a health professional concerning a 68 yr old white retired male with no pertinent medical history who on 13Jul05 was vaccinated IM in the deltoid with a second 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). There was no concomitant medication. Two hrs after the injection on 13Jul05 the pt experienced upper arm swelling, redness and skin warm to touch at the injection site. Unspecified medical attention was sought no laboratory or diagnostic tests.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Information has been received from a physician concerning an adult pt who on 17Oct05 was vaccinated IM with 0.5mL pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). On 17Oct05 the pt developed an injection site reaction included redness and swelling. Unspecified medical attention was sought. Outcome was reported as recovering. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a certified medical assistant (CMA) and a registered nurse (RN) concerning a 72 yr old retired Caucasian adult male (also reported as over 65) with CAD, HTN, cardiomyopathy, NIDDM, and hypercholesterolemia who on 20Oct05 at 13:30 (also reported as the second week of October and a couple weeks ago) was vaccinated IM with a second dose of 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot649697/1038P). On 20Oct05 (also reported as the day after the injection), the pt.Paient has the following illness history - Coronary artery disease; Hypertension; cardiomyopathy; diabetes mellitus non insulin dependent; hypercholesterolaemia..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a 65 year old male with lymphoma who was inadvertently vaccinated with a 1.0mL dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt complained of tenderness and erythema at vaccination site (unspecified), as well as low grade fever. Medical attention was sought. The pt's outcome was unk. Additional information has been requested..Paient has the following illness history - Lymphoma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a licensed practical nurse concerning 3 pt's who were vaccinated with pneumococcal 23v polysaccharide vaccine (lot650327/0792P) and subsequently developed severe injection site reactions, which extended from the deltoid area to the entire arm. All 3 pts sought medical attention, outcomes were unk. The nurse requested a lot check be performed on lot 650327/0792P. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lo.Paient has the following illness history - Arthritis.Patient was receiving Norvasc. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a RN concerning a 71 yr old Caucasian male pt with hypertension and benign prostatic hyperplasia (BPH) who on 25Oct05 at 1:30PM was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot649989/0579P), IM in the right deltoid. There was no illness at the time of vaccination. On 26Oct05 in the PM the pt developed swelling/redness right upper arm, and slight burning sensation began. The pt was seen in the physician's office on 27Oct05. It was also report.Paient has the following illness history - Hypertension; Benign prostatic hyperplasia.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AZ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a healthcare worker concerning a pt (age and gender not specified) who on an unspecified date, was vaccinated with pneumococcal 23v polysaccharide vaccine. On an unspecified date, the pt developed swelling at the injection site and headaches. At the time of this report, the outcome of the events were unk. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Information has been received from a nurse practitioner concerning an adult pt (age and gender not reported) with an unk medical history and unk allergies who on 27Oct05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (651524/0605R). Subsequently, the pt developed an injection site reaction including swelling, redness, pain and local heat. The pt was reported as recovering. There was no product quality complaint involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 21. Information has been received from a female consumer (age not reported) with no reported medical history and an allergy to ampicillin who on 21Oct05 was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Concomitant therapy included losartan potassium HCTZ. The pt reported that on 22Oct05 she developed two separate rashes on the arm she received the injection and that same arm was sore. Subsequently, the pt recovered three days after the injection, 24Oct05. There was.Paient has the following illness history - Penicillin allergy.Patient was receiving Hyzaar. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a pharmacist concerning a healthy 54 yr old female pt with a shellfish allergy who on 24Oct05 was vaccinated IM in the left arm with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot unk). Concomitant therapy included a dose of influenza virus vaccine, given about a week before. On approx 25Oct05, within 24 hrs of the vaccination, the pt experienced severe pain, developed red streaks down the arm and cellulitis. She was treated first with clindamycin and then wi.Paient has the following illness history - Shellfish allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a pharmacist and the step daughter of a 64 yr old male with asthma. On 25Oct05, the pt was vaccinated with pneumococcal 23v polysaccharide vaccine (lot649988/0692P). On an unspecified date, the pt developed redness and swelling of the injection site arm. The pt was prescribed antibiotics. It was further reporter that the pt developed significant swelling, redness and pain from the top of his shoulder down past his elbow. The pt sought unspecified medical attention. At the.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Initial and follow up information has been received from a pharmacist and the daughter of a 58 yr old female with asthma. On 25Oct05, the pt was vaccinated with pneumococcal 23v polysaccharide vaccine (lot649988/0692P). In Oct 2005, the pt developed redness and swelling of injection site arm. The pt was prescribed antibiotics. It was further reported that the pt developed significant swelling, redness from the top of shoulder to the middle of forearm and pain. The pt sought unspecified medical attention. At.Paient has the following illness history - Asthma.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a pharmacist and a friend concerning a 69 yr old female. On 25Oct05, the pt was vaccinated with pneumococcal 23v polysaccharide vaccine (lot649988/0692P). In Oct 2005, the pt developed redness and swelling of injection site arm. It was further reported that the pt developed significant swelling, redness and pain from the top of the shoulder down to the middle of the forearm. The pt sought unspecified medical attention. At the time of this report, the outcome of the events.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a pharmacist and a fried concerning a 73 yr old male who on 25Oct05 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). In Oct 2005, the pt developed redness and swelling of the injection site arm. It was further reported that the pt developed significant swelling, redness and pain from top of the shoulder down to his wrist. The pt sought unspecified medical attention. At the time of this report, the outcome of the events were unk. Additional in.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a registered nurse concerning a female (age not specified) who on approx 10/26/05, the past 48 hours was vaccinated with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On approx 10/26/05, the past 48 hours, the pt developed significant injection site reaction, fever, chills, swelling and redness from elbow to deltoid at injection site. it was also reported that symptoms started within 12 to 24 hours of receiving the vaccine. The pt sought unsp.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a registered nurse concerning a female age not specified who on approx 10/26/05, the past 48 hrs was vaccinated with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On approx 10/26/05, the past 48 hrs, the pt developed significant injection site reaction, fever, chills, swelling and redness from elbow to deltoid at injection site. It was also reported that symptoms started within 12 to 24 hours of receiving the vaccine. The pt sought unspecifie.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a nurse concerning an 8 year old female who on 10/24/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. On 10/24/05, the pt was concomitantly vaccinated with a dose of hepatitis A vaccine inactive. Subsequently, the pt developed injection site redness, a rash, fever, and vomiting. unspecified medical attention was sought. Subsequently, the pt recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a physician's assistant concerning a 55 year old female who on 10/26/05 was attending a clinic and was vaccinated IM with a 0.5ml second dose of Pneumococcal 23v polysaccharide vaccine. The pt reported that she had received the Pneumococcal 23v polysaccharide vaccine six years ago and was requesting another. The reporter noted that she had heard from another health care professional that on 10/7/05 the pt developed a cellulitis like reaction. Unspecified medical attention.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 52 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a healthcare worker concerning a 52-year-old female with a history of organ transplant and no known drug reactions or allergies who on 31-OCT-2005 at 13:30 pm. was vaccinated intramuscular with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). It was reported that the patient had the flu on 26-OCT-2005, however, there was no illness at the time of vaccination. On 01-NOV-2005, the patient developed swelling, stiffness, and a rash on the up.Paient has the following illness history - medical history: organ transplant concurrent conditions: flu.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning an adult patient with unknown medical history and unknown drug reactions or allergies, who "over the last ten days" in October 2005, was vaccinated intramuscularly with a 0.5 ml dose pneumococcal 23v polysaccharide vaccine (Lot# unknown). Subsequently, in October 2005 the patient developed a local reaction at the injection site including soreness, warmth, erythema and swelling. Unspecified medical attention was sought. The patient was repor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a licensed practical nurse concerning a pt over 40 yrs old who on approx 10/24/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). ON approx 10/24/05, the pt experienced a more extreme reaction than usual which included extreme soreness, redness, pain and swelling at the injection site and limb and site tenderness. Unspecified medical attention was sought. Subsequently, the pt recovered. It was noted that the pt did not have a react.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a LPN concerning a physician in the office who on approx 10/31/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651523/0604R. On approx 10/31/05, the physician experienced a more severe reaction than usual to the vaccine. The reaction included pain and swelling at the injection site. Unspecified medical attention was sought. Subsequently, the physician recovered. A investigation into the lot number was requested. No product quality complaint wa.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a healthcare worker concerning a male pt who on 10/26/05 was vaccinated in the arm with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). On approx 10/26/05 the pt experienced numbness in arm, tightness in the chest, low grade fever, and hot red spots on his body. As of 10/28/05 th pt was improving. Additional information has been requested. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a registered nurse concerning a 79 year old female who on 10/26/05 was vaccinated with a second dose of Pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). She called the following day to complain of pain, redness, and swelling at site of injection. The nurse practitioner advised acetaminophen Tylenol for pain and ice packs. She was advised to call the next day if not better. At the time of the report, she had not called. The pt was considered to be recovering. It.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a registered nurse concerning a 69 year old female who on 28-OCT-2005 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). On 31-OCT-2005 the patient called with entire arm sore, stiff, difficulty sleeping on and moving the arm. Unspecified medical attention was sought. The patient was considered to be recovering. It was also reported that two other patient's had an adverse experience following vaccination with pneumococcal 2.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant concerning a female patient who was vaccinated intramuscularly in the right arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 631319/1007P). Subsequently she developed a red, warm, swollen arm at the injection site. It was also reported that she developed a "cellulitis type reaction" and fever. The patient sought medical assistance and was recovering at the time of the report..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant (CMA) concerning a male patient who was vaccinated intramuscularly in left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 651319/1007P). Subsequently the patient developed a red , blotchy arm and fever. The CMA also stated that he developed a red, warm, swollen arm at injection site. The patient sought medical attention and was recovering at the time of this report. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 30. Information has been received from a 75 year old female with no allergies and unremarkable medical history who on 30-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine, in her left arm. Concomitant medication included phenytoin (DILANTIN) and atorvastatin calcium (LIPITOR). On 30-OCT-2005 the patient experienced swelling of elbow, rash 3 inches below and 6 inches above elbow, redness, and warm to touch in area of injection. At the time of the report she was still experiencing most of th.Patient was receiving LIPITOR, DILANTIN. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a 30 year old female patient with asthma and" post partum" thyroiditis, who on 28-OCT-2005 was vaccinated intramuscularly into the arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). There was no concomitant medication. On 28-OCT-2005, about five hours after vaccination, the patient experienced sleepiness. On 29-OCT-2005 the patient experienced soreness at injection site, queezy stomach, chills, sweating, headache, muscle cramping and developi.Paient has the following illness history - Concurrent conditions: asthma, thyroiditis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a nurse concerning a patient with a history of pneumococcal 23v polysaccharide vaccination and unknown allergies who on approximately 26-OCT-2005 ("within the last week") was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot unknown). Subsequently, on an unknown date in 2005, the patient developed redness and swelling at the injection site. The patient sought unspecified medical attention. It was unknown if the patient recovered. There was n.Paient has the following illness history - Medical History: Immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Information has been received from a health professional concerning an adult female who on approximately 27-OCT-2005 was vaccinated in the deltoid with an 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). Within an hour of vaccination, the patient called the physician complaining of painful, red, swollen arm at the site of injection. The physician prescribed diphenhydramine HCL (BENADRYL) and told her to call back if no improvement. The patient called back the next day and report.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning an adult male patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Subsequently, the patient complained of redness, warmth and soreness at the injection site. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information is not expected..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a licensed nurse practitioner concerning an adult female patient, with unknown medical history and unknown drug reactions/allergies, who on 24-OCT-2005 was vaccinated in the left deltoid intramuscularly with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 649979/0531P). The patient called the office the same day complaining of vomiting, body aches, redness and heat in the deltoid about 10 centimeters in diameter. She was seen in the office, given promethazine.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 03. Information has been received from a health professional concerning a 50 year old female with a drug hypersensitivity to codeine, high cholesterol, high blood pressure and diabetes who on 03-NOV-2005 was vaccinated subcutaneously with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). Concomitant therapy included "Meglazine" (NOS), valsartan (DIOVAN), ezetimibe (+) simvastin, amlodipine besylate (NORVASC), calcium (unspecified) and chondroitin sulfate sodium (+) dimethyl sufone (+).Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a health professional concerning a pt who, on 11/1/05, was vaccinated with a first IM dose in the right deltoid of Pneumococcal 23v polysaccharide vaccine (lot 650457/0937P). It was reported that the pt had a pretty significant allergic reaction and would be coming into the physicians office the week of 11/7/05. Follow up information from a woman working in a physicians office indicated that on 11/3/05 the pt called reporting a a local reaction to Pneumococcal 23v polysacc.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Information has been received from a consumer concerning his 74 year old wife, with no medical history and no allergies, who on 10/27/05 was vaccianted once with a 0.5ml IM dose of Pneumococcal 23v polysaccharide vaccine. Concomitant vaccine included a dose of Influenza virus vaccine unspecified. It was reported that, on 10/27/05, the pt had an injection site reaction with a large red mark, sensation of warmth, an inability to lift her arm for two days post dose, and with a transient lump that had moved sli.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a certified medical assistant concerning an adult pt who on 6/30/04w as vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. IN Oct 2005, the pt was inadvertently vaccianted IM with an 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. In Oct 2005, the pt developed injection site reaction to include redness, swelling, pain and warmth. Unspecified medical attention was sought. The pts outcome was unknown. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 04. Information has been received from a physician concerning a 59 year old female with chronic obstructive pulmonary disease who on 11/4/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). Subsequently, on 11/05/05, the pt experienced a severe local reaction. The pt then experienced chills, a fever of 102 deg F, pain and redness at the injection site, and presented to the ER on 11/6/05. the pt was released and treated with antibiotic. On 11/7/05, it was noted that the s.Paient has the following illness history - Chronic obstructive pulmonary disease..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 01. Information has been received from a registered nurse concerning a male who in Oct 2005, was vaccinated with Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed a severe local site reaction described as arm pain. Unspecified medical attention was sought. It was also reported that other pts experienced an adverse event Following vaccination with Pneumococcal 23v polysaccharide vaccine WAES0510USA09350 WAES0511USA01104 and WAES0511USA01106. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 22. Information has been received from a registered nurse concerning a 61 year old female who on 10/22/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed a severe local site reaction described as sore arm, pain, chills and vision changes (she saw the color red). Unspecified medical attention was sought. It was also reported that other pts experienced an adverse event following vaccination with Pneumococcal 23v polysaccharide vaccine WAES0510USA09350, WAES0511USA01104.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a pt who was over 50 years old who was vaccinated with a first dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt experienced local swelling at the injection site. No additional information was available. Additional information had been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a registered nurse concerning a 65 year old female, who on 10/24/05 at 11:30 was vaccinated into the left deltoid with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). There was no illness at the time of vaccination. ON 10/24/05, the pt developed itching and half moon sized redness. By the evening, the pt experienced pain at the site. On 10/25/05, the pts pain was radiating into her left breast, and she complained of swelling and pain in her enti. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a health professional concerning an adult female who on 11/1/05 was vaccinated in the deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). ON 11/1/05, post vaccination, the pt called the office complaining of arm soreness, redness, swelling, and arm was warm to tough. The physician ordered diphenhydramine HCL Benadryl and told the pt to call back. She subsequently called back and said she was fine. At the time of this report, the pts out.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). Subsequently the pt experienced a severe local reaction. It was noted that the physician did not feel comfortable using the remaining doses in the vial and would like an investigation into Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). The records of testing prior to release of this lot have been checked and found to be satisfactory.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a male who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). Subsequently the pt experienced a severe local reaction. It was noted that the physician did not feel comfortable using the remaining doses in the vial and would like an investigation into Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). The records of testing prior to release of this lot have been checked and found to be satisfactory. The. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 83 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a licensed professional nurse concerning an 84 year old male who on 10/20/05 was vaccinated IM in the deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). On approx 10/20/05 the Pt experienced swelling, redness and pain of the injection site. The pt was treated in the ER and was released. No diagnostic or laboratory studies were performed. Subsequently, the LPN reported that the pt recovered. The LPN requested a check of the lot number..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OK, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a physician concerning an adult female who in Nov 2005, was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. The physician reported that in Nov 2005, the pt developed injection site swelling and redness that extended onto her chest. The pt was seen in the ER, but was not admitted. In Nov 2005, the pts injection site swelling and redness resolved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 12. Information has been received from a physician concerning a male who on 10/12/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine (0.5ml), in the arm. Concomitant therapy that day included influenza virus vaccine (unspecified), in the opposite arm. On 10/14/05 the pts arm was swollen (arm vaccinated with Pneumococcal 23v polysaccharide vaccine). The physician did not think that the Pneumococcal 23v polysaccharide vaccine caused the swelling. The pt was prescribed an antibiotic and swelling was go.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician, via a company representative, concerning a male pt age unknown, with unknown medical history and unknown drug reactions/allergies, who on an unspecified date was vaccinated route unknown, with a dose of Pneumococcal 23v polysaccharide vaccine (lot known). The physician reported that the day after the injection the pt experienced a case of breakthrough. The physician also reported that there has been about two other cases that are nearly identical. Unspecified.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a health professional concerning a 46 year old female who on 11/7/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650541/1004P). On 11/8/08 the pt experienced a large knot at the area of the injection site. She also had pain in her arm and trouble moving her arm. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 26. Information has been received from a physician concerning a 52 yr old female diabetic, who on 26Sep05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine. On 28Sep05 about two days post vaccination, the pt experienced generalized arthralgia. Unspecified medical attention was sought. The pt was placed on naproxen. No diagnostic lab studies were performed. At the time of this report, the pt had not recovered. No product quality complaint was involved. Generalized arthralgia was cons.Paient has the following illness history - Diabetes.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a physician concerning a male pt who sometime this week was vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed swelling, redness and cellulitis. It was not known if this was the first dose of vaccine. The physician gave him cortisone injection and was doing fine now. The pt recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a RN concerning a 69 yr old female who in 1999 and on approx 01Nov05 was vaccinated with a first and second dose (lot 649693/0496P) of pneumococcal 23v polysaccharide vaccine (0.5ml) (IM), respectively. On 08Nov05 the pt experienced significant swelling from her elbow to her shoulder. It was also reported that the pt developed painful, swollen, red arm. The pt was reportedly recovering. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a physician concerning an adult pt who on 24Oct05 was vaccinated with an IM 0.5mL first dose pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). On 25Oct05 the pt was diagnosed with cellulitis. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a physician concerning a female who on 24Oct05 was vaccinated with IM with a 0.5mL second dose of pneumococcal 23v polysaccharide vaccine (650302/1039P). It was reported that the pt's first dose of pneumococcal 23 polysaccharide vaccine was administered 5-10 yrs ago. On 25Oct05 the pt was diagnosed with cellulitis in her arm. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a health professional concerning an adult female who on 25Oct05 was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). On 24Oct05 the pt experienced a fever, swelling and arm pain at the injection site. She was seen by the physician and was ordered acetaminophen (Tylenol). At the time of this report, the pt was recovering from swelling and arm pain at the injection site but her fever persisted. Additional information has been reques.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning an 80 yr old female pt with a history of three previous vaccinations with pneumococcal 23v polysaccharide vaccine, who in the last 10 days (approx Sep 2005) was vaccinated with a fourth dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). It was reported that within one day of the vaccination (approx Sep 2005), the pt developed an injection site reaction. Her arm was sore and weak, and she also developed malaise, fatigue. Ther.Paient has the following illness history - Immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning a 59 yr old male pt who in the last 10 days (approx Sep 2005) was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). It was reported that within one day of the vaccination (approx Sep 2005), the pt developed a severe injection site reaction. He also developed a cellulitis, fever and chills. He was treated with an antibiotic. It was noted that the pt did receive the pneumococcal 23v polysaccharide vac.Paient has the following illness history - Immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 27. Information has been received from a nurse practitioner concerning an adult pt (age and gender not reported) with an unk medical history and unk allergies who on 27Oct05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot651524/0605R). Subsequently, the pt developed an injection site reaction which included swelling, redness, pain and local heat. The pt was treated with antibiotics (unspecified). The pt was reported as recovering. There was no product quality complaint involv.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 11. Information has been received from a physician concerning an adult pt (gender and age not provided) who on 11Nov05 was vaccinated ID with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot not provided). On 11Nov05 the pt developed an inflammatory reaction at the injection site. The pt was reported as recovering. There was no product quality complaint involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 21. Information has been received from a physician via a company rep concerning an 83 yr old male a history of previous vaccination with a first dose of pneumococcal 23v polysaccharide vaccine who three weeks ago, on approx 21Oct05 was vaccinated with a dose of pneumococcal 23 polysaccharide vaccine (lot not provided). Three weeks ago, on approx 21Oct05 the pt developed a local injection site cellulitis reaction. The pt was treated with antibiotics for 10 days. In Nov 2005, the pt developed bronchitis. The pt w.Paient has the following illness history - Immunization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning an adult female who in August 2005, was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). In Aug 2005, the pt developed injection site reactions to include pain, local warmth, redness and swelling. The pt's were reported as recovered. There was no product quality complaint involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 33 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a licensed professional nurse (LPN) concerning a 33 yr old female who on 18Oct05 was vaccinated IM in the deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 7091P). Concomitant therapy included hormonal contraceptives (unspecified). On approx 18Oct05 the pt experienced injection site swelling, redness and pain. Unspecified medical attention was sought. Subsequently, the pt recovered. The LPN requested a check of the lot number. Additional information.Paient has the following illness history - Contraception.Patient was receiving Hormonal contraceptives.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a licensed professional nurse (LPN) concerning a 76 yr old female who on 18Oct05 was vaccinated IM in the deltoid with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot reported as 7091P). The LPN reported that the pt was on multiple drugs concomitantly. On approx 18Oct05 the pt experienced injection site swelling, redness and pain. Unspecified medical attention was sought, no diagnostic or laboratory studies were performed. Subsequently, the pt recovered. Addit.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse practitioner concerning a pt (age and gender not reported) with an unk medical history and unk allergies who on an unspecified date was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot unk). Subsequently, the pt developed cellulitis as a result of the vaccination. It was reported that the pt recovered from cellulitis on an unspecified date. The reporter felt that the pt's cellulitis was related to therapy with pneumococcal 23v polysaccha. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Initial and follow up information has been received from licensed practical nurse (LPN) and a healthcare provider concerning a 58 yr old white female pt, with hypertension, diabetes and gastrooesophageal reflux disease and unk drug reactions/allergies, who on 08Nov05 was vaccinated IM in the left deltoid with a 0.5mL first dose of pneumococcal 23v polysaccharide vaccine (lot651329/1047P). On 08Nov05, follow up information from the healthcare provider indicated that the pt's left deltoid area became red, swo.Paient has the following illness history - Diabetes; hypertension; gastrooesophageal reflux disease..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician a pt who in Oct/Nov05, who along with 6 other pt's was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 650331/0749P and 649989/0579P). Some pt's were first time vaccinated while others received a previous injection at least 5 yrs ago. Concomitantly they were vaccinated in separate sites with a dose of influenza virus vaccine (unspecified). Subsequently, the pt developed severe local reactions. The pt was reported as recovered. The records of testin. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a female patient (age and gender not provided) who on unspecified date was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650331/0749P). Subsequently, the patient developed injection site reaction which was uncomfortable and very painful. The patient required treatment with an antibiotic PO (unspecified) and methylprednisolone. The patient was reported as recovered. Injection site reaction was considered to be an othe. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a licensed practical nurse (LPN) concerning a 59 yr old female with no medical history and no known allergies who on 10Nov05 was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651328/1046P). There was no concomitant medication. Subsequently, the pt developed red, hot, painful and grapefruit size areas at the injection site. On 14Nov05, the pt was seen in the office and was treated with compresses. The pt was reported as not recovered. There w.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a male pt greater than 65 yrs of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The pt was reported as generally healthy with no major health problems. Subsequently, the pt developed injection site cellulitis which lasted at the most for 3 days. The pt recovered from the injection site cellulitis. No. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a RN concerning a male (age not provided) who in early Oct 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650331/0749P). Subsequently, the pt developed injection site reaction. The pt was reported as recovered. There was no product quality complaint involved. The registered nurse also provided information regarding another pt's experiences with pneumococcal 23v polysaccharide vaccine (WAES0511USA02165, 0511USA03746). Additional information. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a 71 yr old female with high cholesterol who on 10Nov05 was vaccinated IM in the right deltoid with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Concomitant therapy included simvastatin, latanoprost (Xalatan), antihistamine, acetaminophen/oxycodone hydrochloride (Percocet) and naproxen. On 10Nov05 the pt experienced transient pain on the medial aspect of the injection arm from arm pit to elbow with erythema, warmth, nausea, and difficulty sle.Paient has the following illness history - Cholesterol high.Patient was receiving Percocet; cough,cold and flu therapies; Xalatan; naproxen; Zocor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 15. Information has been received from a registered nurse concerning a 51 year old sister who on approx 10/15/05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. The RN reported that on approximately 10/15/05, immediately after being vaccinated, her sister developed edema like a softball and redness at the injection site. Unspecified medical attention was sought. At the time of this report, the pts edema and redness at the injection site persisted. The follow up it was reported that the re.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2005, 01. Information has been received from a pharmacist concerning a female pt who in March 2005, was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. IN March 2005, the pt experienced redness, swelling and tenderness from the elbow to the shoulder. Unspecified medical attention was sought. It was noted that the pharmacist was unsure of how long the pts symptoms lasted. Subsequently, the pt recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician, via a company representative, concerning a female patient in her mid 60's with diabetes who was on an unspecified date was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot unknown). The patient could not remember getting a previous vaccination. However, after the vaccination, the office personnel discovered that the patient had received it 3 months earlier. Concomitantly she was on several medications ( therapy un.Paient has the following illness history - MEDICAL HISTORY: Immunization, CONCURRENT CONDITIONS: diabetes. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a physician concerning a pt who in Nov 05 was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. In Nov 2005, the pt developed localized reaction in the vaccinated arm. The arm was red and swollen. The pt recovered. The pt has a previous dose of Pneumococcal 23v polysaccharide vaccine in 2004. There was no product quality complaint involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, child 8 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a registered nurse concerning an 8 year old female with sickle cell disease who on 11/7/05 was vaccinated IM with a dose of Pneumococcal 23v polysaccharide vaccine (lot 647635/0864N). It was reported that the vaccine had expired in June of 2005. Following the vaccination (on an unspecified date) the pt developed a severe local site reaction of redness and swelling. The child was taken to see a physician and was treated with oral diphenhydramine hydrochloride Benadryl. The.Paient has the following illness history - Sickle cell disease..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 90 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a medical assistant concerning a 90 year old female who on approx 10/31/05 was vaccinated IM with 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650084/0605P). The pt was also vaccinated separately with influenza virus vaccine unspecified. Concomitant therapy included metoprolol succinate Toprol XL tablets, aspirin and prednisone. On 10/31/05, the pt developed cellulitis. The pt was treated with antibiotics. The pt was reported as not recovered. Additional info.Patient was receiving Aspirin, Toprol XL tablets, Prednisone.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a physician concerning a 64 year old retired female with hypertension, arthritis and mild scoliosis who on 10/31/05 at 1:45pm was vaccinated IM in left arm with a second dose (first dose was 20 years ago) of Pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant therapy included estrogens, conjugated (Premarin), ramipril (Altace), and acetaminophen + propoxyphene napsylate (Darvocet N). On 11/1/05 at 8:00 am, the pt developed severe swelling of left upper.Paient has the following illness history - Immunisation, Hypertension, Arthritis, Scoliosis.Patient was receiving Darvocet N, Premarin, Altace.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 08. Information has been received from a health professional concerning a 62 yr old white female pt with right leg cellulitis who on 08Nov05 was vaccinated IM in the right deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 651328/1046P). Concomitant therapy included esomeprazole magnesium (Nexium), citalopram hydrobromide (Celexa), alprazolam, furosemide (Lasix), albuterol, and amoxicillin/clavulanate potassium (Augmentin). On 08Nov05 the pt developed 7 cm erythema, heat, and pain at inj.Paient has the following illness history - Cellulitis of leg.Patient was receiving Albuterol, alprazolam; Augmentin; Celexa, Nexium, Lasix (Furosemide).. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 27. Information has been received from a physician concerning a 72 yr old retired male pt with an allergy to lidocaine who on 27Sep05 was vaccinated in the left upper arm with a first dose of pneumococcal 23v polysaccharide vaccine (lot650454/0751P). On approx 27Sep05 the pt developed left upper extremity with cellulitic type reaction ie swelling. He was afebrile. The pt's outcome was unk. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician, via a company representative, concerning a 42 year old male, with type I diabetes mellitus, blood pressure and cholesterol, who on an unspecified date was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot# unknown). Concomitant therapy included blood pressure (therapy unspecified) and cholesterol (therapy unspecified) medications, and insulin. Subsequently, the day after the vaccinations and for the whole week, on a.Paient has the following illness history - concurrent conditions: type I diabetes mellitus, blood pressure, cholesterol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Information has been received from a nurse concerning a 63 year old Caucasian male with no medical history who on 14-NOV-2005 at 3:30 pm was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot#650330/0748P), in the left deltoid intramuscularly. There were no illness at the time of vaccination. On 15-NOV-2005 the patient developed severe left arm pain and difficulty lifting arm. The patient came in on 15-NOV-2005 for follow up visit. The patient's doctor diagnosed it as a localiz.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 73 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 16. Information has been received from a certified medical assistant concerning a 73 yr old female pt with hypertension, hypothyroidism and high cholesterol, no known allergies, and a history of immunization, who on 16Nov05 was vaccinated (route unk) with a second dose (0.5mL) of pneumococcal 23v polysaccharide vaccine (Lot649914/0578P). Concomitant therapy included levothyroxine Na (Synthroid), glucosamine, ibuprofen, lansoprazole (Prevacid), potassium (unspecified) and hydrochlorothiazide (manf not reported)..Paient has the following illness history - Immunization; hypertension; hypothyroidism, cholesterol high. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 30 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 15. Information has been received from a 30 year old female with a penicillin allergy who on 15-NOV-2005 was vaccinated "subdermally" with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot# unknown). Concomitant therapy included hormonal contraceptives (unspecified). ON 15-NOV-2005 the patient administered the pneumococcal 23v polysaccharide vaccine in error. She was "supposed to receive a TB test". On 15-NOV-2005, a few after vaccination, she "developed a severe skin irritation, swelling, pain.Paient has the following illness history - concurrent conditions: penicillin allergy.Patient was receiving hormonal contraceptives.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a female patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient experienced pain and swelling with erythema on the injection arm which listed for a couple of days. Medical attention was not sought. There was no product quality complaint involved. The patient recovered. No further information is expected.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a pharmacist concerning a patient who was vaccinated intramuscularly in the deltoid with a "standard" 0.5 ml dose of pneumococcal 23v polysaccharide vaccine 9lot 647661/0055R or 650083/0746P). Subsequently patient the patient developed arm swelling. Unspecified medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant concerning a patient who on an unspecified date was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot#649914/0578P). Subsequently, the patient developed a reaction at the injection site with redness with discoloration, swelling, hardness, and pain. The patient's outcome was not reported. No product quality was involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 79 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a registered nurse concerning a 79 year old white female (148 pounds) with a history of previous immunization with pneumococcal 23v polysaccharide vaccine (1998) who on 26-OCT-2005 was vaccinated intramuscularly, into deltoid muscle, with a dose of pneumococcal 23v polysaccharide vaccine (lot#647661/0055R). On 27-OCT-2005 the patient developed redness at the injection site and experienced severe pain which lasted for 5 days. On approximately 01-DEC-2005, the patient reco.Paient has the following illness history - medical history: immunization. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a registered nurse concerning a 69 year old white female (169 pounds 61") who on 28-OCT-2005, at 10:00 am was vaccinated intramuscularly, into deltoid muscle with a second dose os pneumococcal 23v polysaccharide vaccine (lot#647661/0055R). On 28-OCT-2005 the patient's entire arm was sore and she had difficulty sleeping related to arm pain. It was noted that there was no redness or edema, only pain. On 01-NOV-2005, the patient recovered. Additional information is not e. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from WI, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a health professional concerning a 71 year old, white, male reported weight was 158 pounds (lb) and whose reported height was 5"9", who on 25-OCT-2005 at 10:30 am in the doctor's office was vaccinated intramuscularly in the right (Rt) deltoid muscle with pneumococcal 23v polysaccharide vaccine (lot#647661/0055R). It was reported that the patient had not received any prior doses of pneumococcal 23v polysaccharide vaccine. On 26-OCT-2005. It was reported the patient exper. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 61 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 17. Information has been received a 61 year old female nurse with diabetes mellitus non insulin dependent who on an unknown date in approximately 1999 received her first dose of pneumococcal 23v polysaccharide vaccine and on 17-NOV-2005 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (Lot#651322/1044P). Concomitant therapy included metformin HCl (GLUCOPHAGE), hydrochlothiazide (+) telmisartan (MICARDIS HCT), estrogens, conjugated (PREMARIN) and atorvastatin calcium (LIPITOR). On 1.Paient has the following illness history - concurrent conditions: diabetes mellitus non-insulin dependent.Patient was receiving LIPITOR, PREMARIN, MICARDIS HCT, GLUCOPHAGE.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 18. Edema peripheral; injection site erythema; injections site discoloration; injection site warmth; local reaction; malaise; erythema Information has been received from a a medical assistant and a 58 year old female consumer with a history of "some times medications have the reverse of their intended effect" and allergies to penicillin and indomethacin sodium (Indocin) who on 18-NOV-2005 at approximately 12:00 PM was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #650648/0967P). There w.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 90 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a certified medical assistant concerning a 90 year old female patient with osteoarthritis, osteopenia, gastroesophageal reflux disease, psoriasis, and no known allergies, who on 10-NOV-2005 was vaccinated (route unknown) with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included calcium (unspecified), vitamins (unspecified) and propranolol HCL (Inderal). On 10-NOV-2005, the patient had a reaction at the injection site which included.Paient has the following illness history - CONCURRENT CONDITIONS: Osteoarthritis, Osteopenia, Gastroesophageal reflux disease, Psoriasis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Injection site reaction. Information has been received from a registered nurse concerning a female patient (age not provided) who on unspecified date was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot#650331/0749P). Five days after vaccination the patient developed injection site reaction. The patient was reported as recovered. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 18. Injection site swelling; injection site erythema; injection site warmth Information has been received from a registered nurse concerning a 78 year old male with no medical history who on 18-NOV-2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). There was no concomitant medication. Subsequently in November 2005, the patient experienced severely swollen, red and warm injection site. No diagnostic laboratory tests were performed. Additional information has been.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 18. Injection site swelling; injection site erythema; injection site warmth Information has been received from a registered nurse concerning a 78 year old female who in 1998 was vaccinated with her first dose of pneumococcal 23v polysaccharide vaccine. On 16-NOV-2005 the patient received an influenza virus vaccine (unspecified) in the right arm. On 18-NOV-2005 the patient received a booster dose of pneumococcal 23v polysaccharide vaccine (651329/1047P) 0.5 milliliters one time in the left deltoid IM. Concomitan.Patient was receiving Fosamax Zetia Zocor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Blood pressure decreased; erythema; feeling hot; injection site erythema; injection site swelling; edema peripheral Information has been received from a physician concerning an 81 year old female with hypertension who on 14-NOV-2005 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (650329/0747P). Concomitant therapy included "high blood pressure pills". The physician reported that on 15-NOV-2005 the patient developed a red swollen underside of the arm where the injection was give.Paient has the following illness history - hypertension cholesterol levels raised.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from GA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 19. Injection site urticaria; burning sensation; injection site urticaria; injection site reaction Initial and follow-up information has been received from a 61 year old female patient, with no known pertinent medial history or drug reactions/allergies reported who on 19-OCT-2005 was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (lot # unknown). Concomitant therapy included loratadine (Claritin) and diphenhydramine HCL (Benadryl). On approximately 21-OCT-2005 the patient expe.Patient was receiving Claritin Benadryl. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient, 67 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 28. Injection site pain; injection site erythema Information has been received from a registered nurse concerning a 67 year old female patient with a history of immunization in 2000 and unknown drug reactions/allergies reported who one 28-OCT-2005 was vaccinated intramuscularly in the left deltoid with a 0.5ml booster dose pneumococcal 23v polysaccharide vaccine (lot #649914/0578P). Concomitant therapy included metoprolol succinate (Toprol XL tablets) raloxifen hydrochloride (Evista) and vitamins unspecified..Paient has the following illness history - Immunisation. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Local reaction Information has been received from a registered nurse concerning a 44 year old female with hypothyroidism and type 2 diabetes mellitus and a history of obesity who in November 2005 was vaccinated subcutaneously with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot #649697/1038P). In November 2005, the patient developed a local reaction after receiving her first dose of pneumococcal 23v polysaccharide vaccine. The patient sought unspecified medical attention. At the time of the rep.Paient has the following illness history - Obesity hypothyroidism Type II diabetes mellitus.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a healthcare worker concerning a patient who was vaccinated subcutaneously with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient developed "swelling and heated skin in the area of the injection." It was reported that the patient sought unspecified medical attention and was not hospitalized. At the time of the report is was unknown if the patient recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 62 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Cellulitis Information has been received from a registered nurse concerning a 62 year old white male teacher with no know drug allergies, who on 14-NOV-2005 at 10:00 was vaccinated IM into the right deltoid with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (Lot #651318/1006P). On 14-NOV-2005, the patient experienced a swollen right arm and "flu symptoms." On 15-NOV-2005 the patient went to the emergency room. His arm was red and edematous from the deltoid to the forearm area was warm and pa.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a registered nurse concerning an 85-year-old female with Alzheimer's disease who on 01-NOV-2005 was vaccinated intramuscularly in the left deltoid with a 0.5 ml second dose of pneumococcal 23v polysaccharide vaccine (lot#651318/1006P). Concomitant vaccination on 03-NOV-2005 in the right arm included a dose of influenza virus vaccine (unspecified). It was noted that the patient received a first dose of pneumococcal 23v polysaccharide vaccine five years prior. On an unspe.Paient has the following illness history - concurrent conditions: Alzheimer's disease.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NE, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 11. Information has been received from a health professional concerning a 60 year old female, with no medical history, who on 11-NOV-2005 was vaccinated with a 0.5 ml intramuscular dose in the right arm of pneumococcal 23v polysaccharide vaccine (Lot#650082/0691P). Concomitant therapy on the same day included an intramuscular dose in the left arm of methotrexate. It was reported that the patient was seen by a physician on 18-NOV-2005 complaining of a little swelling where she received her vaccine. The patien.Patient was receiving methotrexate.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a Physician's Assistant (PA) concerning a female patient with a known phenol allergy who in November 2005, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. In November 2005, the patient developed an injection site reaction because of the phenol allergy. The phenol allergy was known before the injection was given. Medical attention was sought. The patient's outcome was unknown. Follow up information has been received from the PA concerning the 85.Paient has the following illness history - Medical history: dysuria, concussion with no loss of consciousness, hematuria, skin abrasion Concurrent conditions: hypersensitivity, hyponatremia, osteoporosis, pelvic pain, urinary tract infection, knee pain, hypothyroidism, hypertension.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 22. Information has been received from a health professional concerning an 80 year old white female with penicillin allergy and no illness at the time of vaccination who at 2:00 pm on 22-AUG-2005 was vaccinated intramuscularly with a second dose of pneumococcal 23v polysaccharide vaccine (lot 649912/0529P). On 22-AUG-2005, the patient called the office with complaint of a red arm, swollen, painful arm. The patient was unable to use affected arm for 2 days due to the pain. The patient was instructed to use co.Paient has the following illness history - Concurrent conditions: Penicillin allergy. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from an approx 60 to 65 yr old physician who on an unspecified date was vaccinated IM with a 0.5mL second dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the physician developed a local reaction and flu like symptoms. The physician sought unspecified medical attention, and subsequently recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 72 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 30. Information has been received from a health professional concerning a 72 yr old white female, with allergy to amoxicillin (diarrhea) and a history of immunization in 1999, who on 30Aug05 was vaccinated at 11:00AM IM in the left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 649912/0529P). On 30Aug05 4:00PM, the pt called the doctor's office and stated that she had welt at site, arm is painful from hand to shoulder, generalized weakness, and no nausea. Subsequently, on an unspecif.Paient has the following illness history - Immunization; diarrhea; penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 14. Information has been received from a female in her twenties or thirties who on 14Nov05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine. On an unspecified date, the pt had a reaction at the injection site. The area was raised, red, and painful. Subsequently, on an unspecified date, the pt recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a licensed practical nurse concerning an adult pt, with unk medical history and unk drug reactions/allergies, who in early Nov 2005, was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649694/0386P). In Nov 2005, the pt developed an injection site reaction to include redness, pain, local heat and swelling. The pt was treated with antibiotics and subsequently, fully recovered. No product quality complaint was involved. No additional informati.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a licensed practical nurse (LPN) concerning a 55 yr old male with diabetes and no known allergies who on approx 07Nov05 was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot651328/1046P). Concomitant therapy included diabetic medication (therapy unspecified). Subsequently, the pt developed red, hot, painful and grapefruit size areas at the injection site. Medical attention was sought. The pt was treated with compresses. The pt was reported as no.Paient has the following illness history - Diabetes.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning an adult female who on an unspecified date was vaccinated with the first 0.5mL dose of pneumococcal 23v polysaccharide vaccine. On approx 14Nov05, week of 14Nov05, the pt developed injection site redness, swelling and fever. The pt sought unspecified medical attention. At the time of this report, the pt had recovered from the events (date unk). Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 30. Information has been received from a RN concerning a 78 yr old female who on 30Nov05 was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot 650648/0967P), IM in the deltoid. On 30Nov05 the pt had a local reaction described as redness, pain and swelling. At the time of the report, the pt was considered to be not recovered. Unspecified medical attention was sought. The reporter would like a lot investigation for lot 650648/0967P). The records of testing prior to release of this lot.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 29. Information has been received from a RN concerning a 65 yr old male with diabetes, heart disease and reaction to tuberculin test who on 29Nov05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5ml) (lot650648/0957P), IM in the deltoid. On 30Nov05 the pt experienced a severe local reaction with redness, severe pain and massive swelling from the elbow to shoulder in arm where pneumococcal 23v polysaccharide vaccine was given. At the time of the report, the pt was considered to be not r.Paient has the following illness history - Diabetes; cardiac disorder; nonspecific reaction to tuberculin test..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered respiratory therapist concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient experienced an adverse event. The patient's outcome was unknown. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a healthcare professional concerning a 78-year-old retires white female patient with no known drug allergies, who on 07-NOV-2005 at 14;00 was vaccinated in the left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (Lot#650648-0967P). She was not ill at the time of vaccination. The patient called the physician's office the day after vaccination, on 08-NOV-2005 and reported that on 07-NOV-2005 at approximately 15:00 her left arm was red, swollen and ve.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a registered nurse a female patient who on approximately 01-NOV-2005 (three weeks ago) was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient experienced an injection site reaction. The patient's outcome was unknown. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2004, 01. Information has been received from a registered nurse concerning a female patient who on 01-DEC-2004 was vaccinated with a dose if pneumococcal 23v polysaccharide vaccine. Subsequently, the patient experienced an injection site reaction. The patient's outcome was unknown. Additional has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 03. Information has been received from a health professional concerning a physician who on approximately 03-NOV-2005 'within the last two weeks" was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot#649914/0578P). Within the last two weeks, the physician developed nausea, vomiting and diarrhea. Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 26. Initial and follow up information has been received from a licensed visiting nurse concerning a 78 year old retired white female with a general symptom, "Wygesic". On 26-SEP-2005, at 10:30 am, the patient was vaccinated intramuscularly into the right deltoid with the first dose of pneumococcal 23v polysaccharide vaccine (Lot#649979/0531P). On 26-SEP-2005, the patient developed injection site reaction. The patient was treated with a topical cream. On 26-SEP-2005, at 7:00 pm, the patient developed itching,.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a female patient greater than 65 years of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The patient was reported as generally healthy with "no major health problems". Subsequently, the patient developed injection site cellulitis which lasted at the most for 3 days. The patient recovered from the. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a female patient greater than 65 years of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. It was reported as generally healthy with "no major health problems". Subsequently, the patient experienced injection site cellulitis which lasted at the most for 3 days. The patient recovered from the inject. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a female patient greater than 65 years of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The patient was reported as generally healthy with "no major health problems". Subsequently, the patient experienced injection site cellulitis which lasted at the most for 3 days. The patient recovered from t. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a female patient greater than 65 years of age who was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine. It was reported that no other vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The patient was reported as generally healthy with "no major health problems". Subsequently, the patient experienced injection site cellulitis which lasted at the most for 3 days. The patient recovered from t. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a licensed practical nurse concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient developed cellulitis. Unspecified medical attention was sought. After several days, the patient recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 06. Information has been received from a nurse practitioner concerning a 64 year old male with a bupropion hydrochloride (WELLBUTRIN) allergy, who on 06-DEC-2005 was vaccinated subcutaneously into the left arm with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine (lot#649697/1038P). Within hours, the patient experienced an injection site reaction to include pain, redness, swelling and local heat all the way to the elbow. It was noted that to was hard for the patient to move his arm due to the pa.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a physician concerning a 71 year old male patient who on 25-OCT-2005 was vaccinated into right deltoid muscle with a dose of pneumococcal 23v polysaccharide vaccine (lot#650331/0749P). Concomitantly the patient was vaccinated into left deltoid muscle with a dose of influenza virus vaccine (unspecified). On 26-OCT-2005, the patient developed severe upper arm swelling, erythema and edema. The patient was reported as recovered. There was no product quality complaint invol. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a medical assistant concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient developed erythema, swelling, and pain of the upper forearm. Unspecified medical attention was sought. Subsequently the patient recovered. No product quality was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 30. Information has been received from a physician concerning a 75 year old male with hypertension, hypothyroidism, high cholesterol, no known allergies and a history of atrial fibrillation, who on 30-NOV-2005 was vaccinated intramuscularly into the right arm with a second 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot#651329/1047P). The patient's list of concomitant medications was not available. On 02-DEC-2005 the patient experienced rash at the injection site and on the legs and trunk. The do.Paient has the following illness history - Medical history: Atrial fibrillation, Concurrent conditions: hypertension, hypothyroidism, cholesterol high.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a health professional concerning a male in his mid 60's who on approximately 10-NOV-2005 was vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot651329/1047P). Subsequently, the patient developed fever, and erythema and edema at injection site. Subsequently, the patient recovered. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a health professional concerning a female in her mid 60's who on approximately 10-NOV-2005 was vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Subsequently, the patient experienced fever, erythema and edema at injection site. Subsequently, the patient recovered. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a health professional concerning a female in mid 60's who on approximately 10-NOV-2005 was vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Subsequently, the patient experienced fever, and erythema and edema at injection site. Subsequently, the patient recovered. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from health professional concerning a female in her mid 60's who on approximately 10-NOV-2005 was vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Subsequently, the patient experienced fever, and erythema and edema at injection site. Subsequently, the patient recovered. No further information is available.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 18. Pt come into health center 2 days after Pneumonia injection, c/o tenderness and redness right arm, evaluated by MD 7/20/06 who described erythema, swelling at distal aspect right upper arm with tenderness, erythema right axilla, MD no adenopathy. MD prescribed Medrol dose pack. Benadryl 25 mg TID x 7 days. cold compresses to right upper arm, Advil PRN, will be follow up in one week.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 63 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 09. Information has been received from a female nurse who on 09-NOV-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). The patient reported that on 09-NOV-2005 approximately four hours post injection she experienced injection site pain, itching, local swelling, and the site feeling "firm and felt thick". She reported that on a later unspecified date she developed a rash and open sores at the injection site. At the time of this report the patient was recovering from the event. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a medical assistant concerning a female (age not reported) who on 12/8/05 was vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). That same day the pt experienced a sore arm. At the time of this report it was unknown if the pt had recovered from the sore arm. Additional information has been requested.. Patient recovered.
 

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a NP concerning a 35 year old female who one week ago (on approx 12/5/05) was vaccinated IM with 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine. On approx 12/5/05 the pt experienced severe cellulitis. The NP reported that the pt is presently recovering. No product quality complaint was involved. Additional information is not expected..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 40 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a licensed practical nurse concerning a 40 year old female with multiple sclerosis who on 12/5/05 at 11:45am was vaccinated, IM into the left deltoid with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Concomitant therapy included interferon beta la Avonex. On 12/5/05 at 6:00pm, the pt developed a sore swollen left arm and a fever body temp of 100. The pt was treated with acetaminophen and codeine phosphate Tylenol with codeine 3. At the time o.Paient has the following illness history - Multiple sclerosis.Patient was receiving Avonex. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female pt with a history of hospitalization, who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. It was noted that the pt went home from the hospital, three weeks later when she was seen in the clinic she was vaccinated again IM with another 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Recently after the second vaccination, the pt experienced a skin reaction. Unspecified medical attention was sought. The pts outcome.Paient has the following illness history - Hospitalization.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed hugh large welts at the injection site. No medical attention was sought. The pts outcome was unknown. No product quality complaint was involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse concerning an elderly pt who was vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Subsequently, the pt developed a hugh rash and swelling at the injection site. Medical attention was sought. Subsequently, the pt recovered. The nurse requested that a lot check be preformed. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. I.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Initial and follow up information has been received from a registered nurse concerning a 46 year old female with allergies to corticosteroids Unspecified (steroids) who on 11/7/05 was vaccinated IM in the right deltoid muscle with Pneumococcal 23v polysaccharide vaccine, (lot 650541/1004P). On 11/8/05, reportedly at 2:04pm, the pt reported that she developed a large knot on area where she received the injection and she couldn't move her arm. The pt reported that she had to leave work and take pain medicatio. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient, 34 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 04. Information has been received from a RN concerning a 34 year old female with no medical history who on 11/4/05 was vaccinated IM in the left arm with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 650541/1004P). There was no illness at the time of vaccination. On 11/4/05 the pts left arm became red, swollen, hot to touch and tender. On 11/5/05 the pt developed a fever to 103. On 11/6/05 the pt developed shortness of breath and a dry, hacky cough. She denied nasal congestion or chest pain. No m. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a licensed Practical nurse concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed cellulitis. Unspecified medical attention was sought. After several days, the pt recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a licensed practical nurse concerning a pt who was vaccianted in a different office with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed cellulitis. Unspecified medical attention was sought. After several days, the pt recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 49 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a licensed practical nurse concerning a 49 year old female with an allergy to morphine and iodine. On 12/8/05, at 3:15pm, the pt was vaccinated IM in the left arm (also reported as the right arm) with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). The next day, on 12/9/05, the pt called to office complaining of a sore arm, nausea, and earache, chills and a fever. She called back a few days later and left a voice mail message stating that her ri.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse from a doctors office concerning a female of unknown age who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (date unknown). Subsequently, following vaccination the pt experienced swelling of her arm and face. Unspecified medical attention was sought. The nurse did not report any details but did say that the pt recovered. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 12. Information has been received from a health professional concerning an adult female with no reported previous medical history who on 12/12/05 at 11:00 am (also reported as 12/13/05, was vaccinated with a 0.5ml IM first dose in the deltoid area of Pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). On 12/13/05 th pt developed a red blotchy rash and there was itching at the injection site. There were no treatments for the conditions. The status of the pt was reported as unknown. Unspecified medical at.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 85 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 10. Information has been received from a health professional concerning an 85 year old female also reported as male with no relevant medical history or illness at time of vaccination who at 2:00pm on 10/10/2005 was vaccinated in the left deltoid with a second dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). AT 1:00 am on 10/11/05 the pt experienced dizziness. The dizziness progressed throughout the day on 10/11/05 to the point that the pt felt that she could not ambulate without assistance. T. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse concerning a elderly pt who was vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Subsequently, the pt developed a hugh rash and swelling at the injection site. The pt was seen in the ER and released. Subsequently, the pt recovered. The nurse requested that a lot check be performed. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was re.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant concerning a patient who in approximately December 2005, was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#649697/1038P). In approximately December 2005, the patient experienced a reaction that extended from his/her shoulder to his/her hand. It was noted to be extremely painful, and severe erythema was noted. The reporter indicated that the patient had a cellulitis-like reaction. The patient.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 14. Information has been received from a nurse from a physician's office concerning a woman in her 40's who on 14-DEC-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On 15-DEC-2005 the patient developed a local reaction characterized by a red, swollen arm. The patient developed a local reaction characterized by a red, swollen arm. The swelling was 3-4 inches in diameter around the injection site. Unspecified medical attention was sought and at that the time of the report the pati.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Sept 2005, 09. Information has been received from a licensed practical nurse concerning a 65-year-old female patient with an allergy to Penicillin, who on 09-SEP-2005 at 09:15 am, was vaccinated subcutaneously with a second dose of pneumococcal 23v polysaccharide vaccine (649694/0386P). It was noted that at the time of vaccination the patient had weight loss and abdominal pain. The licensed practical nurse reported that on 09-SEP-2005, the patient developed an injection site reaction which included redness, pain, local.Paient had abdominal pain, weight decreased.Paient has the following illness history - concurrent conditions: Penicillin allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NJ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a healthcare worker concerning a 71 year old female with a history of osteoporosis and no allergies, who on 30-NOV-2005 was vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (Lot#651318/1006P). Concomitant therapy included alendronate sodium (MSD), calcium (unspecified), vitamin D (unspecified), simvastin (MSD), and folic acid. On 01-DEC-2005 the patient's arm, at the injection site, became red, warm, painful, and swollen. She also h.Paient has the following illness history - Medical history: Osteoporosis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician's assistant concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot#650453/0791P). Subsequently the patient developed a fever, and injection site swelling, pain and redness. Unspecified medical attention was sought. Subsequently, the patient recovered. The reporter expressed a concern about the lot number. No product quality complaint was involved. The records of testing prior to release of this lot have been ch.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NJ, USA. Female patient, 71 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 18. Initial and follow up information was received from a physician and a registered nurse concerning a 71 year old retired white female with no known allergies, diabetes mellitus non-insulin dependent and a thyroid disorder who on 18-NOV-2005 was vaccinated intramuscularly with a 0.5 ml dose pneumococcal 23v polysaccharide vaccine (lot#651318/1006P). Concomitant therapy included levothyroxine Na fluoxetine, metformin, trazodone HCL, "dislosenant", gabapentin, atorvastatin calcium (LIPITOR) and "prophylthiurac.Paient has the following illness history - Concurrent conditions: diabetes mellitus non-insulin dependent, thyroid disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered technician concerning a pt who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot651330/1048P;exp: 4/26/07). Subsequently, the pt experienced red, hot sore arm at injection site within 48 hrs post vaccination. Treatment is unk. The registered tech had no other available information and placed a nurse practitioner on the phone. The nurse practitioner stated that she is not comfortable using this lot 1048P until a lot check is performed. The record.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 14. Information has been received from a physician concerning a 68 yr old (also reported as 86 yr old) female with no known allergies with sickle cell disease, asthma and arthritis who on 14Dec05 was vaccinated with pneumococcal 23v polysaccharide vaccine, .5ml. There was no concomitant medication. On 16Dec05 the pt experienced urticaria and rash. Unspecified medical attention was sought. The pt's urticaria and rash persisted. Additional information has been requested..Paient has the following illness history - Sickle cell disease; asthma; arthritis.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a 55 yr old male who on an unspecified date was vaccinated IM with pneumococcal 23v polysaccharide vaccine. It was unk if the pt received the vaccination in the leg. On an unspecified date, the pt developed a red, painful, local unspecified date, the pt developed a red, painful, local reaction after receiving pneumococcal 23v polysaccharide vaccine. The pt sought unspecified medical attention. It was reported that as a result of these reactio.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 23. Information has been received from a physician's office concerning a 46 yr old white male with a sulfonamide allergy, drug hypersensitivity to naproxen (Naprosyn) and doxycycline, gastrooesophageal reflux disease, chronic obstructive pulmonary disease and depression. On 23Oct05, in the AM, the pt was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine. At the time of vaccination, the pt was noted to have abdominal pain, nausea, vomiting and a small bowel obstruction. On 23Oct05, at 1:2.Paient had Abdominal pain; nausea; small intestinal obstruction; vomiting. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a male who is over 65 yrs old who was vaccinated with pneumococcal 23v polysaccharide vaccine IM several years ago. The physician reported that the pt was given two doses of pneumococcal 23v polysaccharide vaccine within a three year time frame. The pt experienced severe illness, fever and malaise. This occurred several years ago. Unspecified medical attention was sought. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 13. Information has been received from a health professional concerning a female who on 13Dec05 was vaccinated with a 0.5ml IM dose of pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). On 13Dec05 the pt developed a red blotchy rash and there was itching at the injection site. There were no treatments for the condition. The status of the pt was reported as unk. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient, 51 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a licensed practical nurse concerning a 51 yr old white male with no preexisting allergies, birth defects, or medical conditions reported. On 08Dec05, at 3:10 PM (also reported as 3:20PM), the pt was vaccinated IM in the right arm (also reported as left arm) with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). On 09Dec05, the pt complained of soreness of the right arm, but was not seen by the physician. The pt recovered on 12Dec05. A product qua. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a 60 yr old male with no known history or allergies who was vaccinated with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot650329/0747P). Subsequently, the pt experienced a large local site reaction. Unspecified medical attention was sought and the client has since recovered. There was no product quality complaint involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a patient (age not specified) who on unspecified date was vaccinated intramuscularly with pneumococcal 23v polysaccharide vaccine. It was unknown if the patient received the vaccination in the leg. On an unspecified date, the patient developed a "red, painful, local reaction after receiving pneumococcal 23v polysaccharide vaccine". The patient sought unspecified medical attention. It was reported that "as a result of those reactions the o.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 68 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a medical assistant concerning a 68 year old white female who on 25-OCT-2005 was vaccinated in the left deltoid with a second dose pneumococcal 23v polysaccharide vaccine, intramuscular (lot#"06072"). In the evening of 25-OCT-2005, the same day as the vaccination, the patient's arm was warm to the touch and red. The patient was instructed to apply ice and take Ibuprofen (ADVIL). The on 27-OCT-2005, it became worse and the patient went to the emergency room where she was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on July 2005, 05. Information has been received from a health professional concerning a 71 year old female with gastroesophageal reflux disease, an allergic to ciprofloxacin hydrochloride (CIPRO) and pneumococcal 23v polysaccharide vaccine and a history of mastectomy with reconstruction for cancer who on 05-JUL-2005 was vaccinated subcutaneously in the right deltoid with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot#649694/0386P). Concomitant therapy included alendronate sodium (FOSAMAX), rabeprazole sodium.Paient has the following illness history - Medical History: Mastectomy, surgery, breast cancer Concurrent conditions: Gastroesophageal reflux disease, allergic reaction to antibiotics, hypersensitivity.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient who was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (Lot#650087/0815P). Subsequently the patient developed a generalized rash. Subsequently, the patient recovered. There was no product complaint. It was noted that the reporter a lot check to be done on the lot. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot co. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a patient who was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (Lot3650087/0815P). On 14-OCT-2005 the patient developed severe itching and injection site pain, heat and puffiness. Unspecified medical attention was sought. She took aspirin for two days, and used ice packs. Subsequently, the patient recovered. No other information was available. There was no product quality complaint. The nurse request.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 14. Information has been received from a registered nurse concerning a female patient who on 14-OCT-2005 was vaccinated with at least a second dose of pneumococcal 23v polysaccharide vaccine (Lot#650087/0815P). After the vaccination with pneumococcal 23v polysaccharide vaccine, on approximately 14-OCT-2005, the patient experienced rash, hives, swelling of lips and swelling of eyes. She sought medical attention and was treated with Ibuprofen (ADVIL), diphenhydramine (BENADRYL), and Ibuprofen (MOTRIN). The pat.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse (RN) concerning a patient who was vaccinated with an IM dose of pneumococcal 23v polysaccharide vaccine (Lot # 650087/0815P). The RN reported that the patient subsequently experienced injection site soreness, low grade fever and chills. Unspecified medical attention was sought. Subsequently, the patient recovered from the injection site soreness, low grade fever and chills. The reported requested a lot check. The records of testing prior to release of th.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 14. Injection site pain; injection site erythema; injection site induration Information has been received from a registered nurse (RN) concerning a female who on 14-OCT-2005 was vaccinated with IM with a dose of pneumococcal 23v polysaccharide vaccine (lot #650087/0815P). The RN reported that on 14-OCT-2005 the patient developed injection site pain/throbbing, redness and hardness. Unspecified medical attention was sought. Subsequently the patient recovered from the injection site pain/throbbing, redness and har.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 22. Pain, Myalgia Information has been received from a health professional concerning her husband who on 22-DEC-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #651330/1048P). On 22-DEC-2005, the patient developed achy deep muscle soreness. Unspecified medical attention was sought and the patient was treated with acetaminophen (Tylenol) and ice. At the time of the report the patient had not recovered. A product quality complaint was no involved. Additional information has been re.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 22. Injection site pain Information has been received from a health professional concerning a female patient who on 22-DEC 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #651330/1048P). On 22-DEC-2005 the patient experienced an achy deep soreness in the injection arm. It was noted that this may have been her second vaccination with pneumococcal 23v polysaccharide vaccine. At the time of this report the patient had not recovered. Unspecified medical attention was sought. No produ.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered technician concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot#651330/1048P). Subsequently the patient experienced red, hot sore arm at injection site within 48 hours post vaccination. Treatment is unknown. The registered technician had no other available information and placed a nurse practitioner on the phone. The nurse practitioner stated that "she is not comfortable using this lot 1048P until a lot check is perform.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered technician concerning a patient who was vaccinated with pneumococcal 23v polysaccharide vaccine (lot#651330/1048P). Subsequently the patient experienced red, hot sore arm at injection site within 48 hours post vaccination. Treatment is unknown. The registered technician had no other available information and placed a nurse practitioner stated that "she is not comfortable using this lot 1048P until a lot check is performed". The records of testing prior to.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 15. Information has been received from a medical assistant concerning a female patient who on 15-DEC-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (LOT#651330/1048P). The reporter mentioned that it may have been the patient's second dose. On an unspecified date in December 2005, the patient developed joint soreness that felt like bursitis after vaccination. The patient sought medical attention and was treated with acteminophen (TYLENOL) and ice. The joint soreness did not improv.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NM, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse (RN) concerning an approximately 80 year old female with diabetes who in November 2005, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The RN reported that in November 2005, after vaccination, the patient's arm "swelled up like a softball". Unspecified medical attention was sought. Subsequently, the patient's arm swelling fully resolved. Additional information has been requested..Paient has the following illness history - Concurrent conditions: diabetes.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a certified medical assistant concerning a patient who in approximately December 2005 was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#649697/1038P). In approximately December 2005, the patient developed a local injection site reaction which was hot to the touch. Severe erythema was also noted. Subsequently, the patient recovered. The physician indicated he was concerned about this lot number. The records of testing prio.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 21. Information has been received from a license practical nurse concerning a 50-year-old white adult female with an allergy to codeine who on 21-NOV-2005 at 9:30 am was vaccinated subcutaneous with a 0.5 ml second dose of pneumococcal 23v polysaccharide vaccine (Lot#649694/0386P). The patient was noted to be suffering from anxiety and depression at the time of vaccination. On 21-NOV-2005, the patient developed an injection site reaction to include redness, pain, local heat and swelling, noted to be a celluli.Paient had anxiety: depression.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a medical assistant concerning a female patient who was vaccinated with a pneumococcal 23v polysaccharide vaccine (lot#651859/0877R). Subsequently, the patient experienced swelling at the site of injection, numbing of the lips, and itching eyes. No product quality compliant was involved. No other information was provided. The patient recovered. It was also reported that another patient had a similar reaction. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 09. Information has been received from a nurse via company representative concerning her 64 year old husband who in the middle of December ("2nd or 3rd Friday of December"), on approximately 09-DEC-2005 was vaccinated with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot# not provided). The night after receiving vaccination, on approximately 10-DEC-2005 the patient experienced chills, feeling of malaise and developed fever. The patient was given acetaminophen (TYLENOL) to take care of the symptoms.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician via company representative concerning a elderly female (age not provided) who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot# not provided). Subsequently the patient developed reaction (not further specified). The patient's outcome was not reported. There was no product quality complaint involved. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 04. Injection site pain; Injection site reaction; Injection site swelling Information has been received from a health professional concerning a 50 year old white female registered nurse with sarcoidosis who on 04-JAN-2006 at 09:30 was vaccinated SC into the right arm with a first dose of pneumococcal 23v polysaccharide vaccine (lot #651322/1044P). On 06-JAN-2006 at 08:30 the patient experienced tenderness, soreness, swelling at the injection site and a "ring" around the injection site )1-1 1/2 inches). Unspecif.Paient has the following illness history - Sarcoidosis..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Dyspnea; injection site erythema; injection site swelling; mass Information has been received from a 45 year old female with hypertension and borderline diabetes who in October 2004 was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy included pioglitazone hydrochloride )Actos) and "antihypertensive medications". The patient had previously been vaccinated with pneumococcal 23v polysaccharide vaccine between 4 and 8 years prior to October 2004. upon vaccination, the patient experi.Paient has the following illness history - Hypertension Borderline diabetes.Patient was receiving Actos.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 17. Erythema; Pain in extremity; Skin warm; Edema peripheral Information has been received from a health care professional and a 54 year old female white consumer with hypertension, hyperlipidemia, allergic rhinitis and no allergies who on 17-NOV-2005 at 1)30 PM was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot #650329/0747P). Concomitant therapy included HCTZ/triamterene and simvastatin (MSD). Subsequently on 17-NOV-2005 the patient's right arm was swollen ("size of baseball"),.Paient has the following illness history - hypertension hyperlipidemia rhinitis allergic.Patient was receiving hydrochlorothiazide Zocor.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Injection site swelling; pyrexia; injection site erythema; injection site pain Information has been received from a physician's assistant concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #650453/0791P). Subsequently the patient developed a fever and injection site swelling, pain and redness. Unspecified medical attention was sought. Subsequently the patient recovered. The reporter expressed a concern about the lot number. No product quality complaint was in.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Injection site swelling; Pyrexia; Injection site erythema; Injection site pain. Information has been received from a physician's assistant concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #650453/0791P). Subsequently the patient developed a fever and injection site swelling, pain and redness. Unspecified medical attention was sought. Subsequently, the patient recovered. The reporter expressed a concern about the lot number. No product quality complaint was.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physicians assistant concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine 650453/0791P. Subsequently the pt developed cellulitis with a fever, and injection site swelling, pain and redness. The pt went to the ER. Subsequently, the pt recovered. The reporter expressed a concern about the lot number. No product quality complaint was involved. The records of testing prior to release of this lot have been checked and found to be satisfact.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning an adult pt, with unknown medical history and drug reaction/allergies, who on an unspecified date was vaccinated IM in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Subsequently, on an unspecified date, the pt experienced cellulitis of left arm. Unspecified medical attention, treatment was sought. No product quality complaint was involved. The nurse is requesting a lot check. The records of t.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse, via a company representative, concerning a pt age and sex unknown, who on an unspecified date was vaccianted route unknown with a second dose of Pneumococcal 23v polysaccharide vaccine. The pt had previously received Pneumococcal 23v polysaccharide vaccine, but this history was unknown when the pt was given the second dose. Subsequently, on an unspecified date the pt experienced arm soreness. Unspecified medical attention was sought. The pts outcome was.Paient has the following illness history - Immunisation.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician and a medical assistant concerning a pt who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed erythema, swelling and pain of the upper forearm. Unspecified medical attention was sought. Subsequently the pt recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning an adult pt, with unknown medical history and drug reactions/allergies, who on an unspecified date was vaccinated IM in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Subsequently, on an unspecified date, the pt experienced cellulitis of left arm. Unspecified medical attention/treatment was sought. No product quality complaint was involved. The nurse is requesting a lot check. The records of t.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CO, USA. Female patient, 56 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Information has been received from a certified medical assistant concerning a 57 year old white female smoker with chronic obstructive pulmonary disease and a history of upper respiratory tract infection who on 10-JAN-2006 was vaccinated intramuscularly in the left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 650648/0967P). Concomitant therapy include albuterol MDI, tiotropium bromide (SPIRIVA), and PREDNISONE taper finished 08-JAN-2006. At the time if vaccination, the patien.Paient had respiratory disorder.Paient has the following illness history - Medical History: Upper Respiratory Tract Infection, Concurrent Conditions: Chronic Obstructive Pulmonary Disease, smoker.Patient was receiving ALBUTEROL, PREDNISONE, SPIRIVA.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient developed an allergic like reaction post vaccination. The reaction included a swollen, large red area about six inches in diameter around the injection site. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 12. Information has been received from a healthcare worker, and a company representative concerning her 68 year old husband, with no allergies with diabetes, hyperlipidemia, gastroesophageal reflux disease and cardiovascular disorder, who on 12-JAN-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot#551330/1048P) (0.5 ml), intramuscularly. Concomitant therapy included amlodipine besylate (NORVASC), fluvastatin sodium (LESCOL), hydrochlorothiazide (manufacturer unknown), ramipril (AL.Paient has the following illness history - Concurrent conditions: diabetes, Hyperlipidemia, Gastroesophageal reflux disease, Cardiovascular disorder.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 27. Information has been received from a registered nurse concerning a female (age unknown), with unknown medical history and unknown drug reactions/allergies reported, who on 27-DEC-2005 was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (650457/0937P). On 27-DEC-2005 the patient experienced a sore achy arm which was red and hot to touch with swelling to the elbow. Subsequently, on "about" 30-DEC-2005, the symptoms resolved and the patient recovered. Unspecified med.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. Information has been received from a registered nurse concerning a female with drug hypersensitivity to "some antibiotics" who on 10-JAN-2006 was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (lot#650457/0973P). On 10-JAN-2006 the patient experienced a sore and achy arm that was hot to touch and with swelling halfway down the arm. Unspecified medical attention was sought. On approximately 13-JAN-2006, the patient recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female who was vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently the patient's arm hurt so much she could not sleep. The patient went to the emergency room was given medicine, and sent home. The patient recovered. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 46 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 13. Initial and follow-up information has been received from a healthcare worker and a physician concerning a 46 year old male software developer with diabetes and high blood pressure who on 13-JAN-2006 was vaccinated intramuscularly (previously reported as subcutaneous), into the right arm, with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine (lot#651321/1036P). Concomitant therapy included metformin HCL (GLUCOPHAGE), olmesartan medoxomil (BENICAR), rosiglitazone maleate (AVANDIA) and rosuvasti.Paient has the following illness history - Concurrent conditions: diabetes, blood pressure high.Patient was receiving GLUCOPHAGE, BENICAR, AVANDIA, CRESTOR. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a registered nurse concerning a male who in January 2006, was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine. In January 2006, after the vaccination, the patient developed a swollen arm and difficulty breathing. The patient was treated with unspecified antibiotics and diphenhydramine hydrochloride (BENADRYL). At the time of this report, the patient was recovering. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. Information has been received from a healthcare worker concerning a 56 year old female with a penicillin allergy and allergy to ticlopidine hydrochloride (TICLID) who on 28-DEC-2005 was vaccinated subcutaneously with a first 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#650329/0747P). Concomitant therapy included levothyroxine Na (SYNTHROID) and estrogens, conjugated (PREMARIN). The healthcare worker reported that on 30-DEC-2005 the patient's "arm was red and swollen" and there were "there.Patient was receiving PREMARIN, SYNTHROID.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 81 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial and follow up information has been received from a registered nurse concerning a 81 year old (also reported as "71" years old) white male retired pharmacist, with an allergy to celecoxib (CELEBREX), who on 26-OCT-2005 (also reported as 26-OCT-2005), was vaccinated intramuscularly at 2:20 pm in the left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (Lot#unknown). It was reported that the patient was vaccinated in 1999 with a dose of pneumococcal 23v polysaccharide vaccine. O.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 80 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 17. Initial and follow up information has been received from a registered nurse concerning an 80 year old retired female patient, with multiple drug allergies (codeine ("codine"), quinine, cyclobenzaprine hydrochloride (FLEXERIL), acetaminophen (+) hydrocodone bitartrate (Lortab), celecoxib ("CELEBRAN" CELEBRA), and acetaminophen (+) propoxyphene napsylate (DARVOCEY-N), who at 11:20 am on 17-JAN-2006 was vaccinated intramuscularly in the left deltoid with a dose of pneumococcal 23v polysaccharide vaccine (Lot#.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 77 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 10. Initial and follow up information has been received from a registered nurse concerning 78 year old (also reported as 80) retired female patient, with an unknown medical history and unknown drug reactions/allergies, who on 10-OCT-2005 at 11:30 AM was vaccinated intramuscularly in the right deltoid with a dose of pneumococcal 23v polysaccharide (Lot# 649989/0579P). On 10-OCT-2005, the patient developed a severe local cellulitis-like reaction. Follow up information indicated that on the evening of 10-OCT-2005,.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from PA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 10. Initial and follow up information has been received from a nurse practitioner who initially reported that "over the years" several patients were vaccinated (route unknown) with pneumococcal 23v polysaccharide vaccine (Lot #'s unknown) and subsequently experienced local abscesses. Follow up information from the nurse practitioner indicated that there was only one patient who developed a local abscess following vaccination with pneumococcal 23v polysaccharide vaccine in her office. The nurse practitioner clar.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a female patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the patient experienced pain and swelling with erythema on the injection arm which lasted for a couple of days. Medical attention was not sought. There was no product quality complaint involved. No further information is expected.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from KS, USA. Female patient, 78 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 21. Information has been received from a registered nurse (R.N.) concerning a 78 year old female with no past medical history , who on 21-NOV-2005 at 14:0 PM was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot# 650330/0748P). There was no concomitant medication. On the morning of 22-NOV-2005, the patient developed swelling of her arm to her wrist and complained of numbness. It was reported that the patient recovered. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). A company representative reported that on an unspecified date a pt (NOS) was vaccinated with pneumococcal 23v polysaccharide vaccine (lot not provided). The pt developed cellulitis and was treated with an unspecified anti inflammatory medication. Subsequently, the pt recovered from the cellulitis. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received via a company rep from a physician concerning a male pt who on an unspecified date was revaccinated (after 5 yrs) with pneumococcal 23v polysaccharide vaccine (lot not provided). Subsequently, the pt developed an unspecified injection site reaction. The pt recovered from the injection site reaction without any intervention. Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a nurse concerning a pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed an allergic like reaction post vaccination. The reaction included a swollen, large red area about 6 inches in diameter around the injection site. The pt sought unspecified medical attention. At the time of this report, the outcome was unk. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 23. Initial and follow up information has been received from a physician concerning a 39 to 40 yr old female, with unk medical history or drug reaction/allergies reported, who on 23Jan06 was vaccinated (route unk) with a dose of pneumococcal 23v polysaccharide vaccine (lot unk). There was no concomitant medication. On 24Jan06 the pt developed redness and swelling of the injected arm, pain, fever of 102, and shaking chills. On 25Jan06 the physician saw the pt and sent her to the ER. It was noted that the pt had.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient, 75 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a physician concerning a white, 75 yr old, retired female, whose reported weight was 131 pounds with allergies to penicillin, naproxen sodium (Aleve) and Neosporin who on 01Nov05 was vaccinated SC with a 0.5cc dose of pneumococcal 23v polysaccharide vaccine (lot 650082/0691P). The physician reported that this was the pt's 3rd vaccination of pneumococcal 23v polysaccharide vaccine following an every 5 yr pattern. The pt was seen by the physician on 23Jan06. The pt reported. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a health professional concerning a female pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). Subsequently, the pt experienced swelling at the site of injection, numbing of the lips, and itching eyes. No product quality complaint was involved. No other information was provided. The pt recovered. It was also reported that another pt had a similar reaction (WAES0512USA04076). Additional information has been requested.. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MI, USA. Female patient, 65 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 12. Initial and follow up information has been received from a 65 yr old white female registered nurse with asthma, hypertension, sulfonamide allergy, atropine and epinephrine drug hypersensitivity, who on 12Dec05 (previously reported as 22Dec05) was vaccinated (route unk) in her right upper arm with a first dose of pneumococcal 23v polysaccharide vaccine (lot unk). Concomitant therapy included Lisinopril (manf unk), hydrochlorothiazide (manf unk), fluticasone propionate (+) salmeterol xinafoate (Advair), albut.Patient was receiving Albuterol, Albuterol sulfate, Advair, hydrochlorothiazide, Lisinopril. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient, 50 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 26. Information has been received from a registered nurse concerning a 50 year old female with HIV disease, hypertension, shellfish allergy and sulfonamide allergy who on 26-JAN-2006 was vaccinated (route unknown) with a first dose of pneumococcal 23v polysaccharide vaccine. There was no concomitant medication. On 27-JAN-2006 the patient developed swelling at the injection site, a red 1.25 inch area, tenderness, firmness, and induration after vaccination with pneumococcal 23v polysaccharide vaccine. The patient.Paient has the following illness history - HIV Disease; Hypertension; Shellfish Allergy; Sulfonamide Allergy.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 31. Information has been received from a physician concerning a female patient who on 31-JAN-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot# 650302/1039P). On 31-JAN-2006, the patient experienced a swollen arm "twice the size" and was warm to the touch. Unspecified medical attention was sought. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested..Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician, via a company representative, concerning a patient who on an unspecified date was vaccinated (route unknown) with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 649697/1038P). "Within the last 2 months", the patient developed "redness and swelling of the arm where the injection was given". Subsequently, on an unspecified date, the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional inform.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 13. Initial and follow up information has been received from a physician concerning an approximately 59 year old white male retired pharmaceutical executive with an allergy to Penicillin who on 13-OCT-2005 was vaccinated in the right deltoid with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide vaccine (Lot#650453/0791P). Concomitant therapy included glyburide, atorvastatin calcium (LIPITOR), lisinopril (ZESTRIL), hydrochlorothiazide (manufacturer unknown), levothyroxine Na (SYNTHROID) and Allopu.Paient has the following illness history - Concurrent conditions: Penicillin allergy.Patient was receiving Allopurinol, LIPITOR, Glyburide, HYDRODIURIL, SYNTHROID, ZESTRIL.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from AL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 02. Initial and follow up information has been received from a physician concerning his wife, a 67 year old white female, with no pertinent medical history and no history and no drug reactions/allergies reported, who on 02-FEB-2006 at approximately 9:30 am was vaccinated (route unknown) with another 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot# unknown). Concomitant therapy included paroxetine HCL (PAXIL), and levothyroxine sodium (SYNTHROID). Within a few hours of vaccination, on 02-FEB-2006.Paient has the following illness history - Medical History: immunization.Patient was receiving SYNTHROID, PAXIL.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician, via a company representative, concerning a patient who, on unspecified date, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot# not reported). On an unspecified date, ("not recently") the patient developed arm swelling around the injection site. The patient sought unspecified medical attention. Outcome was not reported. There was no product quality complaint involved. Attempts are being made to obtain additional identifying inform.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 02. Information has been received from a registered nurse concerning an adult patient who on 02-NOV-2005 was vaccinated with pneumococcal 23v polysaccharide (0.5 ml) (subcutaneous) (Lot#649912/0529P). On 02-NOV-2005 the patient experienced injection site soreness, warmth, erythema, swelling and general malaise. The patient was considered to be recovering. Unspecified medical attention was sought. Attempts are being made to obtain additional information to distinguish the individual patients mentioned in thi.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 25. Initial and follow up information had been received from a registered nurse and another healthcare professional at the doctors office, respectively concerning a 79 year old white female patient, with allergies to amlodipine besylate (NORVASC), atropine sulfate (+) diphenoxylate hydrochloride (LOMOTIL), acebutolol hydrochloride (SECTRAL), verapamil hydrochloride (CALAN), alendronate sodium (MSD), and metoprolol tartrate (LOPRESSOR), who on the morning of 25-JAN-2006 was vaccinated intramuscularly in the left.Paient has the following illness history - Concurrent conditions: multiple allergies. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from TX, USA. Female patient, 86 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 31. Initial (via a company rep) and follow up information has been received from a RN concerning a retired 85 yr old white female, with a penicillin allergy, an allergy to alendronate sodium, codeine, aspirin and chlorpheniramine maleate (+) phenylpropanolamine hydrochloride (Ornade), and a history of immunization and vaccination adverse reaction, who at 11:30am on 31Jan06 was vaccinated IM in the right arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). There was no illness at the ti.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from VA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 06. Initial and follow up information has been received from a licensed practical nurse concerning a 60 yr old white female restauranteer who on 06Feb06, at 9:00AM was vaccinated IM, into the right deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot651322/1044P). On 06Feb06, in the evening, it was noted that her arm was red, hot, swollen and hard from the injection site to elbow and halfway around her arm. The pt was able to use arm but hurt. Medical attention was sought and the pt was adv.Patient was taken to emergency room. Patient recovered.

PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Information has been received from a physician concerning a female with a history of unspecified hypersensitivity reactions who was recently vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed severe allergic reaction and rash. Medical attention was sought and the pt was treated with 2 courses of unspecified therapies. The pt's outcome was unk. Additional information has been requested..Paient has the following illness history - Hypersensitivity reaction.Patient was taken to emergency room. Patient recovered.
 

http://patientville.com/vaccine/pneumo31_side_effects.htm